Miserlou · February 22, 2018 22:04
diff --git a/array_express_sample_attributes.txt b/array_express_sample_attributes.txt
 Organism: 24155
 organism: 23820
 organism part: 14299
 cell type: 10462
 genotype: 8876
 age: 7687
 strain: 7215
 cell line: 6882
 sex: 5244
 developmental stage: 3943
 strain or line: 3070
 OrganismPart: 2854
 Sex: 2834
 tissue: 2569
 BioSourceType: 2187
 DevelopmentalStage: 2060
 provider: 2017
 Genotype: 2013
 Age: 1949
 StrainOrLine: 1871
 disease: 1752
 BioSourceProvider: 1375
 sample type: 1209
 disease state: 1196
 DiseaseState: 1150
 phenotype: 1105
 ecotype: 1081
 variation: 1067
 CellLine: 1006
 individual: 996
 gender: 971
 GeneticModification: 890
 treatment: 843
 growth condition: 822
 CellType: 821
 cultivar: 820
 Individual: 780
 specimen with known storage state: 755
 genetic background: 687
 TargetedCellType: 577
 TimeUnit: 575
 genotype/variation: 572
 strain background: 556
 chip antibody: 549
 Ecotype: 544
 genetic modification: 537
 infection: 517
 time: 484
 InitialTimePoint: 429
 Stage: 406
 antibody: 381
 tissue type: 374
 treated with: 367
 transfection: 365
 protocol: 359
 strain/background: 350
 replicate: 329
 breed: 326
 condition: 318
 background strain: 300
 passage: 299
 reference: 287
 clinical information: 278
 Organi: 266
 growth phase: 264
 agent: 262
 disease status: 239
 biosource type: 215
 group: 206
 diagnosis: 190
 stress: 169
 Strain: 169
 Phenotype: 165
 Tissue: 164
 IndividualGeneticCharacteristics: 161
 ClinicalInformation: 158
 time point: 153
 initial time point: 152
 histology: 152
 passages: 150
 development stage: 148
 treatment duration: 144
 clinical history: 144
 batch: 144
 stimulus: 143
 patient: 142
 biological replicate: 138
 tumor stage: 134
 treatment group: 134
 subject: 134
 sample description: 134
 line: 134
 transfected with: 131
 infect: 131
 medium: 129
 sample: 128
 molecule subtype: 125
 source: 123
 origin: 122
 sirna: 119
 ethnicity: 119
 ClinicalHistory: 113
 race: 112
 growth protocol: 110
 donor: 110
 diet: 110
 treatment time: 105
 culture condition: 105
 Gender: 105
 tissue source: 104
 transduction: 98
 background: 97
 fraction: 95
 compound: 95
 disease staging: 93
 cell: 91
 chip antibody vendor: 90
 Channel: 86
 status: 85
 sample group: 85
 infected with: 85
 dose: 85
 cell population: 84
 type: 83
 grade: 83
 RNA interference: 82
 population: 81
 knockdown: 81
 DiseaseStaging: 80
 shRNA: 79
 patient id: 79
 transgene: 78
 sampling time point: 78
 media: 78
 variety: 77
 biosource provider: 77
 tissue origin: 75
 OrganismPa: 75
 tumor type: 74
 organ: 74
 growth medium: 74
 weight: 73
 clone: 73
 antibody vendor: 73
 sample id: 72
 stage: 70
 sampling site: 70
 sampling time: 68
 growth stage: 68
 cell subtype: 68
 location: 66
 exposed to: 65
 culture: 65
 subject id: 64
 age years: 64
 treatment protocol: 63
 genome/variation: 62
 stimulation: 60
 harvest date: 60
 host: 59
 cells: 58
 Treatment: 58
 environmental history: 56
 GrowthCondition: 56
 accession: 54
 growth: 53
 expression: 53
 carbon source: 53
 subject status: 52
 morphology: 52
 bmi: 52
 vector: 51
 tumor: 50
 subtype: 49
 plant cell 2001): 49
 isolate: 49
 infection status: 49
 culture type: 49
 age yrs: 49
 vehicle: 48
 progenitor cell type: 48
 organism_part: 48
 concentration: 48
 brain region: 48
 Compound: 48
 ip antibody: 47
 generation: 47
 antibody catalog number: 47
 virus: 46
 smoking status: 46
 separation method: 46
 growth media: 46
 experiment: 46
 rip antibody: 45
 karyotype: 45
 chip antibody manufacturer: 45
 barcode: 45
 Disease State: 45
 timepoint: 44
 source tissue: 44
 animal id: 44
 tumor grade: 43
 route: 43
 phenotype markers: 43
 individual identifier: 43
 ethnic group: 43
 age at diagnosis: 43
 phase: 42
 patient identifier: 42
 injected with: 42
 growth conditions: 42
 chip antibody cat. #: 42
 antibody manufacturer: 42
 tumor grading: 41
 stimulated with: 41
 differentiation: 41
 cell source: 40
 transduced with: 39
 exposure: 39
 temperature: 38
 tag: 38
 strain_or_line: 38
 state: 38
 er: 38
 day: 38
 Time: 38
 mutation: 37
 Organism Part: 37
 Cultivar: 37
 vendor: 36
 EnvironmentalHistory: 36
 mouse strain: 35
 xenograft: 34
 site: 34
 ploidy: 34
 Histology: 34
 technical replicate: 33
 immunoprecipitate: 33
 block: 33
 rin number: 31
 environmental stress: 31
 Observation: 31
 Dose: 31
 rna source: 30
 rin: 30
 response: 30
 culture medium: 30
 culture conditions: 30
 OrganismStatus: 30
 plasmid: 29
 ph: 29
 overexpression: 29
 her2: 29
 er status: 29
 cell line background: 29
 ClinicalTreatment: 29
 pathology: 28
 exclusion markers: 28
 animal: 28
 TumorGrading: 28
 SamplingTimePoint: 28
 RNAi: 28
 tissue subtype: 27
 theiler stage: 27
 sample_description: 27
 passage number: 27
 exposure time: 27
 differentiation stage: 27
 culture time: 27
 tumor location: 26
 treatment dosage: 26
 rna subtype: 26
 rna fraction: 26
 donor id: 26
 date: 26
 biopsy site: 26
 serotype: 25
 estrogen receptor status: 25
 cell origin: 25
 cell line source: 25
 Cell Type: 25
 outcome: 24
 histological subtype: 24
 gestational age: 24
 biological_replicate: 24
 Cell type: 24
 organism status: 23
 disease stage: 23
 class: 23
 cell fraction: 23
 hybridization date: 22
 host strain: 22
 her2 status: 22
 drug treatment: 22
 cohort: 22
 clinical treatment: 22
 SmokingRegimen: 22
 tumor size: 21
 target: 21
 species: 21
 region: 21
 mouse: 21
 model: 21
 growth time: 21
 cell passage: 21
 time h: 20
 time after treatment: 20
 smoking: 20
 pool size: 20
 number: 20
 metastasis: 20
 gleason score: 20
 germplasm: 20
 Cell line: 20
 tissues: 19
 surgery: 19
 subspecies: 19
 reference composition: 19
 patient number: 19
 mouse id: 19
 molecule: 19
 injury: 19
 drug: 19
 chip antibody catalog #: 19
 age y: 19
 age weeks: 19
 age (years): 19
 strain/genotype: 18
 stain: 18
 rna: 18
 pr: 18
 modification: 18
 harvest time: 18
 growth temperature: 18
 duration: 18
 differentiation status: 18
 construct: 18
 chip antibody lot #: 18
 cell markers: 18
 antibody catalog #: 18
 tissue/cell type: 17
 strain name: 17
 source prep description: 17
 single cell well quality: 17
 recurrence: 17
 mating type: 17
 individual id: 17
 id: 17
 ecotype background: 17
 cell phenotype: 17
 cell line origin: 17
 cell description: 17
 cell cycle phase: 17
 breed cattle: 17
 activation: 17
 Ethnicity: 17
 DailyExposureDuration: 17
 year: 16
 tumor status: 16
 tissue of origin: 16
 sample time: 16
 rna extraction date: 16
 replicate number: 16
 od: 16
 markers: 16
 litter: 16
 inbred line: 16
 housing condition: 16
 differentiation state: 16
 cell-type: 16
 cell culture: 16
 antibody lot number: 16
 transfectant: 15
 tissue region: 15
 time hours: 15
 t stage: 15
 source cell type: 15
 size: 15
 run: 15
 rna type: 15
 parental cell line: 15
 other: 15
 od600: 15
 induction: 15
 incubated with: 15
 embryonic day: 15
 diet group: 15
 developmental landmark: 15
 development: 15
 dev.stage boyes et al. plant cell 2001: 15
 clip antibody: 15
 cell lines: 15
 caste: 15
 body mass index: 15
 array: 15
 ID: 15
 CellTy: 15
 treatment type: 14
 tissus: 14
 time of embryo collection: 14
 test: 14
 synonym: 14
 supplier: 14
 strains: 14
 somite count: 14
 sirna transfection: 14
 method: 14
 library type: 14
 incubation time: 14
 genetic variation: 14
 extract: 14
 disease type: 14
 control: 14
 cell state: 14
 cell sex: 14
 cell line type: 14
 body weight: 14
 biorep: 14
 amplification technique: 14
 age group: 14
 age at surgery: 14
 Sample: 14
 Line: 14
 Invivovitro: 14
 ExposureType: 14
 ExposureDuration: 14
 ChromosomalAberrationClassification: 14
 transgenic line: 13
 tissue compartment: 13
 time-point: 13
 subgroup: 13
 sampling date: 13
 sample identifier: 13
 readtype: 13
 mouse model: 13
 lineage: 13
 laboratory: 13
 lab: 13
 family: 13
 environment: 13
 embryonic stage: 13
 description: 13
 datatype description: 13
 datatype: 13
 culture media: 13
 collection time: 13
 collection site: 13
 cell subpopulation: 13
 cell family: 13
 animal number: 13
 Test: 13
 TargetedCellTy: 13
 Smoking status: 13
 Nutrients: 13
 Generation: 13
 Cell Line: 13
 Breed: 13
 ABRC seed stock id: 13
 virus strain: 12
 vaccine: 12
 time post-treatment: 12
 time post-infection: 12
 substrate: 12
 specimen: 12
 sampleID: 12
 sample source: 12
 sample name: 12
 rna integrity number: 12
 readtype description: 12
 read length: 12
 pool: 12
 material: 12
 localization: 12
 life span: 12
 isolation: 12
 infection time: 12
 immunophenotype: 12
 harvest time point: 12
 death: 12
 culture temperature: 12
 composition: 12
 clinical stage: 12
 cell property: 12
 cell cycle stage: 12
 amount: 12
 age months: 12
 Source: 12
 ExternalSampleId: 12
 Ethnic group: 12
 Disease state: 12
 AGE: 12
 who grade: 11
 tnm stage: 11
 time course: 11
 t: 11
 survival: 11
 strategy: 11
 scan date: 11
 sample origin: 11
 response to treatment: 11
 plant age: 11
 patient group: 11
 pathogen: 11
 pair: 11
 pack years: 11
 number per pool: 11
 marker: 11
 ip antibody vendor: 11
 intervention: 11
 immunoprecipitated protein: 11
 identifier: 11
 hba1c: 11
 germplasm name: 11
 feeding: 11
 exposure duration: 11
 electron acceptor: 11
 develomental stage: 11
 cultured with: 11
 colony: 11
 classification: 11
 cellular component: 11
 cell stage: 11
 cell organism: 11
 bacteria: 11
 background mouse strain: 11
 age in years: 11
 TestResult: 11
 Replicate: 11
 NASC:Growth Stage: 11
 Medium: 11
 Host: 11
 Growth condition: 11
 DiseaseStage: 11
 DiseaseLocation: 11
 weight kg: 10
 virus infection: 10
 variant: 10
 tumor site: 10
 time post exposure: 10
 survival status: 10
 storage: 10
 stock: 10
 stimulated: 10
 smoker: 10
 rip antibody vendor: 10
 recipient strain: 10
 pt: 10
 pregnancy: 10
 pn: 10
 original diagnosis: 10
 n: 10
 library: 10
 lentivirus: 10
 labexpid: 10
 inoculation: 10
 infectious agent: 10
 infection code: 10
 hybrid: 10
 hpv status: 10
 host organism: 10
 histological grade: 10
 health status: 10
 feed condition: 10
 experimental group: 10
 event: 10
 disease_state: 10
 developmental stage boyes et al. plant cell 2001: 10
 developemental stage: 10
 days: 10
 day of differentiation: 10
 data processing: 10
 collection date: 10
 chemical: 10
 cell_type: 10
 cell-line: 10
 case: 10
 cancer status: 10
 antibody lot#: 10
 age at death: 10
 WeeklyExposureFrequency: 10
 Smoking Status: 10
 SEX: 10
 ProductCategory: 10
 used for prognostic prediction: 9
 treatment status: 9
 tnm: 9
 time of sample collection: 9
 survival time: 9
 subpopulation: 9
 strain description: 9
 specimen of known storage state: 9
 sorting markers: 9
 sample_description 2: 9
 sample_description 1: 9
 sample collection time post infection: 9
 sample collection time: 9
 sample collection: 9
 relapse: 9
 randomization rank: 9
 purification: 9
 pr status: 9
 patientid: 9
 patient status: 9
 patient age: 9
 parasite strain: 9
 metastatic site: 9
 medip antibody: 9
 lab description: 9
 isolation source: 9
 inoculated with: 9
 genotype variation: 9
 g: 9
 embryo stage: 9
 egfr mutation: 9
 edss at baseline: 9
 dpi: 9
 dosage: 9
 developmental state: 9
 department of genetic medicine id: 9
 days of differentiation: 9
 dataset: 9
 culture age: 9
 conditions: 9
 common reference: 9
 comment: 9
 clinical status: 9
 chip antibody catalog#: 9
 celltype: 9
 cell surface markers: 9
 cell subset: 9
 cell lineage: 9
 biological rep: 9
 array type: 9
 antibody source: 9
 antibody lot #: 9
 amplification: 9
 TestSubstance: 9
 Target: 9
 Status: 9
 RNA: 9
 ProductBrand: 9
 Media: 9
 GeographicLocation: 9
 Genoty: 9
 CancerSite: 9
 vital status: 8
 treatment period: 8
 treament: 8
 transducer: 8
 tranduced with: 8
 tissue status: 8
 time period: 8
 time of day: 8
 time in development: 8
 temp: 8
 technical_replicate: 8
 survival months: 8
 substrain: 8
 subject group: 8
 study phase: 8
 study group: 8
 source type: 8
 source cell line: 8
 sorted fraction: 8
 smoke run: 8
 sample_type: 8
 sample_id: 8
 rip antibody cat. #: 8
 ratio: 8
 pretreated with: 8
 post expose duration: 8
 plate: 8
 parity: 8
 oxygen level: 8
 nicotine concentration mean: 8
 n stage: 8
 mycn status: 8
 mutant: 8
 molecular subgroup: 8
 life stage: 8
 life cycle stage: 8
 library strategy: 8
 lgr5 expression level: 8
 labversion: 8
 irradiation: 8
 incubation time hours: 8
 in vitro production: 8
 hybridization: 8
 hormone treatment: 8
 growth type: 8
 growth rate: 8
 grading: 8
 gfp: 8
 geographical location: 8
 genetic line: 8
 follicular size: 8
 figo stage: 8
 family relationship: 8
 experiment type: 8
 electron donor type: 8
 electron donor: 8
 effect concentration: 8
 duration of treatment: 8
 disease model: 8
 differentiation day: 8
 date of exposure: 8
 cytogenetics: 8
 cultured in: 8
 cultured: 8
 copd status: 8
 clone id: 8
 clinical data: 8
 cimp: 8
 chip-antibody: 8
 chip antibody catalog number: 8
 chemotherapy: 8
 cell surface marker: 8
 cell line description: 8
 cage: 8
 body part: 8
 biotype: 8
 animal age: 8
 allergen: 8
 age (yrs): 8
 TotalExposureDuration: 8
 Ploidy: 8
 NASC:StockCode: 8
 Donor Id: 8
 Developmental stage: 8
 DailyExposureFrequency: 8
 Cause of death: 8
 Behavior: 8
 units of amount: 7
 tumor size cm: 7
 tumor cell line: 7
 treatments: 7
 treatment description: 7
 translocation: 7
 transformed with: 7
 tissue-type: 7
 tissue or cell type: 7
 time of treatment: 7
 time (h): 7
 stressor: 7
 stress treatment: 7
 slide batch: 7
 sirna treatment: 7
 severity: 7
 set: 7
 selection: 7
 sample_description 3: 7
 sacrifice method: 7
 rnaextract: 7
 rep: 7
 reference type: 7
 prototype: 7
 progesterone receptor status: 7
 primary cells: 7
 pre-treatment: 7
 plant cell 2001: 7
 p53: 7
 oxygen concentration: 7
 ontogenetic stage: 7
 od280: 7
 od260: 7
 mouse_id: 7
 molecule type: 7
 moi: 7
 material supplier: 7
 lane: 7
 l: 7
 kras mutation: 7
 isolation method: 7
 inoculum: 7
 injection: 7
 infection duration: 7
 in vivo or in vitro: 7
 illness: 7
 hybridization batch: 7
 hours: 7
 histotype: 7
 histologic type: 7
 growth sugar: 7
 gestation diet: 7
 gene reported: 7
 g): 7
 fuhrman grade: 7
 flow cytometric cell sorting: 7
 enrichment: 7
 egfr: 7
 ecotype/background: 7
 donorid: 7
 develpmental stage: 7
 developmental stages: 7
 derivation: 7
 days in vitro: 7
 cytokine: 7
 crosslinking: 7
 cross: 7
 co-culture: 7
 chromosomal aberration: 7
 chip-seq antibody: 7
 challenge: 7
 cell treatment: 7
 cell line reference: 7
 cell count: 7
 catalog number: 7
 catalog #: 7
 case id: 7
 cancer type: 7
 cancer subtype: 7
 blood pressure: 7
 biomaterial provider: 7
 bacterial cells: 7
 amount to core: 7
 age days: 7
 age (y): 7
 TargetOrgan: 7
 StrainOrLi: 7
 SmokeConcentration: 7
 Population: 7
 Plant Cell 2001): 7
 Other: 7
 MaterialTy: 7
 Light: 7
 Infect: 7
 Individual Identifier: 7
 Genetic background: 7
 Disease: 7
 Development stage: 7
 CigaretteProductCategory: 7
 CigaretteBrand: 7
 BMI: 7
 xenograft host: 6
 well information: 6
 well: 6
 vaccination: 6
 units of age: 6
 tumor subtype: 6
 tumor histology: 6
 trt: 6
 treatment_duration: 6
 treatment-time: 6
 treatment dose: 6
 transgenes: 6
 transfected: 6
 transduced: 6
 transcription factor: 6
 tissue harvested: 6
 tissue derivation: 6
 tissue archive method: 6
 therapy: 6
 techrep: 6
 tcga classification: 6
 subjectid: 6
 studytype: 6
 ss y: 6
 specific growth rate: 6
 source prep: 6
 smoking history: 6
 sirna sequence: 6
 sampling: 6
 sample preservation: 6
 sample description 2: 6
 sample description 1: 6
 sample composition: 6
 rnai: 6
 rnaextract description: 6
 rna subset: 6
 review diagnosis: 6
 restriction enzyme: 6
 reproductive status cattle: 6
 replicates: 6
 reference rna: 6
 recovery time: 6
 proband sex: 6
 primary tumor site: 6
 primary site: 6
 pretreatment: 6
 photoactivatable ribonucleoside and crosslinking wavelength: 6
 patient_id: 6
 patient no.: 6
 pathological stage: 6
 pam50: 6
 packyears: 6
 p53 status: 6
 os: 6
 organismpart: 6
 operation: 6
 notes: 6
 msi-status: 6
 mouse line: 6
 mouse ids: 6
 mouse identifier: 6
 molecular subtype: 6
 mixed_sex: 6
 mgmt: 6
 meiotic stage: 6
 mean age: 6
 maturation: 6
 mating status: 6
 maternal age: 6
 malignancy: 6
 lymph node metastasis: 6
 localisation: 6
 light condition: 6
 light: 6
 ligand: 6
 induced with: 6
 immune status: 6
 igs: 6
 idhmut: 6
 histological type: 6
 histologic grade: 6
 her2 ihc: 6
 her-2: 6
 harvested at: 6
 growth phase od600: 6
 glucose: 6
 genotype/varation: 6
 family history: 6
 expressing: 6
 etiology: 6
 ebv status: 6
 durationunit: 6
 driver: 6
 doseunit: 6
 dosefrequency: 6
 doseduration: 6
 donors: 6
 diseasestate: 6
 dilution: 6
 depth: 6
 date of birth: 6
 data type: 6
 data set: 6
 culture stage: 6
 culture duration: 6
 compound, dose: 6
 compound added: 6
 compartment: 6
 coculture: 6
 co-cultured with: 6
 cluster: 6
 clone name: 6
 chip antibody cat.#: 6
 cell_line: 6
 cell number: 6
 cell karyotype: 6
 cell density: 6
 case history: 6
 c-source: 6
 biopsy: 6
 bioanalyzer results: 6
 behavior: 6
 atcc number: 6
 assaytype: 6
 antibody vendor/catalog: 6
 antibody catalog#: 6
 antibody catalog: 6
 antibody cat. #: 6
 ancestry: 6
 alcohol use: 6
 age description: 6
 age at diagnosis years: 6
 administration: 6
 Weight: 6
 TotalTreatmentDuration: 6
 TestItem2Concentration: 6
 TestItem1Concentration: 6
 Temperature: 6
 RNAi target: 6
 Organ: 6
 NASC seed stock id: 6
 Karyotype: 6
 GeneticModificati: 6
 Genetic modification: 6
 Disease Stage: 6
 Developmental Stage: 6
 CellLi: 6
 Biometrics: 6
 1p19q loh: 6
 xenograft host organism: 5
 whv infection status: 5
 who performance status: 5
 weightunits: 5
 weightbaseline: 5
 weightatsacrifice: 5
 volar or non-volar: 5
 virussubtype: 5
 virusstrain: 5
 virus description: 5
 upper or lower extremity: 5
 type of kras mut: 5
 type of electron donor: 5
 type kras aa change: 5
 tumour stage: 5
 tumour: 5
 tumor_size: 5
 tst: 5
 treatment_type: 5
 treatment_name: 5
 treatment_agent: 5
 treatment gap in months: 5
 transiently transfected with: 5
 tp53 status: 5
 time point (hours): 5
 time of exposure: 5
 time of differentiation: 5
 time of collection: 5
 time in culture: 5
 time dpi: 5
 time day: 5
 time (hours): 5
 targeted cell type: 5
 t cell type: 5
 surface marker: 5
 subject_id: 5
 subject gender: 5
 study id: 5
 stress level: 5
 stress condition: 5
 strain type: 5
 stock code: 5
 stages: 5
 stage of development: 5
 slide: 5
 size mm: 5
 shRNA expression: 5
 serovar: 5
 season: 5
 sample #: 5
 rna_number: 5
 resulting cell type: 5
 responder cells: 5
 responder cell line: 5
 relapses during 12-month follow-up: 5
 relapses during 12 months prior fingolimod: 5
 rb status: 5
 rat id: 5
 progression free survival: 5
 progression: 5
 prognosis: 5
 primer type: 5
 primary tumor: 5
 previous treatment: 5
 preservation: 5
 prenatal exposure: 5
 pregnancy status: 5
 pr ihc: 5
 pooled sample: 5
 pmi: 5
 pgr: 5
 patient type: 5
 parasite: 5
 p53 mutation: 5
 oxygen condition: 5
 overall survival (months): 5
 original tissue: 5
 original entry: 5
 origin tissue: 5
 node status: 5
 negative: 5
 ncbi taxonomy id: 5
 name: 5
 myc status: 5
 muscle type: 5
 mousestrain: 5
 mouseid: 5
 mouse number: 5
 mouse age: 5
 ml: 5
 metastatic potential: 5
 menopausal status: 5
 maternal strain: 5
 material type: 5
 markergroup: 5
 m: 5
 loci sets: 5
 light treatment: 5
 light cycle: 5
 lesion: 5
 karotype: 5
 inhibitor: 5
 infectionvolumeunits: 5
 infectionvolume: 5
 infectionroute: 5
 infectiondose: 5
 infected: 5
 index sequence: 5
 index: 5
 incubation: 5
 ighv status: 5
 hybridization chip: 5
 host cell type: 5
 hiv status: 5
 histology-iw revised: 5
 her2 fish: 5
 height cm: 5
 harvest timepoint: 5
 growth state: 5
 glucose concentration: 5
 geographical region: 5
 genetic_modification: 5
 gener: 5
 fvc: 5
 foxp3 expression: 5
 follicular status: 5
 flt3-itd: 5
 fertility status: 5
 fasting insulin: 5
 fasting glucose: 5
 extract protocol: 5
 expression vector: 5
 er ihc: 5
 embryo age: 5
 egfr-iw type: 5
 egfr status: 5
 egfr index: 5
 edss after 12 months: 5
 dx: 5
 duration in hours: 5
 donor age: 5
 disease subtype: 5
 disease duration in years: 5
 differentiation time: 5
 differentiation step: 5
 diabetes status: 5
 deveopmental stage: 5
 development capacity: 5
 dev.stage (boyes et al. plant cell 2001): 5
 dev stage: 5
 degeneration grading: 5
 days post inoculation: 5
 days post amputation: 5
 day of pregnancy: 5
 data series: 5
 crosslinker and crosslinking wavelength: 5
 control type: 5
 colony morphology: 5
 codon kras mut: 5
 chromosome: 5
 chip antibody provider: 5
 chemical treatment: 5
 challenged with: 5
 cell/tissue type: 5
 cell type origin: 5
 cell status: 5
 cell preparation date batch: 5
 cell marker: 5
 cell line name: 5
 cell collection method: 5
 cell  type: 5
 caryonide: 5
 cancer stage: 5
 breast cancer subtype: 5
 braf: 5
 bmi kg/m2: 5
 biomaterial: 5
 bcg vaccinated: 5
 base change: 5
 assay: 5
 array facility id: 5
 antibodies: 5
 animal_id: 5
 animal #: 5
 anatomical site: 5
 amount of total rna: 5
 alternative identifier: 5
 ageunits: 5
 ageatinfection: 5
 age yr: 5
 age of mouse: 5
 age at dx: 5
 activated with: 5
 activated by: 5
 abnormality: 5
 Type: 5
 SurvivalTime: 5
 SamplingSite: 5
 SampleType: 5
 IndividualChromosomalAbnormality: 5
 Grade: 5
 Diet: 5
 Diagnosis: 5
 DNase treatment: 5
 CountryOrRegion: 5
 Clinical Information: 5
 CellularComponent: 5
 BioSourceTy: 5
 Batch: 5
 Arabidopsis thaliana (col-0)  - harvest date: 5
 Arabidopsis thaliana (col-0)  - dev.stage (Boyes et al. Plant Cell 2001): 5
 yield: 4
 year of birth: 4
 who: 4
 visit: 4
 virulence: 4
 viral strain: 4
 viral infection status: 4
 vascular invasion: 4
 varation: 4
 twin pair: 4
 tumour grade: 4
 tumor size (cm): 4
 tumor biopsy acquisition: 4
 ttf: 4
 trucut biopsy: 4
 tree number: 4
 treatment stage: 4
 treatment response: 4
 transplanted with: 4
 transition/transversion: 4
 transformation construct: 4
 transformation: 4
 transfector: 4
 transduced vector: 4
 transduced factors: 4
 tranfection: 4
 tp53 mutation status: 4
 tp53 mutation: 4
 tobacco use: 4
 tissue subregion: 4
 tissue state: 4
 tissue location: 4
 time post-induction: 4
 time post treatment: 4
 time post infection: 4
 time point day: 4
 time pfs (months): 4
 time os (months): 4
 time of sacrifice: 4
 time hr: 4
 time after shift minutes: 4
 time (min): 4
 thz irradiation conditions: 4
 technology: 4
 tank: 4
 system: 4
 survival timemonths: 4
 survival time days: 4
 surface markers: 4
 subregion: 4
 subject type: 4
 subject identifier: 4
 subfraction: 4
 study: 4
 stress conditions: 4
 strain_description: 4
 strain phenotype: 4
 strain genotype: 4
 strain genetic background: 4
 stimulation duration: 4
 status pfs (0: 4
 starting material: 4
 stage_at_diagnosis: 4
 stably transfected with: 4
 sputum_smear: 4
 sputum_culture: 4
 spike-in hsa-mir-429: 4
 spike-in hsa-mir-383: 4
 spike-in hsa-mir-338-3p: 4
 spike-in hsa-mir-219-5p: 4
 spike-in hsa-mir-211: 4
 spike-in hsa-mir-147: 4
 sorted cells: 4
 sorted cell: 4
 somite stage: 4
 smoking_status: 4
 skin: 4
 side: 4
 shrna: 4
 serum creatinine: 4
 selected line: 4
 sampling time h: 4
 sampling point: 4
 sample pair: 4
 sample material: 4
 sample description 3: 4
 sacrifice: 4
 rna-seq method: 4
 rna integrity number (rin): 4
 risk: 4
 ripening stage: 4
 rip antibody lot #: 4
 retroviral vector: 4
 resistance: 4
 reproductive state: 4
 repeat: 4
 region of birth: 4
 reference rna lot #: 4
 reference rna cat. #: 4
 randomization_date: 4
 randomization date: 4
 radiation: 4
 pten status: 4
 protein: 4
 project: 4
 progression-free survival status: 4
 procedure: 4
 prior_tx_for_mets: 4
 pregnancy stage: 4
 precursor spike-in hsa-mir-383: 4
 precursor spike-in hsa-mir-338-3p: 4
 precursor spike-in hsa-mir-147: 4
 post-mortem interval pmi: 4
 pooling: 4
 plant line: 4
 pig: 4
 physiological stage: 4
 physical status: 4
 photoperiod: 4
 phase of infection: 4
 phase angle: 4
 perturbagen: 4
 payne grade: 4
 patient gender: 4
 patient disease status: 4
 pathological type: 4
 paternal strain: 4
 par-clip antibody: 4
 paired samples: 4
 originial tumor type of initial cell: 4
 o2: 4
 o-methyl spike-in hsa-mir-429: 4
 o-methyl spike-in hsa-mir-219-5p: 4
 o-methyl spike-in hsa-mir-211: 4
 number of mice: 4
 nominal dose (mg/l): 4
 no: 4
 nitrogen source: 4
 mutation type: 4
 muscle: 4
 motility: 4
 morphant: 4
 month: 4
 molecular.diagnosis: 4
 mode of growth: 4
 microrna source: 4
 miRNA: 4
 mch pc20 (mg/ml) at pre-challenge: 4
 mch pc20 (mg/ml) at post-challenge: 4
 maternal genotype: 4
 maternal diet: 4
 material sample: 4
 mass: 4
 manufacturer: 4
 lymphoma type: 4
 lymph node status: 4
 lot#: 4
 localization description: 4
 ln: 4
 litter identifier: 4
 linker: 4
 line pair: 4
 light regime: 4
 lifestage: 4
 library selection: 4
 library protocol: 4
 library preparation: 4
 library construction: 4
 length: 4
 l): 4
 kras: 4
 irradiation dose: 4
 ip protein: 4
 ip antibody cat. #: 4
 ip: 4
 inoculant: 4
 injected agent: 4
 inflammation: 4
 infiltration: 4
 infection influenza strain: 4
 infection agent: 4
 induction time: 4
 immunotolerance group: 4
 immortalization method: 4
 idh1 status: 4
 huvos grade: 4
 hours post infection: 4
 host cell line: 4
 histosubtype: 4
 histopathology: 4
 herd: 4
 height m: 4
 health state: 4
 health: 4
 harvesting date: 4
 haplotype: 4
 growth_phase: 4
 growth properties: 4
 grown in: 4
 glyc replaced by c, d, v and a: 4
 gleason: 4
 gfp status: 4
 gestational stage: 4
 gestational age weeks: 4
 gestation: 4
 genotype/variaton: 4
 genotype/variataion: 4
 genotype of ecat15-2: 4
 genotype of ecat15-1: 4
 gene: 4
 genbank: 4
 gcb.abc.signature: 4
 food: 4
 follow-up time months: 4
 ffpe block storage duration (yrs): 4
 fate: 4
 facs: 4
 fab: 4
 extraction method: 4
 expression construct: 4
 exposure length: 4
 experimental variable: 4
 experimental procedure: 4
 exercise state: 4
 estrogen receptor: 4
 es cell line: 4
 environmental factor: 4
 enrichment procedure: 4
 egfr mutation pattern: 4
 egfr mutation exon: 4
 egfr activating mutation: 4
 egf level: 4
 ebv: 4
 duke's stage: 4
 doxycycline induction: 4
 doxcycline treatment: 4
 doubling time: 4
 donor cell: 4
 disease_specific_survival_years: 4
 disease_specific_survival_event: 4
 disc level: 4
 develpomental stage: 4
 developmetal stage: 4
 developmental_stage: 4
 developmental age: 4
 density: 4
 debulking: 4
 death due to cancer: 4
 day of sacrifice: 4
 day length: 4
 date_of_progression: 4
 date of progression: 4
 culture system: 4
 culture protocol: 4
 cultivars: 4
 ctnnb1 mutation: 4
 crp: 4
 cre: 4
 coriell cell line repository identifier: 4
 control group: 4
 confluency: 4
 component sampled: 4
 common name: 4
 color: 4
 collection time point: 4
 collection month: 4
 clutch: 4
 circadian time: 4
 cilia length: 4
 chip antibody supplier: 4
 chemo: 4
 cells line differentiation: 4
 cell types: 4
 cell type subset: 4
 cell type derived from: 4
 cell sorting: 4
 cell sampling: 4
 cell isolation method: 4
 cell cycle: 4
 cell clone: 4
 cell #: 4
 cd4 count: 4
 cattle breed: 4
 carcinoma type: 4
 capsule: 4
 body mass: 4
 birth date: 4
 biosource 4: 4
 biosource 3: 4
 biosource 2: 4
 biosource 1: 4
 biopsy type: 4
 biological source: 4
 biological replica: 4
 binet stage: 4
 batch number: 4
 bacterial strain: 4
 background/strain: 4
 b cell type: 4
 asthma: 4
 assayed molecule: 4
 assay_physiological_state: 4
 array id: 4
 array batch: 4
 area: 4
 application: 4
 antibody target: 4
 antibody provider: 4
 analysis: 4
 alcohol preference: 4
 ajcc stage: 4
 airway region: 4
 age year: 4
 age range: 4
 age of onset: 4
 age of culture: 4
 age month: 4
 age in weeks: 4
 age at baseline: 4
 age (days): 4
 afp: 4
 administered form: 4
 adjuvant chemo: 4
 activation status: 4
 aa change cys vs. other: 4
 TumorSize: 4
 Test_: 4
 TNM: 4
 Subject_reference: 4
 Sample_reference: 4
 Region: 4
 Race: 4
 RNAi treatment: 4
 Phenoty: 4
 Origin: 4
 Organism part: 4
 OpticalDensity: 4
 OS time: 4
 MC1R(20): 4
 Longitude: 4
 Listeria monocytogenes EGD; note: 4
 Latitude: 4
 Infection: 4
 Induction time: 4
 Histolo: 4
 HER2 status: 4
 Group: 4
 Driver: 4
 Clinical info: 4
 ChromosomalAberration: 4
 Cells: 4
 BreslowThickness: 4
 BioSource Provider: 4
 BioSource: 4
 Background Srain: 4
 Arabidopsis thaliana (columbia)  - harvest date: 4
 Age(years): 4
 A: 4
 1:event:relapse/progression/death): 4
 1 death): 4
 % fall in fev1 (late): 4
 % fall in fev1 (early): 4
 zone: 3
 zap-70 %: 3
 years to outcome: 3
 xylem type: 3
 xenograft tissue: 3
 xenograft batch: 3
 wur10000125_genotype: 3
 who histologic subtype: 3
 weight_gain: 3
 weigh: 3
 weeks_to_pap: 3
 weeks of treatment: 3
 weekly exposure frequency: 3
 vs: 3
 virus concentration: 3
 viral load: 3
 viral infection: 3
 vineyard location: 3
 viewpoint: 3
 viability: 3
 vh status igvh mutational status fais et al. j clin invest, 1998: 3
 vh status: 3
 ventricle: 3
 vector type: 3
 vaccine or treatment: 3
 used for microrna profiling: 3
 updrs motor score: 3
 ulceration status: 3
 type_kras_aa_change: 3
 type of thyroid tissue: 3
 txt: 3
 tumour location: 3
 tumorsite: 3
 tumor_size_cm: 3
 tumor.location: 3
 tumor tissue: 3
 tumor state: 3
 tumor stage/grade: 3
 tumor source: 3
 tumor size (cm3): 3
 tumor size (%): 3
 tumor model: 3
 tumor loation: 3
 tumor content: 3
 ttts stage: 3
 trimester: 3
 treatment_route: 3
 treatment_frequency: 3
 treatment_dose mg/kg/d: 3
 treatment time-point: 3
 treatment outcome: 3
 treatment length: 3
 treatment condition: 3
 treatment agent: 3
 treatment 2: 3
 treatment 1: 3
 treated: 3
 treat phase 2: 3
 treat phase 1: 3
 transplantation: 3
 transition_transversion: 3
 transgenic mouse: 3
 transgenic expression: 3
 transfection vector: 3
 transfection protocol: 3
 transfection construct: 3
 transfected construct: 3
 transduced gene: 3
 trait: 3
 training.test: 3
 toxoplasma parasite strain: 3
 toxicant treatment: 3
 total urinary arsenic specific gravity adjusted ug/l: 3
 total rna: 3
 total exposure duration: 3
 tnm.stage: 3
 tnm stages: 3
 tnm classification t: 3
 tnm classification n: 3
 tnm classification m: 3
 tissue_type: 3
 tissue group: 3
 tissue grade: 3
 tissue derived: 3
 time to outcome: 3
 time to b-met days: 3
 time to 1st recurrence months: 3
 time to 1st recurrence days: 3
 time quit (@ initial consult): 3
 time post-surgery: 3
 time post-stimulation: 3
 time post vaccination or treatment: 3
 time post amputation: 3
 time points: 3
 time min: 3
 time in ll: 3
 time after stimulation: 3
 time after media shift: 3
 time (post-infection): 3
 thy1: 3
 tgf-beta treatment: 3
 test item phase 2: 3
 temperature c: 3
 temperature at sampling: 3
 technique: 3
 tcdd dose: 3
 tc classification: 3
 taxane: 3
 target organ: 3
 tansfected with: 3
 take down date: 3
 tail_array: 3
 t-stage: 3
 survival in years: 3
 survival event: 3
 survival days: 3
 survival (years): 3
 surgical margins: 3
 surgery date: 3
 surgdte/tb_date: 3
 surface: 3
 supplement: 3
 sucrose density gradient fraction: 3
 subset: 3
 subjects: 3
 subjected to: 3
 subject_reference: 3
 subject/sample source id: 3
 subclone: 3
 studymainsource: 3
 stress response: 3
 strainorline: 3
 strain/line: 3
 strain source: 3
 strain form: 3
 strain (or line): 3
 stimulation type: 3
 stimulation condition: 3
 stadium: 3
 stable transfection: 3
 st. george's total score: 3
 ssea1: 3
 specimen type: 3
 specimen id: 3
 source strain background: 3
 source material: 3
 source gender: 3
 sorting: 3
 sorted population: 3
 song playback experience: 3
 song exposure: 3
 smoker status: 3
 smear of index case: 3
 sleep protocol: 3
 sledai: 3
 site of specimen collection: 3
 site of 1st recurrence: 3
 sire: 3
 single/co-culture: 3
 single cell ID: 3
 shRNA sequence: 3
 sfebq: 3
 serum 25-oh-d: 3
 series: 3
 sequencing depth: 3
 sequenced molecule: 3
 sequence mutations: 3
 sentrix_position: 3
 sentrix_id: 3
 selected line rep: 3
 seed stock id: 3
 secretion: 3
 sample_name: 3
 sample tag: 3
 sample status: 3
 sample size: 3
 sample set: 3
 sample preparation: 3
 sample origin/type: 3
 sample number: 3
 sample fraction: 3
 sample date: 3
 sample collection time post-infection: 3
 sample collection (zt): 3
 run-timing group: 3
 rppa subgroup: 3
 rna treatment: 3
 rna preparation: 3
 rna prep date: 3
 rna prep: 3
 rna extracted from: 3
 rna concentration ng/ul: 3
 rna concentration: 3
 rip: 3
 retrovirus: 3
 retroviral expression: 3
 response to vtd therapy: 3
 reproductive history: 3
 repository: 3
 reporter: 3
 replicate description: 3
 replica: 3
 rep(tank): 3
 regeneration level: 3
 reference pool: 3
 recurrence within the 60-months follow-up: 3
 recurrence type: 3
 recurrence status: 3
 recurrence location: 3
 recurrence event: 3
 rectype1: 3
 receptor: 3
 recdte1: 3
 rearing conditions: 3
 read type single/paired-end: 3
 reaction_group: 3
 rd: 3
 raw data id: 3
 radiation time point: 3
 radiation sensitive or not: 3
 radiation dose: 3
 quit how many years ago: 3
 purity: 3
 ptnm: 3
 pt-stage: 3
 psa progression: 3
 psa before surgery: 3
 psa at recurrence: 3
 psa: 3
 properties: 3
 progesterone receptor: 3
 processing control: 3
 processing: 3
 prior treatment: 3
 prime_route: 3
 prime_dose: 3
 prime_date: 3
 prime_agent: 3
 primary tumor thickness mm: 3
 primary tissue: 3
 preservative: 3
 preop_psa: 3
 pregnancy day: 3
 prechemo tumor size: 3
 pre-existing serum ad5 neutralizing antibody titer class: 3
 postmortem interval h: 3
 postmortem interval (brain specimens only): 3
 post-mortem interval (hours): 3
 positive nodes: 3
 positive lymph nodes: 3
 position along eigenstrat axis 3 (ethnicity correction): 3
 position along eigenstrat axis 2 (ethnicity correction): 3
 position along eigenstrat axis 1 (ethnicity correction): 3
 pooled: 3
 pneumonia: 3
 pm: 3
 platelet count: 3
 plasma vtg (mg/ml): 3
 plant stage: 3
 pig live weight: 3
 pig id: 3
 physiology: 3
 physiological state: 3
 pgr status: 3
 pfsm month: 3
 pfs: 3
 period: 3
 peptide: 3
 pcl type: 3
 patient.sex: 3
 patient source: 3
 patient reference: 3
 patient no: 3
 patient disease: 3
 pathologic t stage: 3
 pathologic n stage: 3
 pathogen exposure: 3
 paternal male grandparent genotype: 3
 paternal genotype: 3
 paternal female grandparent genotype: 3
 parent strain: 3
 pap_no_24_weeks: 3
 pap_no_20_wks: 3
 pancreatic tumor cell line: 3
 pam50 subgroup: 3
 paclitaxel resistance: 3
 pack yrs: 3
 p53 mutation status: 3
 oxygen: 3
 ovs (months): 3
 overexpressed tf: 3
 overall survival time: 3
 overall survival os: 3
 overall survival event: 3
 overall survival (years): 3
 overall survival: 3
 osbin: 3
 originating cell line: 3
 original tumor type of initial cell: 3
 origin cell line: 3
 organoid: 3
 organism part : 3
 organ/tissue: 3
 organ metastasis at surgery: 3
 organ metastasis after surgery: 3
 onset site: 3
 od600 at harvest: 3
 nutritional status: 3
 number of individuals pooled: 3
 nras: 3
 npm1 mutation status: 3
 npm1 mutation: 3
 npm1: 3
 node positive: 3
 nodal status: 3
 nitrogen condition: 3
 newborn weight grams: 3
 newborn sex: 3
 neuropathology: 3
 neoadjuvant therapy: 3
 necrosis: 3
 name biosource 4: 3
 name biosource 3: 3
 name biosource 2: 3
 name biosource 1: 3
 n/c  ratio moln / cmol: 3
 multiplicity of infection: 3
 mskcc histology: 3
 mouse genotype: 3
 mouse IDs: 3
 mother's age years: 3
 monocyte subset: 3
 molecule source: 3
 modal x-ray grade: 3
 mitotic index: 3
 million pbmc: 3
 milking frequency: 3
 microenvironment: 3
 microarray scanner: 3
 microarray hybridization date: 3
 microarray batch: 3
 mice group: 3
 mg condition: 3
 metastatic tumor site: 3
 metal: 3
 menopause_status: 3
 medium type: 3
 mating system: 3
 maternal treatment: 3
 maternal state: 3
 maternal male grandparent genotype: 3
 maternal female grandparent genotype: 3
 material with known storage state: 3
 matching copy number data: 3
 matched pair id: 3
 mapalgorithm description: 3
 mapalgorithm: 3
 manipulation: 3
 male parent genotype: 3
 lymph node: 3
 lymph: 3
 lung cancer: 3
 lot number: 3
 ln status: 3
 linfonodes: 3
 light/dark condition: 3
 light intensity: 3
 library id: 3
 length of treatment: 3
 length of diet: 3
 legend: 3
 lauren type: 3
 last tracked zone: 3
 last tracked date: 3
 last status: 3
 last f/u: 3
 larval stage: 3
 l-dopa/da agonist treatment: 3
 kras_mut_type: 3
 kras_mut_iw: 3
 kras_mut_codon: 3
 kras status: 3
 ki67 surg: 3
 ki67: 3
 jak inhibitor: 3
 isolate_sensitivity: 3
 irradiate: 3
 irf4.status: 3
 irf4.probability: 3
 irf4.prediction: 3
 intstat: 3
 intrec1: 3
 inss stage: 3
 insert size standard deviation bp: 3
 insert size bp: 3
 input: 3
 inoculation status: 3
 injected into: 3
 infestation: 3
 infection group: 3
 infected host: 3
 inducible vector: 3
 inducer: 3
 index_case_disease_site: 3
 incubation timedays: 3
 incubation medium: 3
 in vitro treatment: 3
 in vitro culture: 3
 implant host: 3
 immunohistochemistry: 3
 immortalization: 3
 image analysis program: 3
 ighv gene: 3
 igg: 3
 idd related diseases: 3
 iPSilateral event: 3
 hypercalcemia: 3
 hybdate: 3
 hyb date: 3
 human subject anonymized id: 3
 human epidermal growth factor receptor 2 her2 status: 3
 http: 3
 hras: 3
 hours post invasion: 3
 hour: 3
 host tissue: 3
 host strain info: 3
 host strain background: 3
 host mouse strain: 3
 host mouse gender: 3
 host genetic background: 3
 host gender: 3
 host cell: 3
 hormone-therapy: 3
 hmox: 3
 histological response: 3
 hh cluster: 3
 hemisphere: 3
 hematocrit: 3
 heifer age: 3
 healthy control: 3
 health condition: 3
 hatching time: 3
 hairpin: 3
 grpstage: 3
 growth status: 3
 growth duration: 3
 growth conditions time/temp/shaking: 3
 growing condition: 3
 groups: 3
 graft: 3
 grade eortc: 3
 grade elston: 3
 grade combined: 3
 gonad wt (g): 3
 gold stage: 3
 glyc_replaced_by_c_d_v_a: 3
 gleason grade: 3
 gestational age wks: 3
 gestation stage: 3
 geographic origin: 3
 gentoype: 3
 genotyping: 3
 genotype/varitaion: 3
 genotype/variaion: 3
 genotype rb: 3
 genotype p53: 3
 genome build: 3
 genetic variant: 3
 gender (sex): 3
 gendar: 3
 gating: 3
 fvc pre-bronchodilator % predicted: 3
 fusion transcrit: 3
 functional: 3
 fruit stage: 3
 follow-up time days: 3
 follow-up time: 3
 follow-up (months): 3
 flowcell: 3
 flow cytometry cell subset proportions: 3
 flour type: 3
 final diagnosis: 3
 field: 3
 fev1: 3
 fertility: 3
 fermentation time: 3
 fermentation stage: 3
 fermentation: 3
 female parent genotype: 3
 fed with: 3
 father: 3
 fasting blood: 3
 extraction: 3
 extracted molecule: 3
 extract_protocol: 3
 extract_concentration: 3
 extract_amount: 3
 extra: 3
 expt6_cy5: 3
 expt6_cy3: 3
 expt5_cy5: 3
 expt5_cy3: 3
 expt4_cy5: 3
 expt4_cy3: 3
 expt3_cy5: 3
 expt3_cy3: 3
 expt2_cy5: 3
 expt2_cy3: 3
 expt1_cy5: 3
 expt1_cy3: 3
 exposure_latent: 3
 exposure duration phase 2: 3
 exposure duration phase 1: 3
 experimental treatment: 3
 experimental period: 3
 experimental design: 3
 experimental condition: 3
 experimental batch number: 3
 experiment_date: 3
 estrus cycle stage: 3
 estrogen receptor er status: 3
 er bl: 3
 epithelial: 3
 epigenetic feature: 3
 enzyme: 3
 environmental condition: 3
 environment condition: 3
 enteric flora status: 3
 efs (months): 3
 edss: 3
 eae day: 3
 drug response: 3
 drug exposure: 3
 donor strain: 3
 donor sex: 3
 dmfs event: 3
 dlco % predicted: 3
 distant metastasis: 3
 dissection: 3
 disposition: 3
 disease_stage: 3
 disease severity: 3
 disease progression: 3
 disease location: 3
 disease group: 3
 disease causing mutation: 3
 digestion: 3
 differetion day: 3
 differentiation protocol: 3
 diet_group: 3
 diagnosis date: 3
 diabetes: 3
 developmental time: 3
 developmental stage (boyes et al. plant cell 2001): 3
 development of metastasis: 3
 dev.stage (boyes et al. plant cell 2001) boyes: 3
 depositor: 3
 deathdte: 3
 death_ind: 3
 death status: 3
 death event: 3
 death at fu: 3
 dead of disease: 3
 days post-infection: 3
 days post-colonization: 3
 days of exposure: 3
 days in culture: 3
 days in co-culture with p. minimum: 3
 days after treatment: 3
 days after stimulation: 3
 daylight: 3
 day post treatment: 3
 day of estrous cycle: 3
 date of measurement: 3
 date of isolation: 3
 daily exposure duration: 3
 culture position: 3
 cultiver: 3
 cultivation: 3
 cultivar/ecotype: 3
 ct-id: 3
 ct: 3
 cryptic fusions: 3
 crna amount: 3
 creatinine: 3
 count: 3
 corresponding tumor sample in gse19977: 3
 control_group: 3
 control composition: 3
 contributing person: 3
 contributing institute: 3
 confluence: 3
 concomitant t790m: 3
 collection method: 3
 code: 3
 coat: 3
 clone type: 3
 clip-antibody: 3
 clinical phenotype: 3
 clinical group: 3
 clinic: 3
 cisplatin sensitivity: 3
 cirrhosis: 3
 circadian time point: 3
 cinsarc group: 3
 chip-seq antibody vendor: 3
 chip antibody details: 3
 character: 3
 challenge dose tcid50: 3
 center: 3
 cell type/component: 3
 cell type mammary cell subpopulation: 3
 cell signature: 3
 cell line passage: 3
 cell line id: 3
 cell ine: 3
 cell id: 3
 cell growth stage: 3
 cell cycle state: 3
 cell bank no: 3
 cell  line: 3
 cdna type: 3
 cd38 %: 3
 cd16 %: 3
 cause of death: 3
 carbohydrate: 3
 capsule infiltration: 3
 cancer site: 3
 cad: 3
 bsa source: 3
 brca1 mutation: 3
 brca1 expression: 3
 brain tissue: 3
 brain as isolated 1st site of recurrence: 3
 brain area: 3
 boost_route: 3
 boost_dose: 3
 boost_date: 3
 boost_agent: 3
 bone mineral density: 3
 bone marrow cell source strain: 3
 bone marrow cell receiver or control strain: 3
 block age: 3
 bioreplicate id: 3
 bioreplicate comparison groups (which mutant replicate goes with which wt replicate): 3
 biopsy site grouped: 3
 biopsy location: 3
 biopsy dimensions: 3
 biological source of exosomes or cells: 3
 biological replicates: 3
 bee type: 3
 baseline subtype: 3
 baseline ror s: 3
 baseline ror p: 3
 base_change: 3
 bal_smear: 3
 bal_culture: 3
 background cell line: 3
 backgroud: 3
 b-met: 3
 b cell stage: 3
 average insert size: 3
 average age: 3
 auc: 3
 atf6a genotype: 3
 atcc: 3
 aso: 3
 arsenic in drinking water ug/l: 3
 arrhythmia: 3
 array_scan_date: 3
 array.qc: 3
 array rep: 3
 array name: 3
 arabidopsis thaliana columbia  -  dev.stage boyes et al. plant cell 2001: 3
 apparent sex: 3
 antibody vendor/catalog#: 3
 antibody vender: 3
 antibody cat#: 3
 antibody 2: 3
 antibody 1: 3
 animal type: 3
 animal tag no: 3
 animal identifier: 3
 anatomical site of primary tumor: 3
 anastomotic leak: 3
 amputation site: 3
 amount in ug: 3
 alsfrs: 3
 allele: 3
 all type: 3
 ahr: 3
 ageyears: 3
 agent dose: 3
 agent compound added: 3
 age_years: 3
 age_in_years: 3
 age_at_onset: 3
 age.at.diagnosis: 3
 age when sampled: 3
 age of sampling: 3
 age of patient: 3
 age at surgery yrs: 3
 age at sacrifice: 3
 age at onset: 3
 age at initial dose: 3
 age at diagnosis (years): 3
 age at death days: 3
 age at biopsy: 3
 age (yr-old): 3
 age (months): 3
 age (day): 3
 adjuvant therapy: 3
 additional neurological diagnosis: 3
 additional id: 3
 adapter: 3
 aa_change_cys_vs_other: 3
 TreatPhase2: 3
 TreatPhase1: 3
 TreatPhase: 3
 Transfect: 3
 Timepoint: 3
 TimeUn: 3
 Theiler stage: 3
 TestSubstanceConcentration: 3
 TestItemPhase2: 3
 TestItemPhase1: 3
 TestItemPhase: 3
 TestItemConcentration: 3
 TestItem3Concentration: 3
 TestItem3: 3
 TestItem2: 3
 TestItem1: 3
 TestItem0: 3
 Supplier: 3
 Subsets: 3
 StrainOrLineDatabase: 3
 Strain Name : 3
 Smoking: 3
 Sample ID: 3
 Sample Description: 3
 RecoveryDuration: 3
 RandomizationRank: 3
 PopulationDensity: 3
 Pathology: 3
 OrgansimPart: 3
 Organsim Part: 3
 Number of individuals: 3
 Model: 3
 Grading of acute GVHD: 3
 Goat no.: 3
 GeneticVariation: 3
 GENDER: 3
 Fraction: 3
 FamilyHistory: 3
 FISH wet wt (g): 3
 FISH size: 3
 FISH analysis: 3
 Extraction_amount: 3
 ExposureTime: 3
 ExposureFrequency: 3
 ExposureDurationPhase2: 3
 ExposureDurationPhase1: 3
 DiseaseState <1>: 3
 DiseaseOutcome: 3
 CultureMedium: 3
 Culture: 3
 Condition: 3
 Compou: 3
 Case: 3
 BodyMassIndex: 3
 Arabidopsis thaliana (landsberg erecta)  - dev.stage (Boyes et al. Plant Cell 2001): 3
 Arabidopsis thaliana (columbia)  - dev.stage (Boyes et al. Plant Cell 2001): 3
 Arabidopsis thaliana (columbia)  - age: 3
 Animal: 3
 Age of patient: 3
 Age category: 3
 Age at onset: 3
 17p13 deletion: 3
 0-survival): 3
 73: 3
 46: 3
 zygosity: 2
 zt: 2
 zic1 injection: 2
 young_id: 2
 yfp expression: 2
 yes: 2
 yearsquitsmking: 2
 years of smoking: 2
 years: 2
 xenograft model: 2
 xenograft inflammation: 2
 xenograft host strain: 2
 xenograft fibrosis: 2
 xenograft differentiation: 2
 xenograft MultiOmicsClassification: 2
 xenograft CIMPclass: 2
 wounded: 2
 wood type: 2
 white blood cell count: 2
 weight of protein recovered: 2
 weeks: 2
 wbc: 2
 vo2max per kg: 2
 vo2max ffm: 2
 vital: 2
 virus taxon id: 2
 virus genus: 2
 virus family: 2
 virus dose: 2
 virus accession number: 2
 viral transduction: 2
 viral genus: 2
 viral family: 2
 vineyard name: 2
 vendor/catalog#: 2
 vehicle_route_designation: 2
 vegetative stage: 2
 vdrc transformant id: 2
 variaton: 2
 valid: 2
 vaccine status: 2
 url: 2
 unsupervised analysis: 2
 uno side: 2
 units of harvest time point: 2
 uams 70gene index: 2
 type of replicate: 2
 type of plants: 2
 tx-ptdl interval months: 2
 tx: 2
 twin pair id: 2
 tweak treated: 2
 tumour type: 2
 tumour size: 2
 tumour histological grade: 2
 tumour content: 2
 tumorigenicity: 2
 tumorigenic subline: 2
 tumorgrading: 2
 tumore stage: 2
 tumor_grading: 2
 tumor_class: 2
 tumor-derived cell line: 2
 tumor weight in grams: 2
 tumor subpopulation: 2
 tumor staging: 2
 tumor size mm: 2
 tumor size in cm: 2
 tumor size (mm): 2
 tumor origin: 2
 tumor number: 2
 tumor id: 2
 tumor genotype: 2
 tumor formation: 2
 tumor foci: 2
 tumor cell type: 2
 tts: 2
 ttf-1 expression: 2
 tstage: 2
 triple-negative status: 2
 triple negative or basal-like subtype: 2
 trial: 2
 tree type: 2
 tree: 2
 treatments comments: 2
 treatment_time: 2
 treatment_schedule: 2
 treatment/time period: 2
 treatment/expansion cycle number within schedule: 2
 treatment/cell subtype: 2
 treatment timepoint: 2
 treatment time point: 2
 treatment pre-hormone: 2
 treatment concentration: 2
 treatment code: 2
 treatment arm: 2
 treatement time: 2
 treatement: 2
 treated twice with: 2
 treated in: 2
 treament time: 2
 treament duration: 2
 treament dose: 2
 tratment: 2
 transposon vector: 2
 transposon: 2
 translocations: 2
 transient transfection: 2
 transgenic strain: 2
 transgenic mice: 2
 transgenic: 2
 transformant: 2
 transfection time: 2
 transfection status: 2
 transfection reagent: 2
 transfected sirna: 2
 transfected shrna: 2
 transfected plasmid: 2
 transfected agent: 2
 transduction protocol: 2
 transcription factors used to induce mefs: 2
 transcript factor: 2
 transcfection: 2
 trans-gene: 2
 training state: 2
 train: 2
 tp53 sequence: 2
 tp53 copy number: 2
 toxicant: 2
 total tag counts: 2
 total rna ug: 2
 total rna source: 2
 total rna amount: 2
 tnfa treatment time point: 2
 tnbc subtype: 2
 tmprss2-erg: 2
 tlx1 status: 2
 tlr stimulation: 2
 tki status: 2
 tisue: 2
 tissue_name: 2
 tissue/treatment id: 2
 tissue/cell line: 2
 tissue treatment: 2
 tissue supergroup: 2
 tissue site: 2
 tissue sample: 2
 tissue or cells: 2
 tissue id: 2
 tissue harvest methods: 2
 tissue diagnosis: 2
 tissue condition: 2
 tissue archive: 2
 tissue and passage: 2
 timepoint of sample collection: 2
 time(weeks): 2
 time to survival: 2
 time to recurrence (years): 2
 time to outcomel: 2
 time to metastasis (years): 2
 time to meta or recurrence: 2
 time since sample1 months: 2
 time sampled: 2
 time recovery (hour): 2
 time post vbg: 2
 time post transfection: 2
 time post inoculation: 2
 time post initiation of treatment: 2
 time post host castration: 2
 time point min: 2
 time point hr: 2
 time point hours: 2
 time point (days): 2
 time of visit: 2
 time of testing: 2
 time of progression: 2
 time minutes after fertilization: 2
 time minutes: 2
 time hrs post infection: 2
 time hpi: 2
 time harvest time, post-spore inoculation: 2
 time h post-infection: 2
 time from t1d diagnosis months: 2
 time from surgery: 2
 time from seroconversion months: 2
 time differentiated: 2
 time d.p.i: 2
 time d: 2
 time culture: 2
 time after wounding: 2
 time after vaccination: 2
 time after transplantation: 2
 time after surgery: 2
 time after infection: 2
 time after induction: 2
 time after i.p. injections: 2
 time after exposure: 2
 time (post virus infection): 2
 time (min after alpha-factor release): 2
 time (hr): 2
 time (days): 2
 tiime: 2
 thelier stage: 2
 tet2 status: 2
 testosterone at sacrifice: 2
 testis region: 2
 test result: 2
 test item2 concentration: 2
 test item1 concentration: 2
 test item phase1: 2
 test article: 2
 terminator exonuclease: 2
 term: 2
 temperature (c): 2
 telomere status: 2
 telomere maintanence mechanism: 2
 technical replicates: 2
 technical batch: 2
 tech.replicate: 2
 teatment: 2
 tcr coreceptor: 2
 tc class: 2
 tbefore: 2
 targeted gene: 2
 tamoxifen induction: 2
 tag type: 2
 tabaquism: 2
 t1dcase/t1dcontrol pair: 2
 t-dna insertion line: 2
 t-all source: 2
 t- psa: 2
 t cell subset: 2
 systolic/diastolic: 2
 sys bp mm hg: 2
 symptom: 2
 surgically implanted into: 2
 surgical procedure: 2
 surgery status: 2
 supplements: 2
 supplementation: 2
 supplementary file: 2
 subpopulation labeling: 2
 subline: 2
 subject's disease state: 2
 subject status/id: 2
 subject number: 2
 subject condition: 2
 subject age yrs: 2
 subject age range: 2
 subject age: 2
 subcellular fraction: 2
 subcellular compartment: 2
 subarray: 2
 studyid: 2
 study number: 2
 study day_body weight measurement: 2
 stress type: 2
 stress tolerance: 2
 stress time: 2
 stranded: 2
 strain_id: 2
 strain that es cell-line is derived from: 2
 strain number: 2
 strain info: 2
 strain id: 2
 strain donor: 2
 stimulus duration: 2
 stimulus concentration: 2
 stimulation time: 2
 stent: 2
 std insert size: 2
 status after 5 years: 2
 state of endometrium: 2
 staging: 2
 stage or passages: 2
 stage of oogenesis: 2
 stage of maturity: 2
 stage of embryo: 2
 stage in reprogramming: 2
 stage grouping: 2
 stage at diagnosis: 2
 stably expressing: 2
 stable transduction: 2
 stable shrna: 2
 sputum smear status: 2
 spikeinpool: 2
 spike-in: 2
 sphere and tumor forming efficiency: 2
 specimen of known storage type: 2
 specimen name: 2
 specimen mutation: 2
 specific growth conditions: 2
 source tissue type: 2
 source organ: 2
 source age: 2
 source  tissue: 2
 sorting strategy: 2
 sorted cell type: 2
 sorted cell genotype: 2
 sorted cell fraction: 2
 sorted: 2
 sort population: 2
 softwareversion: 2
 smoking regimen: 2
 smoking packyears: 2
 slide number: 2
 slide id: 2
 slice: 2
 skin age: 2
 size selection: 2
 size cm: 2
 site of involvement of lymphoma: 2
 sirna treatment time point: 2
 sirna treatment group: 2
 sirna knockdown: 2
 simulation condition: 2
 side scatter: 2
 sib: 2
 si: 2
 shrna treatment: 2
 shRNA transfection: 2
 sgrna: 2
 sex type: 2
 sex male/female: 2
 sex and age: 2
 sex (gender): 2
 setnr: 2
 set_class: 2
 serum c3 mg/l: 2
 serum: 2
 sequentially infected with: 2
 sequencing protocol: 2
 sequencing method: 2
 sequencing date: 2
 sequencing: 2
 sequence: 2
 sepsis response signature group: 2
 sepsis: 2
 separation: 2
 sensitivity: 2
 self-fertile and virulent on host plants: 2
 selection marker: 2
 seizure: 2
 seed type: 2
 sectioning direction: 2
 schisto exposure: 2
 schedule: 2
 scaring: 2
 sarcoma subtype: 2
 sampling,time: 2
 sampling year: 2
 sampling study day: 2
 sampling campaign: 2
 samples collection: 2
 sampleid: 2
 sample_reference: 2
 sample_group: 2
 sample_description 4: 2
 sample order: 2
 sample no: 2
 sample location: 2
 sample info: 2
 sample description 4: 2
 sample day: 2
 sample complexity: 2
 sample age: 2
 sample ID: 2
 salinity: 2
 sacrifice time: 2
 rwc: 2
 run id: 2
 rrna depletion: 2
 rqi experion: 2
 rp: 2
 rotation: 2
 rnai treatment: 2
 rna_id: 2
 rna.extraction.method: 2
 rna rin value: 2
 rna purification date: 2
 rna purification batch: 2
 rna purification: 2
 rna pool: 2
 rna person: 2
 rna ng/ul: 2
 rna integrity number rin: 2
 rna injection: 2
 rna extraction method: 2
 rna date: 2
 rna concentration ug/ul: 2
 rna chaperone hfq: 2
 rna amount: 2
 rna 260/280 nanodrop: 2
 rna 260/230 nanodrop: 2
 rip-chip antibody: 2
 rip ref.: 2
 rfs.event: 2
 rfs.delay: 2
 retroviral transduction: 2
 response to chemotherapy: 2
 response to artemsinin: 2
 resistant: 2
 resistance status: 2
 resistance mechanism: 2
 residual disease: 2
 resectable: 2
 rer end: 2
 rer: 2
 reproductive status: 2
 reproductive stage: 2
 reproduction mode: 2
 repetition: 2
 renal graft bx: 2
 relative iq within twin pair: 2
 relationship: 2
 relapse yr: 2
 relapse type: 2
 relapse time: 2
 relapse months: 2
 regulator_tested_activity: 2
 regulator_tested: 2
 reference source: 2
 reference sample: 2
 reference rna 2 lot #: 2
 reference rna 2 cat. #: 2
 reference rna 2: 2
 reference pool construction: 2
 reference pool composition: 2
 recurrence_frequency: 2
 recurrence time: 2
 recombinant protein: 2
 recipient gender: 2
 recipient: 2
 rec (1): 2
 reanalysis of: 2
 read length bp: 2
 rcb_0_i_prediction: 2
 ratid: 2
 rat strain/background: 2
 rat: 2
 random barcode: 2
 radiotherapy: 2
 radiation treatment: 2
 race_white: 2
 race_indian_alaska: 2
 race_hispanic: 2
 race_asian: 2
 race_aa: 2
 rabbit id: 2
 r26eyfp genotype: 2
 quorum sensing (qs) phenotype: 2
 putrescine producer: 2
 purification strategy: 2
 purification method: 2
 pull down: 2
 ptnm stage: 2
 pt stage: 2
 pstage: 2
 provenance somatic cell: 2
 provenance: 2
 protein expressed: 2
 protein complex: 2
 prostate region: 2
 prostate cancer xenograft: 2
 propagation: 2
 promoter construct: 2
 promoter: 2
 progressive status: 2
 progression-free survival years: 2
 progression-free survival weeks: 2
 progression-free survival time months: 2
 progression-free survival time (months): 2
 progesterone receptor pgr: 2
 progesterone concentration ng/ml: 2
 progesteron receptor immunohistochemestry: 2
 progenitor mother: 2
 progenitor father: 2
 progenitor cell line: 2
 profiling: 2
 processing batch: 2
 proband age: 2
 priming method: 2
 primary culture: 2
 primary cell type: 2
 primary all sample: 2
 primary: 2
 present: 2
 presence of data after operation 1=present, 0=not tested: 2
 preperation kit: 2
 preparation: 2
 preoperative chemo: 2
 prediction: 2
 predicted risk: 2
 predicted: 2
 pred: 2
 prechemo t stage: 2
 prechemo t: 2
 prechemo nodal status: 2
 prechemo n: 2
 pre-existing serum ad5 neutralizing antibody titer merck assay: 2
 pre exercise/ post exercise: 2
 pr_status_ihc: 2
 pr_dbcg: 2
 pr.ihc: 2
 pr status ihc: 2
 potassium downshift: 2
 postoperative survival (months): 2
 postnatal social treatment: 2
 postmortem delay: 2
 post-mortem interval in hours: 2
 post-mortem interval hours: 2
 post-mortem delay hours: 2
 post-mortem delay: 2
 post-instillation period: 2
 post-infection time points: 2
 pooled sample composition: 2
 polysome fraction: 2
 polyq: 2
 polyploid level: 2
 poly-a selection: 2
 point: 2
 pn stage: 2
 pmn%: 2
 pluripotent state: 2
 plume zone: 2
 ploidy level: 2
 platinum sensitivity: 2
 platinum: 2
 plate id: 2
 plasmids: 2
 plasmaid: 2
 plasma vtg: 2
 plant replica: 2
 plant genotype: 2
 plant cell 2001 boyes: 2
 place to metastasis: 2
 pkyrs: 2
 pir knock-down: 2
 pigmentation level: 2
 pigmentation: 2
 pigid: 2
 pig number: 2
 pid: 2
 phytoplasma growth: 2
 physiological condition: 2
 physician global assessment cm, range 0-10: 2
 phosphate concentration: 2
 phentoype: 2
 pfsm (month): 2
 pfsc 1=progressed; 0=not progressed: 2
 pfsc (1=progressed; 0=not progressed): 2
 pfs (m): 2
 personal pathological hystory: 2
 perinatal stage: 2
 performer: 2
 percentage ki67 ihc: 2
 percent tumor: 2
 percent necrosis: 2
 pdl: 2
 pdac: 2
 pcr.v.rd: 2
 pcr: 2
 pc20: 2
 pc dyscrasia: 2
 pax3 injection: 2
 patient/control: 2
 patient.age: 2
 patient condition: 2
 patient code: 2
 pathological family history: 2
 pathologic_response_rcb_class: 2
 pathologic_response_pcr_rd: 2
 pathologic t staging: 2
 pathologic n staging: 2
 pathologic grade: 2
 pathogenicity: 2
 pathogen strain: 2
 pathgs: 2
 paternal genotype/variation: 2
 paternal genetic modification: 2
 paternal ecotype: 2
 passsage number: 2
 passage no.: 2
 passage #: 2
 pasi: 2
 participant id: 2
 parental/reprogrammed state: 2
 parental/ne-like state: 2
 parental strains: 2
 parental strain: 2
 parental line: 2
 parent: 2
 parasites: 2
 parasitemia: 2
 pap_susceptibility_class: 2
 pam50agilent: 2
 pam50_class: 2
 pam50 classification: 2
 pairing phenotype: 2
 paired rna-seq: 2
 pT_Stage: 2
 pN_Stage: 2
 pM_Stage: 2
 p63 ihc: 2
 p53.mutant: 2
 oxygen tension: 2
 oxidative stress: 2
 oxidation: 2
 overall tp53 status: 2
 overall survival years: 2
 overall survival weeks: 2
 overall survival months: 2
 overall survival month: 2
 overall survival in days: 2
 overall survival delay: 2
 overall survival days: 2
 overall survival censor (1-censored,0-non-censored): 2
 ovariectomized: 2
 outbred line: 2
 other: Sample Pooling Protocol: 2
 os event: 2
 os (m): 2
 originator's sample label: 2
 original mes cell line: 2
 original cells: 2
 origin of cells: 2
 organism_status: 2
 organism type: 2
 organ-tropism: 2
 organ culture date batch: 2
 optical density: 2
 oncogenes: 2
 oncogene: 2
 ompa copies per swab: 2
 ogd treatment: 2
 offspring genotype: 2
 offspring gender: 2
 offspring age: 2
 obsolete_sex: 2
 obese status: 2
 nutrient limitation: 2
 nutrient condition: 2
 number pack years smoked: 2
 number of samples in the pool: 2
 number of samples in pool: 2
 number of sample in pool: 2
 number of mice per chip: 2
 nucleofection cycles: 2
 nucleic acid: 2
 nuclear hybridization: 2
 nqo1 rs1800566 genotype: 2
 note: 2
 notch1: 2
 normalizationcombatmod: 2
 normalizationcombatbatch: 2
 normal: 2
 nontumorigenic subline: 2
 nodes: 2
 node positivity: 2
 node: 2
 nodal_status: 2
 no. of metastases: 2
 ni concentration: 2
 nfkbiz shrna expression: 2
 nf2 mutational status of cell line: 2
 neutrophils: 2
 neutralizing anti-interferon alpha antibody titers-1 100 = undetected: 2
 nefa exposure stage: 2
 nefa concentration: 2
 ne group: 2
 nbefore: 2
 nationality: 2
 natalizumab responder type: 2
 narrow diagnosis: 2
 n.a.:not available: 2
 n-stage: 2
 n-myc expression: 2
 mycorrhiza: 2
 mycn 1: 2
 mycn: 2
 myc.status: 2
 myc: 2
 mutations: 2
 mutation_hgvs: 2
 mutation_: 2
 mutation notes: 2
 mutant description: 2
 mutant collection: 2
 mtdna: 2
 mst2:: 2
 mscv cre-gfp retroviral infection: 2
 mpl w515k/l status: 2
 mouse.no: 2
 mouse type: 2
 mouse tissue: 2
 mouse strain/background: 2
 mouse strain of origin: 2
 mouse model strain: 2
 mouse genotype/variation: 2
 moult status: 2
 mother id: 2
 mother generation: 2
 morphotype: 2
 morphologic form: 2
 morph: 2
 months to last contact or death: 2
 months to last clinical assessment: 2
 months to first progression: 2
 monocyte subsets: 2
 monkey: 2
 molecular group: 2
 molecular diagnosis: 2
 mof supplementation: 2
 modulating agent: 2
 mode_of_action: 2
 mobilization: 2
 mmr.status: 2
 ml): 2
 mirna: 2
 million monocyte: 2
 million modc: 2
 million dcs: 2
 microsatellite instability (msi) status: 2
 microdissection: 2
 microbiota status explanation: 2
 microbiota status: 2
 microbial condition: 2
 microarray.outlier: 2
 microarray slide block: 2
 microarray barcode: 2
 mic_van: 2
 miRNA transfection: 2
 miRNA source: 2
 mhc.ii subpopulation: 2
 metastatic status: 2
 metastatic: 2
 metastasis (1-yes, 0-no): 2
 metastases: 2
 metal concentration: 2
 metabolic status: 2
 meta or recurrence within 3 years: 2
 menstrual phase mp: 2
 menstrual phase: 2
 menopause: 2
 menopausal status ms: 2
 melanoma: 2
 meis1 genotype: 2
 meis1 expression levels: 2
 medium supplement: 2
 medip antibody vendor: 2
 medications: 2
 medical history: 2
 media type: 2
 meat quality: 2
 measurement group: 2
 measurement: 2
 mean weight: 2
 mean bmi: 2
 mdv sensitivity: 2
 matrix: 2
 maternal treatment group: 2
 maternal genotype/variation: 2
 maternal genetic modification: 2
 maternal ecotype: 2
 material support: 2
 matching input: 2
 mass size cm: 2
 marker line: 2
 mark: 2
 mammary epithelial cell population: 2
 mammalian host: 2
 malignancy stage: 2
 male.type: 2
 male parent: 2
 male: 2
 main epithelial component: 2
 magnetic cell sorting: 2
 m stage 0: 2
 lymph node ln status: 2
 lung cell population: 2
 lumb_brca2_pred_agilent: 2
 lrrk2 genotype: 2
 lrg5 status: 2
 lot: 2
 location of tumor: 2
 location of lesion: 2
 lnige: 2
 lm: 2
 liver vtg mrna: 2
 liver sample group: 2
 liver esr1 mrna: 2
 liver: 2
 litter id: 2
 limited_source: 2
 light timepoint: 2
 light conditions: 2
 ligand treatment: 2
 life cycle: 2
 library source: 2
 library label: 2
 level of expression of the sox9-egfp reporter gene: 2
 leukemia type: 2
 leukemia stem cells (lsc): 2
 lesion score: 2
 lesion id: 2
 lentivirus vector: 2
 lentivirus infection: 2
 lentiviral infection with nf2 either wt or l46r inactive mutant: 2
 lentiviral infection: 2
 lentiviral construct: 2
 leaf-stage: 2
 laterality: 2
 landrace: 2
 laboratory strain: 2
 laboratory batch: 2
 labelling batch: 2
 labeling_reference: 2
 labeling agent: 2
 labeled cdna: 2
 kshv +/-: 2
 kras-iw mutation  yes/no: 2
 kras-iw mutation  (yes/no): 2
 kps: 2
 knockout: 2
 kit: 2
 ki67 ihc: 2
 k562 cells: 2
 k562 cell: 2
 k562: 2
 jun status: 2
 jak2 v617f quantitative genotyping: 2
 jak2 amp9p24.3: 2
 jak inhinitor: 2
 ivm concentration: 2
 itraconazole resistance: 2
 isolation/cell type: 2
 isolation date: 2
 isolate type: 2
 isolate sensitivity: 2
 isolate details: 2
 isogenic line: 2
 isoform: 2
 iron source: 2
 iron concentration (um): 2
 ipi: 2
 intragastric administration: 2
 internal id: 2
 interaction: 2
 insulin sensitivity: 2
 insulin: 2
 institution: 2
 insertlength: 2
 insecticide resistance: 2
 inoculation method: 2
 injected activity: 2
 initial highest diameter in mm by image: 2
 initial clinical size in mm by palpation: 2
 influenza strain: 2
 infiltrating t-cells: 2
 infiltrated with: 2
 inferred cell type: 2
 infection type: 2
 infection phase: 2
 infecting parasite species: 2
 infected host cell line: 2
 infected construct: 2
 induction agent: 2
 inducer treatment: 2
 induced gene: 2
 individual/donor id: 2
 individual identifier 3: 2
 individual identifier 1: 2
 indication: 2
 incubation temperature: 2
 incubation duration: 2
 included in analysis: 2
 in9-lb: 2
 in9-hb: 2
 in5-lb: 2
 in5-hb: 2
 in1-lb: 2
 in1-hb: 2
 in vivo treatment: 2
 immunodepletion: 2
 immuno-supression: 2
 immunized with: 2
 ihc: 2
 igm: 2
 igf1r knockdown: 2
 ifna dose: 2
 idh1/2 mutations: 2
 identifier of donor: 2
 iclip antibody: 2
 iPSc source: 2
 hystotype: 2
 hypoxia: 2
 hybridisation chip: 2
 hybridation batch: 2
 humidity: 2
 hu306 classification: 2
 hu subtype: 2
 hs class: 2
 hras_genotype: 2
 hpca51t psa-positive cells: 2
 hpca51t psa-negative cells: 2
 hpca49t psa-positive cells: 2
 hpca49t psa-negative cells: 2
 hpca47t psa-positive cells: 2
 hpca47t psa-negative cells: 2
 hpca46t psa-positive cells: 2
 hpca46t psa-negative cells: 2
 hours post fertilization hpf: 2
 hours post fertilization: 2
 host variety: 2
 host plant: 2
 host diet: 2
 hospital: 2
 hormone: 2
 hormonal therapy: 2
 hla-dqb1 genotype: 2
 hive: 2
 hit.status: 2
 history: 2
 histopatological desription: 2
 histopathological diagnosis: 2
 histology subtype1: 2
 histology subtype: 2
 histology procedure: 2
 histology group: 2
 histology (p63): 2
 histological_subtype_primary tumor: 2
 histological diagnosis: 2
 histologic subtype: 2
 histologic diagnosis: 2
 his type: 2
 high fat diet: 2
 her2_status: 2
 her2_dbcg: 2
 her2/neu: 2
 her2 immunohistochemestry: 2
 her2 (fish) status: 2
 her status: 2
 hemolysis score hs: 2
 hemoglobin a1c: 2
 hemoglobin: 2
 hematopoiesis population: 2
 height: 2
 heart rate beats/min: 2
 hearing status: 2
 healthy donor: 2
 hdl: 2
 hdh genotype: 2
 hd number: 2
 hcv_rna_negative_at_wks: 2
 hbsag: 2
 hb: 2
 hasenclever score: 2
 has_carc_array: 2
 has.2.paps: 2
 harvest year: 2
 harvest time post treatment: 2
 haplogroup: 2
 hair growth cycle: 2
 hai titer (day 28) - b/malaysia/2506/2004: 2
 hai titer (day 28) - b/florida 4/2006: 2
 hai titer (day 28) - b/brisbane/3/2007: 2
 hai titer (day 28) - a/wisconsin/67/2005 (h3n2): 2
 hai titer (day 28) - a/uruguay/716/2007  nymc x-175c (h3n2): 2
 hai titer (day 28) - a/uruguay (h3n2): 2
 hai titer (day 28) - a/south dakota/6/2007 (h1n1): 2
 hai titer (day 28) - a/brisbane/59/2007 (h1n1): 2
 hai titer (day 28) - a/ solomon islands/3/2006 (h1n1): 2
 hai titer (day 0) - b/malaysia/2506/2004: 2
 hai titer (day 0) - b/florida 4/2006: 2
 hai titer (day 0) - b/brisbane/3/2007: 2
 hai titer (day 0) - a/wisconsin/67/2005 (h3n2): 2
 hai titer (day 0) - a/uruguay/716/2007  nymc x-175c (h3n2): 2
 hai titer (day 0) - a/uruguay (h3n2): 2
 hai titer (day 0) - a/south dakota/6/2007 (h1n1): 2
 hai titer (day 0) - a/brisbane/59/2007 (h1n1): 2
 hai titer (day 0) - a/ solomon islands/3/2006 (h1n1): 2
 h3f3a status: 2
 h37rv:: 2
 guide rna: 2
 gsi: 2
 gse35624 study sample accessions: 2
 growth substrate: 2
 growth satge: 2
 growth phase and conditions: 2
 growth mode: 2
 growth factors in the culture medium: 2
 grown on substrate: 2
 grow conditions: 2
 gonad wt g: 2
 glomerular filtration rate: 2
 global bilag score each a = 9, each b = 3, each c = 1: 2
 ggi_class: 2
 ggi: 2
 gfp-construct: 2
 gestational salt status: 2
 gestational diabetes: 2
 gestational day: 2
 gestation day: 2
 germplasm line: 2
 germline knock-down: 2
 germ-free): 2
 germ cell generation: 2
 genoytpe: 2
 genotype/variations: 2
 genotype/variation: ApcD14/+: 2
 genotype/variation vector: 2
 genotype/cultivar: 2
 genotype state: 2
 genotype of the cells: 2
 genotype 2: 2
 genotype 1: 2
 genomic subtype: 2
 genomic composition: 2
 genome variation: 2
 genome composition: 2
 genome accession: 2
 genome: 2
 genetics: 2
 genetic manipulation: 2
 genetic background ecotype: 2
 generations: 2
 general_brca2_pred_agilent: 2
 general_brca1_pred_agilent: 2
 geneotype/variation: 2
 gene expression: 2
 gender,: 2
 gcn5:: 2
 gc responder type: 2
 gal4 line: 2
 g0 mother treatment: 2
 fvc-group: 2
 fusion: 2
 fresh tissue: 2
 frequency of maternal licking/grooming and arched-back nursing: 2
 frequency maternal licking/grooming and arched-back nursing: 2
 frequency: 2
 fragmentation: 2
 fpc trachoma score: 2
 forward scatter: 2
 followup time: 2
 follow-up months: 2
 follow-up loss: 2
 folfiri status: 2
 fluorescence: 2
 fluid: 2
 flower type: 2
 fl grade: 2
 fixation: 2
 fish number: 2
 fish description: 2
 fish: 2
 first progression or relapse: 2
 final surgery date: 2
 final pathology size in mm: 2
 final number of resected ganglia: 2
 final number of positive ganglia: 2
 final clinical size in mm by palpation: 2
 field location: 2
 ffpe block storage duration time (yrs): 2
 fetus generation: 2
 fetal sex: 2
 fetal age: 2
 fermentor: 2
 female.type: 2
 female parent: 2
 female: 2
 feeding period: 2
 feeders: 2
 feature: 2
 fat: 2
 family id: 2
 familial status: 2
 factors: 2
 factor: 2
 facs sorting: 2
 facs sorted for: 2
 facility: 2
 fab subtype: 2
 fab classification: 2
 f- psa: 2
 f: 2
 extreme phenotype group: 2
 extraction_reference: 2
 extraction_amount: 2
 extraction date: 2
 extent of disease: 2
 exptl group: 2
 exposure concentration: 2
 exposed stress: 2
 explant timepoint: 2
 experimentor: 2
 experimentid: 2
 experimenter: 2
 experimental_replicate: 2
 experimental status: 2
 experimental batch: 2
 experiment date: 2
 experiment batch: 2
 experimantal conditions: 2
 exogenous hormone ovarian stimulation: 2
 exercise type aerobic or resistance: 2
 exercise group: 2
 excision to snap freeze min: 2
 ex vivo t production (ng/ml/12h): 2
 ex vivo e2 (ng/ml/12h): 2
 ets group: 2
 ets fusion status: 2
 etoh/dox treatment: 2
 ethnicity c= caucasian, h=hispanic, aa=african american, a=asian: 2
 estrogen receptor immunohistochemestry: 2
 estrogen receptor er: 2
 esr1_status: 2
 esr1 genotype: 2
 erg group: 2
 ercc_mix: 2
 erbb2_status: 2
 era: 2
 er_status_ihc_esr1_for indeterminate: 2
 er_status_ihc: 2
 er_status: 2
 er_dbcg: 2
 er.ihc: 2
 er status ihc: 2
 er positive vs negative: 2
 eqtl: 2
 eporcre genotype: 2
 ephb2 surface abundance: 2
 epcam: 2
 engraftment: 2
 energy balance: 2
 end borg: 2
 embryonic treatment: 2
 embryonic region: 2
 embryonic age: 2
 embryo identifier in litter: 2
 embryo biopsy result: 2
 embryo  identifier: 2
 embryo: 2
 embedding strategy: 2
 eluate: 2
 electroacupuncture frequency: 2
 edss after 1 year: 2
 ectopic barts: 2
 ecotype/cultivar: 2
 ecdysone treatment: 2
 ebv-status: 2
 ebv +/-: 2
 eae grade average: 2
 e2f1 genotype: 2
 e-cadherina ihc: 2
 duration of the experiment: 2
 duration of infection: 2
 duration of illness: 2
 dukes stage: 2
 dsrna treatment: 2
 dsdna ab titers u/l by farr assay: 2
 drug treatment time point: 2
 drug sensitivity: 2
 drug pre-treatment: 2
 drosha expression: 2
 drip loss phenotype: 2
 drfs_even_time_years: 2
 drfs_1_event_0_censored: 2
 drawing year: 2
 doxycycline treatment: 2
 doxycycline: 2
 dox treatment: 2
 dox induction: 2
 dose_unit: 2
 dose ug/kg: 2
 dose group: 2
 dormancy state: 2
 donor tissue: 2
 donor status: 2
 donor pool ethnicity: 2
 donor of hepatocytes: 2
 donor number: 2
 donor id number: 2
 donor group: 2
 donor ethnicity: 2
 donor disease status: 2
 domestication: 2
 dnmt3b overexpression: 2
 dna-damage: 2
 dna source: 2
 dlda30_prediction: 2
 dlco: 2
 div: 2
 distributor: 2
 distal recurrence time: 2
 distal recurrence: 2
 diseasestatus: 2
 diseasestaging: 2
 disease_status: 2
 disease_location: 2
 disease_free_survival_years: 2
 disease_free_survival_event: 2
 disease/status: 2
 disease-free survival time dfs: 2
 disease specific survival years: 2
 disease recurrence: 2
 disease phenotype: 2
 disease free survival time (months): 2
 disease course: 2
 disease activity: 2
 differentiation days: 2
 differentiation condition: 2
 dietary group: 2
 dietary fat: 2
 diet intervention time: 2
 diet group dam: 2
 diet during pregnancy/lactation: 2
 diagonsis: 2
 diagnosis age: 2
 diabetes type: 2
 dia bp mm hg: 2
 dfs event: 2
 dex treatment: 2
 developmental time point: 2
 developmental stage/cell type: 2
 developmental stage rna isolation: 2
 developmental stage and caste: 2
 developmental period: 2
 dev.stage (boyes et al. plant cell 2001): boyes: 2
 dev.stage: 2
 derived from metastatic site: 2
 deletion: 2
 del20q13.11: 2
 del17p: 2
 deathweight: 2
 death yr: 2
 death months: 2
 death (1): 2
 days_alive: 2
 days_after_senescence: 2
 days-followup: 2
 days post-inoculation: 2
 days post infection: 2
 days post exposure: 2
 days of eb differentiation: 2
 days of ddc treatment: 2
 day post wound closure: 2
 day of sampling: 2
 day of sample collection post-innoculation: 2
 day of isolation: 2
 day of in vitro differentiation: 2
 day of collection: 2
 day after sirna treatment: 2
 date_start: 2
 date_sac: 2
 date of visit: 2
 date of viral origin: 2
 date of sampling: 2
 date at relapse: 2
 date at death: 2
 data at diagnosis: 2
 dasl,plate,row: 2
 dasl,plate,column: 2
 dasl,plate: 2
 dark timepoint: 2
 dam: 2
 cytology: 2
 cytokines: 2
 cytokine treatment: 2
 cytokine condition: 2
 cytogenetic and fish findings: 2
 cyto risk: 2
 cycling state: 2
 cycle day: 2
 current risk category: 2
 cultures: 2
 cultured medium: 2
 culture,stage,sd: 2
 culture,stage,mean: 2
 culture time hrs: 2
 culture status: 2
 culture results: 2
 culture place: 2
 culture optical density: 2
 culture method: 2
 culture intensity: 2
 cultivation time: 2
 cultivation temperture: 2
 cultivar/variety: 2
 ctid: 2
 creatinine clearance: 2
 covrs status: 2
 corresponding to gse17536: 2
 copy number abnormalities: 2
 copy number aberrations: 2
 copper conc.: 2
 copd: 2
 control): 2
 control pool: 2
 control for: 2
 contamination status: 2
 consumer product phase 2: 2
 consumer product phase 1: 2
 conidial age: 2
 condition/variation: 2
 condition specifics: 2
 component: 2
 common reference composition: 2
 colony id: 2
 colonization status: 2
 collection day: 2
 collaborative cross line genetic background: 2
 code progression-free survival: 2
 code overall survival: 2
 code disease-specific survival: 2
 co2 level: 2
 co2: 2
 co-culture time: 2
 cms: 2
 cm: 2
 clone phenotype: 2
 clone id origin: 2
 clonality: 2
 clip antibody info.: 2
 clinical_t_stage: 2
 clinical_nodal_status: 2
 clinical_ajcc_stage: 2
 clinical trial arm: 2
 clinical t stage: 2
 clinical subtype: 2
 clinical signs: 2
 clinical sample: 2
 clinical response: 2
 clinical procedure: 2
 clinical outcome: 2
 clinical m staging: 2
 clinical info: 2
 clinical follow up: 2
 clinical characteristics: 2
 class genotype: 2
 ckit facs: 2
 cit-induced switching: 2
 cit-coloncancermolecularsubtype: 2
 cisplatin response (complete response or incomplete response): 2
 cis_dose: 2
 circadian cycle time point: 2
 cinsarc: 2
 cigarettes/day: 2
 chx treatment: 2
 cholesterol: 2
 cho cell line: 2
 chip/dip antibody: 2
 chip or dip: 2
 chip number: 2
 chip id: 2
 chip average background: 2
 chip antibody manufactuer: 2
 chip antibody lot. #: 2
 chip antibody lot#: 2
 chip antibody information: 2
 chip antibody info.: 2
 chip antibody info: 2
 chip antibody 2: 2
 chip antibody 1: 2
 chimera description: 2
 chemotherapy4: 2
 chemotherapy3: 2
 chemotherapy2: 2
 chemotherapy1: 2
 chemotherapy.adjuvant: 2
 chemotherapy treatment: 2
 chemotheraphy: 2
 chemostat: 2
 chemosensitivity_prediction: 2
 chemosensitivity: 2
 chemoresponse: 2
 chemical treatment conditon: 2
 chemical treatment condition: 2
 chemical group: 2
 chek2 1100delc mutation status: 2
 characteristics: 2
 channel: 2
 chamber batch: 2
 challenge status: 2
 cghdata.available: 2
 centre: 2
 cells used: 2
 cellline: 2
 celll line: 2
 cell-treatment: 2
 cell variant: 2
 cell surafce marker: 2
 cell subline: 2
 cell storage: 2
 cell sorting strategy: 2
 cell purification: 2
 cell preparation: 2
 cell or tissue type: 2
 cell of origin defined by ihc: 2
 cell morphology: 2
 cell mixture: 2
 cell line/tissue: 2
 cell line source tissue: 2
 cell line source gender: 2
 cell line source ethnicity: 2
 cell line source age: 2
 cell line or clinical sample: 2
 cell line info.: 2
 cell line info: 2
 cell line genotype/variation: 2
 cell group: 2
 cell cycle transition: 2
 cell culture phenotype: 2
 cell culture condition: 2
 cell cultivation: 2
 cell component: 2
 cell compartment: 2
 cell  ine: 2
 cebpa: 2
 cd5: 2
 cd4 %: 2
 cd161 subtype: 2
 cd14 %: 2
 cd evolution time years: 2
 catalog#: 2
 catalog numbers: 2
 catalog: 2
 case_id: 2
 case/control pair: 2
 case-control status: 2
 case diagnosis: 2
 cartridge: 2
 carbohydrate source: 2
 car: 2
 calr status: 2
 c: 2
 bv-hsvtk purification method: 2
 buffy coat: 2
 buffer: 2
 bromouridine labeling time: 2
 bromouridine labeling start: 2
 broad diagnosis: 2
 breed (cattle): 2
 breast affected: 2
 break induction on chr.iv: 2
 brain ph: 2
 brain metastasis: 2
 brain location: 2
 brain bank: 2
 brafv600e mutation: 2
 braf/ret/ras status; braf+- v600e mutation presence; ret+- ret rearrangement presence, ras+ - ras mutation presence: 2
 braf inhibitor resistance: 2
 braak stage: 2
 body weight g: 2
 body weight exposure: 2
 body weight before anaesthetics: 2
 body weight before allocation: 2
 bmngrd: 2
 blood source: 2
 blood island injection at 28 hpf: 2
 blood flow: 2
 blood: 2
 bleed date: 2
 birthweight: 2
 birads: 2
 biosourcetype: 2
 bioremediation treatment: 2
 biopsy time: 2
 biopsy site (grouped): 8: 2
 biopsy site (grouped): 1: 2
 biological sources: 2
 biological source of exosomes: 2
 biological replicate number: 2
 biological repeat: 2
 biological eplicate: 2
 biofilm type: 2
 biofilm age: 2
 biofilm: 2
 bio.replicate: 2
 behaviour: 2
 bcr: 2
 bcp all subtype: 2
 bcl6.break: 2
 bcl2.break: 2
 bcg: 2
 batch year: 2
 batch id: 2
 basal_brca1_pred_agilent: 2
 bardcode: 2
 barcode sequence: 2
 barcode first 3 nt for fastq files of chip-seq libraries, first 4 nt for fastq files of small rna libraries: 2
 barcode already removed: 2
 barcode 5'->3': 2
 bar code: 2
 bacteriophage: 2
 bacteriology score: 2
 bacterial status: 2
 bacterial numbers in urine: 2
 bacterial inoculant: 2
 background genotype: 2
 back ground strain: 2
 b-cell subset: 2
 average gic50 nm: 2
 average gic50: 2
 authority: 2
 atopy status: 2
 atl subtype: 2
 atherosclerotic plaque size pretreatment: 2
 atherosclerotic plaque size postreatment: 2
 atcc catalog number: 2
 at 8: 2
 at 6: 2
 at 4: 2
 at 22: 2
 at 20: 2
 at 2: 2
 at 18: 2
 at 12: 2
 at 10: 2
 at 0: 2
 artery type: 2
 arrayname: 2
 array_batch: 2
 arm: 2
 apol1 genotype: 2
 antibody treatment: 2
 antibody name: 2
 antibody manufactuer: 2
 antibody lot: 2
 antibody info: 2
 antibiotic treatment: 2
 antibiotic: 2
 anti-double stranded dna ab titers farr units/ml: 2
 ann arbor stage: 2
 animaltype: 2
 animals in pool: 2
 animalid: 2
 animal_number: 2
 animal number rxid: 2
 ancestral strain: 2
 anatomical region: 2
 anatomical localisation: 2
 anatomic location: 2
 amplification date: 2
 amount used (ng): 2
 amoeba: 2
 aml sample identifier: 2
 alt_id: 2
 all subtype: 2
 all lineage: 2
 alk mutation status: 2
 alive-or-dead: 2
 alive at endpoint: 2
 alcohol consumption: 2
 al 2001: 2
 ajcc staging: 2
 ajcc stage 7th edition, 2010: 2
 ageunit: 2
 agents: 2
 agent concentration: 2
 agent batch: 2
 agemonths: 2
 age unit: 2
 age quit smoking: 2
 age or tumor stage: 2
 age of trees: 2
 age of punction: 2
 age of plants: 2
 age of donor: 2
 age of diagnosis: 2
 age of blood draw: 2
 age of biopsy: 2
 age in days: 2
 age category: 2
 age at start: 2
 age at sample months: 2
 age at menarche: 2
 age at infection: 2
 age at harvest: 2
 age at drawing: 2
 age at dosing: 2
 age at diagnosis yrs: 2
 age at death yrs: 2
 age at death in years: 2
 age 1: 2
 age (yr): 2
 affinity tag: 2
 affinity purification method: 2
 affected status: 2
 affected lymph node: 2
 advanced: 2
 administration into mice: 2
 adjuvant rx: 2
 adiological signs: 2
 adenovirus infection: 2
 additive: 2
 additional information: 2
 added nutrient: 2
 adar1 genotype: 2
 adaptation status: 2
 activity: 2
 activated: 2
 acquisition date: 2
 ablation: 2
 a53t: 2
 a260/280: 2
 a260/230: 2
 ^sample: 2
 Weight (kg): 2
 Virus Strain: 2
 Variety: 2
 VO2 max: 2
 VH status: 2
 Type of donor: 2
 Tumour_Subtype: 2
 Tumour_Grade: 2
 TumourSide: 2
 TumourKeratinisation: 2
 Tumor_grading: 2
 TumorPercentage: 2
 Tumor Type: 2
 Tumor Size(cm): 2
 Tumor Size: 2
 Tumor Grade: 2
 Trial: 2
 TreatmentDuration: 2
 Time_to_Cancer_Related_Death_Years: 2
 Time_to_Cancer_Recurrence_Years: 2
 TimePoint: 2
 Time point: 2
 Time (min): 2
 TestType: 2
 Te: 2
 Taxname: 2
 Taxid: 2
 TP53 mutation: 2
 TNM_Stage: 2
 TIME: 2
 T Cell Activation: 2
 Survival_Status_at_Last_Followup: 2
 Study Group: 2
 Strain Name: 2
 Strain : 2
 Stimulation: 2
 State: 2
 Stain: 2
 Specimen with known storage state: 2
 Source tissue: 2
 Size: 2
 Serum creatinine: 2
 SamplingTime: 2
 Sample type: 2
 Sample Type: 2
 STRAIN: 2
 Replicate culture: 2
 Renal graft bx: 2
 Relapsed: 2
 Recurrence_Site: 2
 Recurrence: 2
 RNAi construct: 2
 RNAi against: 2
 RNAconcentration ng per microL: 2
 RNA Integrity Number: 2
 RIN: 2
 Provider: 2
 ProportionMurineRNA: 2
 Progression Free Survival(days): 2
 Prognosis: 2
 ProductCode: 2
 Primary_Tumour_Location: 2
 PreservationType: 2
 PreservationTy: 2
 Positive_Nodes: 2
 Personal_History_of_HNPCC: 2
 Personal_History_of_FAP: 2
 Patient identifier: 2
 Patient No.: 2
 Passage: 2
 Pack Year: 2
 PR: 2
 PMD 5: 2
 PMD 30: 2
 PMD 3: 2
 PMD 29: 2
 PMD 18: 2
 PMD 17: 2
 PMD 14: 2
 PMD 1: 2
 PMD: 2
 PKYRS: 2
 OverallSurvival: 2
 Overall Survival(days): 2
 OrganismPart <2>: 2
 OrganismPart <1>: 2
 OS status: 2
 Number of mice per chip: 2
 No_Regional_Lymph_Nodes_Assessed: 2
 No_Positive_Nodes: 2
 Neuralizing Antibody Titer: 2
 Mice: 2
 Menstrual cycle phase: 2
 Maximum_Tumour_Diameter_cm: 2
 MatchID: 2
 Lymphovascular_Invasion: 2
 LymphNodeStatus: 2
 Length_of_Followup_Years: 2
 Legend: 2
 Last_Followup_Date: 2
 Labeling_reference: 2
 LVI: 2
 Injury: 2
 InitialTimePoi: 2
 IndividualGeneticVariation: 2
 IL-6 (pg/ml): 2
 Histotype: 2
 Height (m): 2
 HIST: 2
 Growth stage: 2
 Genome_ID: 2
 GeneticVariationType: 2
 GeneticBackground: 2
 Genetic Modification: 2
 Gender : 2
 GI: 2
 GENOTYPE: 2
 Family_History_of_CRC: 2
 FamilyRelationship: 2
 FISH wet wt g: 2
 FISH strain: 2
 FISH: 2
 FIGO stage: 2
 FIGO Substage: 2
 FIGO Stage: 2
 FEV1 pred: 2
 FEV1 / VC max: 2
 Extraction_reference: 2
 Exposure: 2
 Experiment: 2
 EstrogenReceptorStatus: 2
 Escherichia coli O157: 2
 EnvironmentalStress: 2
 Ectopic Gene: 2
 ERBB2: 2
 ER: 2
 EIC: 2
 E. coli O157: 2
 Donor: 2
 Disease_staging: 2
 DiseaseState <2>: 2
 DiseaseLocati: 2
 Disease-Free Survival: 2
 Disease free interval (DFI) in  months: 2
 Developmental_stage: 2
 Description: 2
 Date_of_Surgery: 2
 Date_of_Cancer_Related_Death: 2
 Date_of_Cancer_Recurrence: 2
 DSS time: 2
 DOSE: 2
 Culturing Conditions: 2
 Coriell cell line repository identifier: 2
 ComplexAction: 2
 ColonyType: 2
 Cohort: 2
 ClinicalInformation: Date_of_surgery: 2
 ClinicalInformation: Date_of_birth: 2
 Class: 2
 CellularModification: 2
 Cell-Line: 2
 Cancer_Related_Death: 2
 Cancer_Recurrence: 2
 CTNNB1 mutation: 2
 CO2 treatment: 2
 Block_Age_at_RNA_Extraction_Years: 2
 BiologicalReplicate: 2
 Banff'97: 2
 Backgroud: 2
 Asbestos Exposure: 2
 Arabidopsis thaliana columbia  - dev.stage Boyes et al. Plant Cell 2001: 2
 Arabidopsis thaliana col-0  - dev.stage Boyes et al. Plant Cell 2001: 2
 Arabidopsis thaliana (wassilewskija)  - harvest date: 2
 Arabidopsis thaliana (col-0)  mutant (pGreen: 2
 Arabidopsis thaliana (col-0)  - age: 2
 Amp: 2
 AlcoholAbuse: 2
 Age_at_Diagnosis: 2
 Age(d): 2
 Age (years): 2
 Age : 2
 Action: 2
 Accession: 2
 8-week disease control 1=yes, 0=no: 2
 8-week disease control (1=yes, 0=no): 2
 7q32 deletion: 2
 5' barcode: 2
 36(12): 2
 3' adaptor: 2
 28 day survival: 2
 260-280Ratio: 2
 260-230Ratio: 2
 24hr reperfusion: 2
 1p status: 2
 198(12): 2
 18s: 2
 17q status: 2
 17beta-estradiol treatment time: 2
 17(1): 2
 16-gene classifier: 2
 12h: 2
 11q status: 2
 0: no): 2
 - sex: 2
 - date of surgery: 2
 - date of birth: 2
 %_Tumour_Cell_Content: 2
 280: 2
 230: 2
 97: 2
 5: 2
 zygotic treatment: 1
 zygote generation: 1
 zt time: 1
 zt at harvest: 1
 znso4 treated: 1
 zll dependency: 1
 zinc exposure: 1
 zinc concentration: 1
 zebrafish strain: 1
 zebrafish line: 1
 zap-70 status: 1
 zap-70 expression: 1
 zadoks' growth scale: 1
 yrr1_ allele transformed: 1
 yr): 1
 youngest): 1
 young/old: 1
 young shoot: 1
 yield loss group: 1
 yes - harvest date: 1
 yellow fever antibody measurement: 1
 yeast strain: 1
 years]: 1
 years to last followup: 1
 years to dialysis: 1
 years passed since quitting: 1
 year reared: 1
 year of storage: 1
 year of sample collection: 1
 y-lineage: 1
 xrn1: 1
 xray: 1
 xprG:: 1
 xist expression: 1
 xenotransplantation site: 1
 xenotransplantation host: 1
 xenografts host mice: 1
 xenografts: 1
 xenografted into host: 1
 xenograft strain: 1
 xenograft source: 1
 xenograft recipient mice strain: 1
 xenograft line: 1
 xenograft cell type: 1
 xenograft cell line: 1
 xenoestrogen: 1
 xam strain: 1
 x-ray exposure: 1
 x origin: 1
 wz4002 resistant: 1
 wwtr1 expression level: 1
 wtissue: 1
 wt1 mutation status: 1
 wt or mutant: 1
 wound id: 1
 worst pattern of invasion wpoi: 1
 worm stage: 1
 work-place: 1
 wood substrate line: 1
 wood dust exposure: 1
 wood density: 1
 wnt3a treatment: 1
 wnt2 expression: 1
 wnt suppression: 1
 wmelpop infection: 1
 wk8 response: 1
 wk30 response: 1
 wing section color: 1
 wing section: 1
 wing phenotype: 1
 wing: 1
 wilms tumor sample: 1
 wildtype line: 1
 wild-type vs male-sterile: 1
 wild type line: 1
 wild type: 1
 wild or lab strain: 1
 whorl: 1
 whole organ harvested at: 1
 whole cells: 1
 whole body insulin sensitivity index: 1
 who histotype: 1
 who 2009 dengue classification: 1
 who 1997 dengue classification: 1
 white cells count: 1
 white blood count: 1
 well_location: 1
 well watered: 1
 weiss score of tumor: 1
 weigth: 1
 weightlossfromusual: 1
 weightloss: 1
 weightg: 1
 weight_g: 1
 weight/length: 1
 weight(kilograms): 1
 weight start: 1
 weight of animal: 1
 weight loss: 1
 weight inoculation g: 1
 weight end: 1
 weight class: 1
 weight autopsy g: 1
 weight at infection (kg): 1
 wei id: 1
 weeks since first clinic visit: 1
 weeks post-tarnsplantation: 1
 weeks after treatment: 1
 week5insulin uiu per ml: 1
 week5glucose mg per dl: 1
 week of gestation: 1
 week: 1
 weaning: 1
 wcc: 1
 wbc_unm: 1
 wbc_cells_per_ul: 1
 wbc/r: 1
 wbc/dg: 1
 wbc at diagnosis 10e9/l: 1
 wbc 10e9/l: 1
 wbc 1000s/mm3: 1
 wbc (x10^3/mcl): 1
 wbc  /mm3: 1
 wave pattern: 1
 water/food access: 1
 water-limitation: 1
 water type: 1
 water temperature: 1
 water stress: 1
 water salinity %: 1
 water availability regime: 1
 warm/hot temperature regimen: 1
 waist to hip ratio: 1
 waist hip ratio: 1
 wafer locus: 1
 voraconazole resistance: 1
 vonsattel grade: 1
 volunteer id: 1
 volunteer group: 1
 volunteer: 1
 volume of injection: 1
 volume: 1
 vo2max /kg: 1
 vo2max: 1
 viticola: 1
 vital_status: 1
 vital.status: 1
 visit number: 1
 visit date: 1
 virus used for infection: 1
 virus serotype: 1
 virus replication time: 1
 virus genotype: 1
 virulence_time as used for model: 1
 viral transduction status: 1
 viral status: 1
 viral mrna: 1
 vip staining: 1
 vineyard site: 1
 vincristine auc: 1
 vincristine: 1
 vin/con rats dyad group: 1
 vili  condition: 1
 viability status: 1
 vhl status: 1
 vh status = igvh mutational status fais et al. j clin invest, 1998: 1
 vfa cm2: 1
 vet path diagnosis: 1
 vessel type: 1
 vesicle size: 1
 vernalization treatment: 1
 venus detected: 1
 ventilation type: 1
 venotype/variation: 1
 vendor/catalog/lot: 1
 vendor and part number: 1
 vender name and catalog number: 1
 vehicle for chemical: 1
 vehicle 2: 1
 vehicle 1: 1
 vegf module tertile: 1
 vector transfection: 1
 vector construct: 1
 vascular.invasion: 1
 variation/fusion type: 1
 variation (of transplanted cells): 1
 variant type: 1
 variaion: 1
 varat: 1
 varaiation: 1
 vancomycin and daptomycin susceptibility: 1
 vaccine treatment: 1
 vaccine group: 1
 vaccine challenge: 1
 vaccination time: 1
 vaccination status: 1
 vaccination group: 1
 vaccination for wnv: 1
 vaccinated with: 1
 v617f jak2: 1
 v. vinifera co-culture: 1
 v and a: 1
 uvr treatment: 1
 uvb treated: 1
 uva treatment at day 1: 1
 uv exposure: 1
 uv: 1
 usp28-genotype: 1
 used in mgus vs healthy comparison (1-yes): 1
 used in fl/emzl vs healthy comparison (1-yes): 1
 used in cll vs healthy comparison (1-yes): 1
 used in classifier training: 1
 used in analysis: 1
 used for qpcr of microrna in chr19q13.41: 1
 used for analysis: 1
 used for: 1
 urticaria status: 1
 urothelial recurrence: 1
 urine protein: 1
 urbp level: 1
 upper_protocol: 1
 upn: 1
 updrs score: 1
 updated diagnosis: 1
 up: 1
 unp identifier: 1
 unnatural amino acid: 1
 units of treatment time: 1
 units of treatment repeat: 1
 unit: 1
 uniprotkb id: 1
 unesterified chol mg per dl: 1
 umbiical cord blood lactate level: 1
 uid: 1
 uiccstage: 1
 uicc tumor stage: 1
 uicc stage: 1
 uhrf1 study: 1
 uhc-subgroup: 1
 ugt1a6 genotype: 1
 ud: 1
 ucss: 1
 uc flare up: 1
 u-unmethylated: 1
 tyramine producer: 1
 types of treatment: 1
 types of teeth: 1
 type taxane: 1
 type of yfp: 1
 type of transfer: 1
 type of thyroid tussue ptc denotes papillary thyroid cancer: 1
 type of surgical procedure: 1
 type of stress: 1
 type of sirna: 1
 type of sample: 1
 type of primary melanoma: 1
 type of operation: 1
 type of melanoma: 1
 type of lung transplant: 1
 type of injury: 1
 type of infection: 1
 type of ifn: 1
 type of hcv: 1
 type of exercise: 1
 type of electron acceptor: 1
 type iib fiber %: 1
 type i fiber %: 1
 type case=1\contr=0: 1
 txprimary: 1
 txdate: 1
 two-species biofilm: 1
 twins: 1
 twin zygosity: 1
 twin type: 1
 twin set: 1
 twin id: 1
 twin condition: 1
 twin a or twin b: 1
 twin: 1
 tutor experience: 1
 tumour width cm: 1
 tumour site: 1
 tumour percentage: 1
 tumour of origin: 1
 tumour length cm: 1
 tumour component: 1
 tumour cell line used for conditioning medium: 1
 tumour behaviour: 1
 tumorigenic or nontumorigenic: 1
 tumorigenic cell type: 1
 tumorigenic: 1
 tumorid: 1
 tumorgenecity: 1
 tumorburden: 1
 tumor_subtype_0na_1classical_2basal: 1
 tumor_stage: 1
 tumor_location: 1
 tumor_entity_subtype: 1
 tumor_cell_line: 1
 tumor/normal: 1
 tumor.in.left.right.lobe: 1
 tumor-nodes-metastasis tnm classification - t: 1
 tumor-nodes-metastasis tnm classification - n: 1
 tumor-nodes-metastasis tnm classification - m: 1
 tumor-nodes-metastasis classification t: 1
 tumor-nodes-metastasis classification n: 1
 tumor-nodes-metastasis classification m: 1
 tumor who grade: 1
 tumor weight (gm): 1
 tumor volume mm3: 1
 tumor type and origin: 1
 tumor tissue source: 1
 tumor suppression: 1
 tumor subtype ihc: 1
 tumor subsite: 1
 tumor subclassification: 1
 tumor stage uicc-7th: 1
 tumor stage of patient: 1
 tumor stage inss: 1
 tumor stage ajcc: 1
 tumor stage (uicc 2002): 1
 tumor stage (according to tnm classification 2002): 1
 tumor size t: 1
 tumor size grade: 1
 tumor size (t): 1
 tumor size (1: 1
 tumor secretion profile: 1
 tumor sample id: 1
 tumor sample histological grade: 1
 tumor regression (days): 1
 tumor recurrence (days): 1
 tumor phenotype/subtype: 1
 tumor pecam1 staining: 1
 tumor organ site: 1
 tumor or normal lhc: 1
 tumor or normal: 1
 tumor occurrence: 1
 tumor no.: 1
 tumor necrosis: 1
 tumor nature: 1
 tumor mass: 1
 tumor localisation: 1
 tumor load in percent: 1
 tumor line: 1
 tumor injection: 1
 tumor infiltration pattern: 1
 tumor group: 1
 tumor grade who: 1
 tumor grade histological: 1
 tumor grade g1 - well differentiated; g2 - moderately differentiated; g3 - poorly differentiated; g4 - undifferentiated: 1
 tumor grade g: 1
 tumor endothelial cells: 1
 tumor differentiation: 1
 tumor diameter (cm): 1
 tumor diameter: 1
 tumor composition: 1
 tumor cell subpopulation: 1
 tumor cell line implanted in mouse: 1
 tumor cell line 152 origin: 1
 tumor case id: 1
 tumor biopsy origin: 1
 tumor bank: 1
 tumor (t) vs healthy (s): 1
 tumer size: 1
 tularensis exposure status: 1
 tuicc: 1
 tubulus grade: 1
 tubule formation: 1
 tuberculin skin test: 1
 tubercle score: 1
 tu-vs-nl: 1
 tt.drfs: 1
 tsi: 1
 tsc passage number: 1
 trypanosomes measurement: 1
 true_cold_ischemic_time_min: 1
 trtlong: 1
 trreatment: 1
 troponin at presentation: 1
 tropical race: 1
 trna state: 1
 triton addition: 1
 trisomy 4 and 10 : 1
 triple negative tumor: 1
 triple negative 1= yes, 0= no: 1
 trio: 1
 trimester_of_diagnosis: 1
 trigyceride: 1
 triglycerides mg/dl: 1
 triglycerides: 1
 trifluoroleucine resistance: 1
 trglycerides mg per dl: 1
 trg: 1
 treg presence: 1
 treg depletion using dt tx: 1
 treg cell type: 1
 tree identifier: 1
 treatmock infectedent: 1
 treatment_given: 1
 treatment_by_lot: 1
 treatment_2: 1
 treatment_1: 1
 treatment2_in vivo treatment: 1
 treatment-duration: 1
 treatment time(minutes): 1
 treatment time in days: 1
 treatment time hours: 1
 treatment time (hours): 1
 treatment temperature: 1
 treatment substance: 1
 treatment status (censoring day): 1
 treatment state: 1
 treatment start timepoint: 1
 treatment start age: 1
 treatment short label: 1
 treatment route: 1
 treatment result: 1
 treatment response of glioma in vitro_proliferation.score: 1
 treatment response of glioma in vitro_proliferation.label: 1
 treatment response of glioma in vitro_migration.score: 1
 treatment response of glioma in vitro_migration.label: 1
 treatment response of glioma in vitro proliferation score: 1
 treatment response of glioma in vitro proliferation label: 1
 treatment response in vivo: 1
 treatment response in vitro: 1
 treatment repeat: 1
 treatment protocol of gut microbiome: 1
 treatment pairs: 1
 treatment of total rna prep: 1
 treatment of rbc donor: 1
 treatment of mouse: 1
 treatment of macrophage donor: 1
 treatment notch activation or inhibition: 1
 treatment name: 1
 treatment line: 1
 treatment length hrs: 1
 treatment injection: 1
 treatment initiation date: 1
 treatment in utero of g0 mother: 1
 treatment humidity: 1
 treatment gp: 1
 treatment exposure: 1
 treatment event (1: 1
 treatment duration hours: 1
 treatment duration days: 1
 treatment drug or buffer control timing: 1
 treatment drug name: 1
 treatment drug: 1
 treatment delivery: 1
 treatment compound: 1
 treatment class: 1
 treatment before panicle inititation: 1
 treatment before panicle initiation: 1
 treatment batch: 1
 treatment bacteria: 1
 treatment at booting stage: 1
 treatment age onset: 1
 treatment age: 1
 treated with tert: 1
 treated w/ stz: 1
 treated w/ 5-aza-2'-deoxycytidine: 1
 treated w/ 4f-glcnac: 1
 treated w/: 1
 treated tissue: 1
 treated on: 1
 treated for: 1
 treated duration: 1
 treated daily with: 1
 treated condition: 1
 treated at: 1
 treament group: 1
 treament condition: 1
 treaetd with: 1
 trasnfection protocol: 1
 trasfection: 1
 trap line: 1
 transversion: 1
 transposon side: 1
 transposon element: 1
 transposon (mini-tn5) knock out: 1
 transplants: 1
 transplanted: 1
 transplantation method: 1
 transplant generation: 1
 translocation type: 1
 translocation t(4;14): 1
 translocation chromosome between chromosomes 6 & 9 t6-9 043-1: 1
 transition: 1
 transgenic variant: 1
 transgenic status: 1
 transgenic rice line: 1
 transgenic plants used in the experiment: 1
 transgenic plants: 1
 transgenic plant: 1
 transgenic mouse line: 1
 transgenic generation: 1
 transgenic description: 1
 transgenic construct: 1
 transgene status: 1
 transgene name: 1
 transgene genotype: 1
 transgene expression: 1
 transgene 2: 1
 transgene 1: 1
 transformed by: 1
 transfection with: 1
 transfection virus: 1
 transfection or treatment: 1
 transfection of microrna: 1
 transfected_gene: 1
 transfected trpv3 variant: 1
 transfected transcriptome: 1
 transfected tetraspanin: 1
 transfected rna duplex: 1
 transfected rna: 1
 transfected non-coding rna: 1
 transfected mirna or sirna: 1
 transfected gene: 1
 transfectant type: 1
 transepithelial electrical resistance: 1
 transdueced with: 1
 transduction of gene: 1
 transduction construct: 1
 transduction condition: 1
 transduced/nucleofected with: 1
 transduced virus: 1
 transduced factor: 1
 transcriptome: 1
 transcription factors: 1
 transcription factor treatment: 1
 tranfected with: 1
 tranfected molecules: 1
 tranfected: 1
 tranfectant: 1
 tranduction: 1
 trait 2 see description below: 1
 trait 2 (see description below): 1
 trait 1 see description below: 1
 trait 1 (see description below): 1
 trainingtest: 1
 training timepoint: 1
 training status: 1
 training set: 1
 training or test set : 1
 training: 1
 traduced with: 1
 traditional histological type: 1
 tracheal section: 1
 tra160: 1
 tra specificity: 1
 tptcd: 1
 tpt: 1
 tp53mut: 1
 tp53.protein.expression: 1
 tp53.gene.mutation.status: 1
 tp53 mutant: 1
 tp53 accumulation in cancer cells assesed by immunohistochemistry: 1
 tp53: 1
 toysv infection: 1
 toxplasma gondii strain: 1
 toxoplasma strain: 1
 toxicology_experiment_date: 1
 toxicology: 1
 tourniquet test: 1
 totalrna amount: 1
 totalfat: 1
 total volume: 1
 total triglycerides: 1
 total testosterone: 1
 total symptom score: 1
 total rna quantity: 1
 total rna input amount: 1
 total rna input: 1
 total reads: 1
 total rd duration: 1
 total obtained reads: 1
 total number survived treatment sum across treatment replicates: 1
 total number died from treatment sum across treatment replicates: 1
 total islet number: 1
 total i score: 1
 total cholesterol: 1
 total chol mg per dl: 1
 total body irradiation dose: 1
 topology: 1
 topoihc: 1
 topo2: 1
 top2atri: 1
 top2a ihc status: 1
 top2a: 1
 tooth type: 1
 tooth development: 1
 toluene concentration mm: 1
 tolerance: 1
 tod: 1
 tnm-stage: 1
 tnm stage who 2004: 1
 tnm classification: 1
 tnfa activity: 1
 tnf ir: 1
 tn5: 1
 tn status: 1
 tmprss2: 1
 tmn pathological staging: 1
 tm locomotor treadmill training: 1
 titer pfu/g: 1
 tisuue: 1
 tissuet type: 1
 tissues used: 1
 tissues developmental stage: 1
 tissuer type: 1
 tissue_mg: 1
 tissue: cell line: 1
 tissue/stage: 1
 tissue/sector: 1
 tissue/origin: 1
 tissue/development stage: 1
 tissue/cell preparation: 1
 tissue/cell: 1
 tissue-of-origin: 1
 tissue-cy5: 1
 tissue-cy3: 1
 tissue weigth: 1
 tissue weight: 1
 tissue type analyzed: 1
 tissue type : 1
 tissue typ: 1
 tissue subsection: 1
 tissue storage: 1
 tissue stage: 1
 tissue separation: 1
 tissue segment: 1
 tissue rna source: 1
 tissue region enriched for: 1
 tissue provider: 1
 tissue preserve method: 1
 tissue preservation type: 1
 tissue portion: 1
 tissue population: 1
 tissue part: 1
 tissue pair: 1
 tissue origination: 1
 tissue origin of cancer cell: 1
 tissue morphology: 1
 tissue location p-d: 1
 tissue location l-r: 1
 tissue location a-p: 1
 tissue lineage: 1
 tissue harvest time: 1
 tissue harvest site: 1
 tissue harvest: 1
 tissue for msc establishment: 1
 tissue extraction: 1
 tissue enriched for: 1
 tissue donor strain: 1
 tissue donor: 1
 tissue differentiation state-specific region: 1
 tissue cpllection date&time: 1
 tissue composition of reference: 1
 tissue color: 1
 tissue collection time: 1
 tissue collection: 1
 tissue class: 1
 tissue cancer status: 1
 tissue and developmental stage: 1
 tissue and developemental stage: 1
 tissue anatomic site: 1
 tissue age: 1
 tissue 4: 1
 tissue 3: 1
 tissue 2: 1
 tissue 1: 1
 tissu: 1
 tisse source for mscs: 1
 timpoint shrna induction: 1
 timpe point: 1
 timp1 ng/mg protein: 1
 timing: 1
 timie: 1
 timetofirstszmin: 1
 timesincemating: 1
 timesampletaken: 1
 timepoints: 1
 timepointhours: 1
 timepoint/developmental stage: 1
 timepoint minutes: 1
 timepoint hrs: 1
 timepoint hours post invasion: 1
 timepoint dpi: 1
 timepoint after treatment: 1
 timepoint after sirna transfection: 1
 timepoint (wks): 1
 timepoint (hrs): 1
 timeminutes: 1
 timecollected: 1
 time_to_metastasis (years): 1
 time_in_freezer: 1
 time_hpi: 1
 time/hpf: 1
 time/developmental stage according to pmid 15599763: 1
 time.to.recurrence.or.last.follow-up.months: 1
 time-to-progession months: 1
 time(wpi): 1
 time(hours): 1
 time weeks: 1
 time unit: 1
 time under flooding (h): 1
 time to treatment (days): 1
 time to recurrence or censorship (months): 1
 time to progression ii: 1
 time to progression i: 1
 time to next relapsedays: 1
 time to first recurrence: 1
 time submerged: 1
 time stimulated with anti-igm: 1
 time since wetting: 1
 time since t0: 1
 time since last treatment days: 1
 time since iptg addition: 1
 time since injury: 1
 time since diagnosis of advanced disease: 1
 time sample taken: 1
 time sacrificed: 1
 time relative to induction: 1
 time pre-exercise and post-exercise 30 min, 3h, 24h: 1
 time post-wound: 1
 time post-vaccination: 1
 time post-protocol: 1
 time post-perforation: 1
 time post-oxaliplatin: 1
 time post-irradiation days: 1
 time post-instillation period: 1
 time post-inoculation: 1
 time post-injection: 1
 time post-exposure: 1
 time post-dox: 1
 time post-copulation: 1
 time post transplant: 1
 time post surgery: 1
 time post mcao before sample: 1
 time post injury: 1
 time post injection: 1
 time post consumption hours: 1
 time post bloodmeal: 1
 time post F. tularensis SchuS4 infection: 1
 time points post-infection: 1
 time point visit: 1
 time point sampled: 1
 time point relative to carbon source depletion: 1
 time point pup age: 1
 time point post-surgery: 1
 time point post-infection: 1
 time point of sampling minutes: 1
 time point minutes after 4-cell: 1
 time point minutes: 1
 time point insulin treatment: 1
 time point in hours: 1
 time point in batch cycle: 1
 time point hours post-exposure: 1
 time point hours after inoculation: 1
 time point hour: 1
 time point h: 1
 time point days post-infection: 1
 time point days post infection dpi: 1
 time point days: 1
 time point after stress: 1
 time point (week end): 1
 time point (post-inoculation): 1
 time point (day): 1
 time pi weeks: 1
 time period of attachment: 1
 time p.i.: 1
 time of wbc and fatigue score collection: 1
 time of treatment with fk866: 1
 time of treatment hours: 1
 time of tamoxifen treatment: 1
 time of stimulation: 1
 time of specimen collection: 1
 time of sample harvesting: 1
 time of purification: 1
 time of hcmv infection: 1
 time of growth: 1
 time of exercise: 1
 time of death after treatment: 1
 time of day sampled: 1
 time of day at sacrifice (AM or PM): 1
 time of cacrifice: 1
 time of biopsy post transplant (days): 1
 time of biopsy: 1
 time of atoh1 expression: 1
 time of admission post injury: 1
 time months until progression or last follow-up: 1
 time months until death or last follow-up: 1
 time months overall survival: 1
 time minutes cellularization stage: 1
 time min after fertilization: 1
 time measured post wounding: 1
 time lysis after stimuli addition: 1
 time lysis after stimuli addiction: 1
 time interval: 1
 time injected: 1
 time in n-depletion: 1
 time in minutes: 1
 time in ll zt: 1
 time in light or darkness: 1
 time in continuous light: 1
 time in constant light hours: 1
 time hrs: 1
 time hours after cd3/cd28 activation: 1
 time h in sporulation medium: 1
 time graft: 1
 time fter actd: 1
 time from transplantation to sample collection: 1
 time from start of therapy to the first relapse (in months): 1
 time from rt to second biochemical recurrence days: 1
 time from rt to last follow up-censored days: 1
 time from injury months: 1
 time for cold acclimation: 1
 time extraction: 1
 time dpa: 1
 time days post-infection: 1
 time days post infection: 1
 time days post differentiation: 1
 time days of culture: 1
 time days in in vitro culture: 1
 time d.p.i.: 1
 time culture hours: 1
 time course period: 1
 time co-cultured with target cell: 1
 time class: 1
 time between uv exposure and rna extraction: 1
 time between uv exposure and bru labeling: 1
 time between donor death and sample collection: 1
 time between bru labeling and rna extraction: 1
 time before sampling: 1
 time and stimulation: 1
 time after treatment hours: 1
 time after transfer to soil: 1
 time after transfection hr: 1
 time after transfection: 1
 time after the end of methyl-deficient diet: 1
 time after stroke h: 1
 time after scale removal: 1
 time after release from g1 arrest min: 1
 time after ra stimulation: 1
 time after plating: 1
 time after low-k exposure: 1
 time after lesion (days): 1
 time after last injection: 1
 time after isolation: 1
 time after injury hours: 1
 time after injury: 1
 time after infection h: 1
 time after immunization: 1
 time after hepatectomy: 1
 time after h2o2 treatment: 1
 time after glucose spike min: 1
 time after crossing: 1
 time after actinomycin d treatment: 1
 time after actd: 1
 time 0h/2h/24h post infection: 1
 time (wpi): 1
 time (post-treatment): 1
 time (incubation): 1
 time (hours) post-synchronization: 1
 time (duration): 1
 time (duration of cold-treatment): 1
 time (doxorubicin): 1
 time (days post-infection): 1
 time (d): 1
 tie2 type: 1
 tick attachment to sample: 1
 ticagrelor: 1
 tic class: 1
 tibia length mm: 1
 ti: 1
 thyroid tissue type: 1
 thrombosis: 1
 thompson grade: 1
 thermia: 1
 therapy_response: 1
 therapy response: 1
 therapeutic response: 1
 therapeutic agent: 1
 th2 group: 1
 th-mycn mouse genotype: 1
 th cell subtype: 1
 tgt value: 1
 tgrade: 1
 tgleason: 1
 tgfbr2 status: 1
 tgfb1: 1
 tg type strain: 1
 tg rsponse to statins status: 1
 tex-treated: 1
 tex: 1
 tet2: 1
 tet-off: 1
 testosterone supplementation: 1
 testis: 1
 testicular involvement : 1
 testicular histology: 1
 testa/endosperm rupture status: 1
 test set: 1
 test item phase 1: 1
 test item 1 concentration: 1
 test item: 1
 test group: 1
 test centre: 1
 test cell type: 1
 test article cas no: 1
 terc-/- p53/foxo3a phosphorylation status: 1
 temporal block: 1
 template preparation: 1
 template number: 1
 temperature treatment: 1
 temperature stress: 1
 temperature shift y/n: 1
 temperature deg.c: 1
 tem1 expression: 1
 telomere length: 1
 tecrep: 1
 technology used: 1
 technological phase: 1
 technical replicate number: 1
 technical replicate group: 1
 technical rep: 1
 tech rep: 1
 teat type: 1
 teat phenotype: 1
 teat affection status: 1
 tdtomato labelling: 1
 tcr transgene: 1
 tcr specificity (or naive): 1
 tchol mmol/l: 1
 tcga subtype: 1
 tcga id: 1
 tcell population: 1
 tce concentration: 1
 tcdd sample: 1
 tcat: 1
 tbx3 promoter activity: 1
 tbx1 genotype: 1
 tbt contamination: 1
 tb-infection status: 1
 taxonomy_test_rin_float: 1
 taxonomy_id: 1
 taxonomy: 1
 taxid: 1
 tat1 progress^to minv/cystectomy/dead: 1
 targeted promoter: 1
 targeted by: 1
 target_prep_date: 1
 target-molecules: 1
 target molecule: 1
 target gene unc-122 tagged by 3xFlag:: 1
 target gene unc-119 tagged by 3xFlag:: 1
 target gene ser-2 tagged by 3xFlag:: 1
 target gene myo-3 tagged by 3xFlag:: 1
 target gene hlh-17 tagged by 3xFlag:: 1
 target gene glr-1 tagged by 3xFlag:: 1
 target gene ges-1 tagged by 3xFlag:: 1
 target gene dpy-7 tagged by 3xFlag:: 1
 target gene dat-1 tagged by 3xFlag:: 1
 target gene clh-4 tagged by 3xFlag:: 1
 target cell for co-culture: 1
 taqman pool by age: 1
 tap treatment: 1
 tap tag: 1
 tansgenic line: 1
 tamoxifen-citrate treatment: 1
 tamoxifen treatment duration: 1
 tamoxifen treatment: 1
 tamoxifen sensitivity: 1
 tamoxifen protocol: 1
 tamoxifen phenotype: 1
 tamoxifen: 1
 tame or aggressive phenotype: 1
 tail_id: 1
 tae684 sensitivity: 1
 ta tubular atrophy: 1
 t4.14: 1
 t16.20: 1
 t14.16: 1
 t11.14: 1
 t.rfs: 1
 t.os: 1
 t-score: 1
 t-helper cell subset: 1
 t-cell type: 1
 t-cell subset: 1
 t(9;11)(p22;q23): 1
 t(8;21)(q22;q22): 1
 t(15;17)(q24;q21): 1
 t tumor or n normal: 1
 t tnm score: 1
 t rfs months: 1
 t extent of primary tumor: 1
 t cells mrna mass ng: 1
 t cell mechanism: 1
 t (tnm stage): 1
 syt-ssx fusion type: 1
 systemic sclerosis subtype: 1
 synthetic rna: 1
 synthetic hexaploid line: 1
 synaptofysin staining: 1
 symptoms rss or no rss: 1
 symptoms onset date: 1
 symptom event: 1
 symbiont: 1
 switching phase: 1
 swimming pool water exposure time: 1
 swi6:: 1
 swab: 1
 susceptibility to T. circumcincta infection: 1
 survivor: 1
 surviving fraction at 2gy: 1
 survivin-dex3: 1
 survivin-3b: 1
 survivin-2b: 1
 survivin-2a: 1
 survivin: 1
 survivaltime_months: 1
 survivallastfollowup: 1
 survivalday: 1
 survival_time: 1
 survival_status 0: 1
 survival_months: 1
 survival_month: 1
 survival/death: 1
 survival years: 1
 survival status 0: 1
 survival rate: 1
 survival group: 1
 survival from stage iii tumour banked months: 1
 survival from primary melanoma months: 1
 survival available: 1
 survival (yrs): 1
 survival (months): 1
 survival (days): 1
 surval months: 1
 surgtype: 1
 surgical_margins: 1
 surgical status: 1
 surgical stage: 1
 surgical margin status: 1
 surgery.date: 1
 surgery week: 1
 surgery time period: 1
 surgery procedure: 1
 surgery outcome: 1
 surgdate: 1
 surg: 1
 surface phenotype: 1
 surface markers to isolate cells by facs-based methods: 1
 surface cd146: 1
 supporting culture organism: 1
 superovulated: 1
 supernatant: 1
 sunscreen treatment: 1
 sunitinib response: 1
 sum of neurofibrillary tangles density in multiple brain regions: 1
 sum of cerad rating scores in multiple brain regions: 1
 sulfur deprivation time: 1
 sulfide production: 1
 sulf-2 expressing: 1
 sugar species: 1
 sugar: 1
 suderman.et.al: 1
 sucrose gradient step: 1
 sucrose conc. %: 1
 suc: 1
 subtypes: 1
 subtypeihc: 1
 subtypege: 1
 subtype of tumor or matched tumor: 1
 subtype of ptc classical denotes classical variant of ptc; ptc-f denotes ptc with dominant pattern of follicular structures; ptc-s denotes ptc with dominant pattern of solid areas; ptc-fs denotes ptc with dominant pattern of folicular and solid areas: 1
 substrate stiffness: 1
 substrate description: 1
 substrate conversion: 1
 subsets: 1
 submitted: 1
 subline_id: 1
 subjid: 1
 subject/sample id: 1
 subject/donor: 1
 subject id#: 1
 subject class: 1
 subfration: 1
 subcutaneous g: 1
 subcohort: 1
 subclone source: 1
 subcellular localization: 1
 subcellular: 1
 subarrayid: 1
 subarray id: 1
 sub-strain: 1
 sub-population: 1
 sub-cultured: 1
 sub-clone: 1
 sub strain: 1
 stz injection: 1
 study no.: 1
 study cluster id: 1
 structure: 1
 stromal signature: 1
 stromal cells: 1
 stroma_subtype_0na_1low_2normal_3activated: 1
 stroke: 1
 stripped array: 1
 strin: 1
 stress/flow condition: 1
 stress duration: 1
 strandedness: 1
 strain: H37Rv:deltaRv3133c:: 1
 strain: C57Bl/6strain: 1
 strain/variation: 1
 strain/sex: 1
 strain/model: 1
 strain/isolate: 1
 strain/condition: 1
 strain/background strain: 1
 strain/accession: 1
 strain, toxoplasma gondii: 1
 strain, lifestage: 1
 strain(s): 1
 strain resistance: 1
 strain recipient: 1
 strain provider: 1
 strain origin: 1
 strain of the clone: 1
 strain of paternal pronucleus: 1
 strain of ooplasm: 1
 strain of mouse: 1
 strain of maternal pronucleus: 1
 strain name jackson lab: 1
 strain name as in the paper: 1
 strain m type: 1
 strain information: 1
 strain info.: 1
 strain host: 1
 strain gender: 1
 strain for plasma: 1
 strain for pbmcs: 1
 strain fgsc number: 1
 strain duplicate (a or b): 1
 strain derivative: 1
 strain cm702 strain is distingished from the wt by the following genetic characteristics: 1
 strain balb/cnctr-npc1m1n/j: 1
 strain backround: 1
 strain background for tissue: 1
 strain background bloomington stock number: 1
 strain backgroud: 1
 strain (of recipient mice): 1
 strain (cy5): 1
 strain (cy3): 1
 strain  background: 1
 storage method: 1
 storage before pre-enrichment: 1
 stock lines: 1
 stn/ibrutinib sensitivity: 1
 stn-hfs: 1
 stn sensitivity: 1
 stimulus id: 1
 stimulator: 1
 stimulation_type: 1
 stimulation status: 1
 stimulation protocol: 1
 stimulation conditions: 1
 stimulating agent: 1
 stimulated s: 1
 stimulated by: 1
 stimulant: 1
 stimuation: 1
 stimuated with: 1
 stim_type: 1
 stestosis: 1
 steriod usage: 1
 stepsperday: 1
 stephensen risk classification: 1
 stem-like: 1
 stem cells: 1
 stem cell lines: 1
 stem: 1
 steatosis: 1
 steastosis: 1
 steady-state or pulse: 1
 stdev for insert size: 1
 std. dev. insert size: 1
 status.all: 1
 status on endocrine agent: 1
 status of osteochondrosis disoder: 1
 status of negative energy balance: 1
 status of disease 5 years: 1
 status of disease: 1
 status of conceptus attachement site: 1
 status of aggressiveness: 1
 status at the end of follow up: 1
 status after follow-up: 1
 status 1: 1
 status (1-death,0-survival): 1
 statue: 1
 statin user y/n: 1
 statin treated: 1
 statin: 1
 stathmin ihc score: 1
 state of recurrence: 1
 stat1 module tertile: 1
 starved/non-starved: 1
 starvation duration (minutes): 1
 starting wt kg: 1
 starting molecule: 1
 starting left ventricular weight mg: 1
 starting cell type: 1
 starting amount of total rna: 1
 starting amount: 1
 stanford internal vaccine reference id: 1
 standard deviation: 1
 stain background: 1
 stage2 molecular divisions of lung development: 1
 stage1 canonical stages of lung development: 1
 stage/age: 1
 stage.code: 1
 stage of the parasite: 1
 stage of progression: 1
 stage of pregnancy: 1
 stage of infection: 1
 stage of escc: 1
 stage of disease: 1
 stage at which the spiking in of exogenous trna was performed: 1
 stage at primary diagnosis 5th edition: 1
 stage at collection: 1
 stage (durie-salmon): 1
 stably overexpressing: 1
 stable over-expression status: 1
 stable line: 1
 stable human tsh receptor expression: 1
 stable cell line: 1
 stable cad for at least 4 months: 1
 stabilization: 1
 ssx expression: 1
 ssea4: 1
 ssea3 expression: 1
 ssea-1: 1
 ssc: 1
 srsf2 mut: 1
 srek ligation: 1
 src module tertile: 1
 srain: 1
 sr protein: 1
 spt15: 1
 sprout length: 1
 sprain: 1
 spot14 gfp status: 1
 sporulation timepoint: 1
 sporadic case: 1
 spontaneous pulmonary adenoma severity: 1
 spontaneous pulmonary adenoma frequency: 1
 splenectomy: 1
 spleen weight: 1
 spine surgery: 1
 spinal cord region: 1
 spiking of exogenous trna: 1
 spiked with: 1
 spike-in dilution: 1
 spike-in conc.: 1
 sphingosine kinase 1 activity: 1
 spf status: 1
 spermatogenic stage (johnsen score): 1
 sperm source: 1
 sperm injected: 1
 specimen with known storage type: 1
 specimen preparation: 1
 specimen group: 1
 specific-host: 1
 specific host: 1
 specific growth rate (h-1): 1
 species type: 1
 species status: 1
 spea2 genotype: 1
 spdpct: 1
 spatial response type: 1
 spat: 1
 sp110b overexpression status: 1
 soybeanmealfeed: 1
 sox7 level: 1
 sox2: 1
 sown in 96 cell flats in Promix 1:1 Metro: 1
 sow identifier: 1
 source_region_family_id: 1
 source tissue info.: 1
 source tissue for cell line: 1
 source strain: 1
 source site: 1
 source sample: 1
 source placenta: 1
 source of pn: 1
 source of cells: 1
 source longitude_latitude_elevm: 1
 source id: 1
 source classification: 1
 source cell line/subject: 1
 source animal id: 1
 sorting tetramer epitope: 1
 sorting phenotype: 1
 sorting parameter: 1
 sorting marker: 1
 sorting gate: 1
 sortfraction: 1
 sortedflag: 1
 sorted for: 1
 sorted cell population surface phenotype: 1
 sorted cell population: 1
 sorted by surface marker: 1
 sort characteristic: 1
 sort: 1
 somite number: 1
 somatic tp53 mutation: 1
 somatic tissue: 1
 somatic or tumor: 1
 soil type: 1
 soil site: 1
 soil nitrogen composition: 1
 soil mix: 1
 soil crust status: 1
 soil: 1
 software analysis key current: 1
 social rank: 1
 social form: 1
 so2: 1
 sms: 1
 smrna: 1
 smp8-il4r transgene: 1
 smooth muscle markers: 1
 smokingstat: 1
 smokingpack-years: 1
 smoking_history: 1
 smoking stop date: 1
 smoking status (n.a.=data not available): 1
 smoking start date: 1
 smoking regimen 2: 1
 smoking regimen 1: 1
 smoking pack years: 1
 smoking habits: 1
 smoking habit: 1
 smoking duration years: 1
 smoking dose cigarettes/day: 1
 smoking behavior: 1
 smoking amount: 1
 smoker?: 1
 smoke at death: 1
 smoke: 1
 smokcignow: 1
 smarcb1: 1
 small rna library prep method: 1
 small rna classes: 1
 small rna: 1
 slot: 1
 slocus genotype: 1
 slideno: 1
 slide_position: 1
 slide_number: 1
 slide number and position of the samples in each array: 1
 sleepprotocol: 1
 sleep timing: 1
 slaughter batch: 1
 sl2 treatment: 1
 skin source site: 1
 skin color: 1
 skeletal muscle tissue: 1
 skatole level: 1
 sizecm: 1
 size of tumor (t factor): 1
 size of myocardial infarction: 1
 size fractionation: 1
 size class prior to infection: 1
 size (bin): 1
 siv strain: 1
 siv status: 1
 siv infection status: 1
 sitype: 1
 site2: 1
 site1: 1
 site.of.recurrence: 1
 site of primary melanoma: 1
 site of biopsy ii: 1
 site of biopsy i: 1
 site detail: 1
 sister with bc: 1
 sister: 1
 sirt7 allele: 1
 sirt1 expression: 1
 sirna/shrna: 1
 sirna type: 1
 sirna treatment conditions: 1
 sirna treated: 1
 sirna transfection time: 1
 sirna transfection protocol: 1
 sirna target sequence: 1
 sirna target point on wdr5 cds: 1
 sirna source: 1
 sirna no.: 1
 sirna name: 1
 sirna mediated knockdown: 1
 sirna knocked down: 1
 sirna knock-down target: 1
 sirna knock down: 1
 sirna concentration: 1
 single/coculture: 1
 single species biofilm / culture: 1
 single cells or cluster: 1
 single cell passage and self-ograinzation into neural tubes: 1
 single cell necrosis: 1
 simulated organism: 1
 similar to: 1
 silicic acid (um): 1
 silencer: 1
 signal: 1
 sigH mutant (H37Rv sigH: 1
 sigE mutant (H37Rv sigE: 1
 side of relapse: 1
 side of brain: 1
 side of body: 1
 side graft: 1
 sibling pair: 1
 sibling: 1
 siRNA transfection: 1
 short hairpin: 1
 short: 1
 shoot type: 1
 shock wave pressure: 1
 shock: 1
 shigella flexneri 2a str. 2457T: 1
 shield-1 concentration: 1
 shell diameter: 1
 sheep id: 1
 shedding type: 1
 shearing protocol: 1
 shear force: 1
 shconstruct: 1
 shRNA vector: 1
 shRNA treatment: 1
 shRNA target sequence: 1
 shRNA target: 1
 shRNA expressing: 1
 shRNA construct for transduction: 1
 shRNA construct: 1
 sgn40dx: 1
 sg: 1
 sf2: 1
 sexual maturity: 1
 sexr: 1
 sexed: 1
 sexe: 1
 sex/mating type: 1
 sex-chromosome parent-of-origin: 1
 sex of offspring: 1
 sex known: 1
 sex chromosome complement: 1
 sex (m=male; f=female): 1
 severity class: 1
 severe  feather pecking: 1
 setdb1: 1
 set-nup214: 1
 set id matched samples: 1
 set class: 1
 session: 1
 serum volume: 1
 serum used: 1
 serum starved: 1
 serum source: 1
 serum level in cell culture medium following transfection: 1
 serum level: 1
 serum component: 1
 serum autoantibody: 1
 serotonin staining: 1
 series, 1 = lr+/rt+, 2 = lr-/rt+, 3 = lr+/rt-, 4 = lr-/rt-: 1
 serialnumber: 1
 sera: 1
 sequencing_platform: 1
 sequencing_date: 1
 sequencing type: 1
 sequencing time: 1
 sequencing run type: 1
 sequencing run: 1
 sequencing primer: 1
 sequencing library type: 1
 sequencing library: 1
 sequencing lane: 1
 sequencing facility: 1
 sequencing chemistry: 1
 sequence events: 1
 sequence change: 1
 seqc sample: 1
 sepsis stage: 1
 sepsis model: 1
 sensory neuron subset: 1
 sensitized and challenged with: 1
 sensitized: 1
 sensitivity to sunitinib up to day 8: 1
 sensitisation: 1
 senescent or non-senescent: 1
 senescence induction: 1
 seminal vesicle invasion: 1
 semen parameters: 1
 semen exposure: 1
 self-administration drug volume/infusion: 1
 selectioncriteria_status: 1
 selection medium: 1
 selection antibiotic: 1
 selected with: 1
 selected size: 1
 selected: 1
 seizure.at.diagnosis: 1
 seizure time: 1
 seizure latency: 1
 segmental level: 1
 segment: 1
 seedling growth: 1
 seedling age: 1
 seeding density: 1
 seeding condition: 1
 seed source: 1
 seed part: 1
 seed developmental stage: 1
 seed compartments/tissue: 1
 seed (8-hour time point): 1
 seed: 1
 sectioning thickness: 1
 section type: 1
 section thickness: 1
 secondary type: 1
 secondary treatment duration: 1
 secondary treatment: 1
 secondary time course: 1
 secondary leukemia: 1
 secondary host strain: 1
 secondary ar pathway antagonism arpa: 1
 second-strand synthesis: 1
 second intervention: 1
 second cutter and restriction site sequence: 1
 second apc mutation: 1
 second amplification: 1
 seawater co2 concentrations: 1
 season of biopsy collection: 1
 season month: 1
 sdf file: 1
 sdad2 genotype: 1
 sd): 1
 scp: 1
 scots: 1
 score: 1
 scolex-neck proglottids: 1
 sclerotinia sclerotiorum strain: 1
 scl-tal1: 1
 schold score: 1
 scheuer score s: 1
 scheuer score g: 1
 scca site: 1
 scanstrain: 1
 scanning the array: 1
 scanner update: 1
 scananimal: 1
 scan_date: 1
 scan pmt: 1
 scan method: 1
 scan batch: 1
 scales: 1
 scaled bmi: 1
 scaled age: 1
 scale factor: 1
 scaffold: 1
 sbv challenge gold standard: 1
 sbr grade: 1
 sbp mmhg: 1
 satellite cell origin: 1
 satb1 status: 1
 sarcomatoid component: 1
 sarcoma/tumor: 1
 sarcoma derived from: 1
 sarcoma cell-of-origin: 1
 sarcoma and primary cell type: 1
 sapsii: 1
 sandwich type: 1
 sampling_time_point: 1
 sampling_method: 1
 sampling timepoint: 1
 sampling time to first treatment (years): 1
 sampling time after initiation of treatment: 1
 sampling source geographic: 1
 sampling site for LCM: 1
 sampling protocol: 1
 sampling position: 1
 sampling method: 1
 sampling location: 1
 sampling day: 1
 sampling age: 1
 sampletype: 1
 sampletime: 1
 samples of different individuals pooled?: 1
 samples harvested on: 1
 samples: 1
 samplematerial: 1
 sample_time: 1
 sample_pair: 1
 sample_number: 1
 sample_description 5: 1
 sample_amount: 1
 sample/tissue type: 1
 sample/tissue info: 1
 sample/donor pairing: 1
 sample.ID: 1
 sample#: 1
 sample wt (mg): 1
 sample viability, % of sample, -1=unavailable : 1
 sample types: 1
 sample treatment and extract: 1
 sample tracking control (stc): 1
 sample tpe: 1
 sample time point: 1
 sample subtype: 1
 sample subseries: 1
 sample storage: 1
 sample source set: 1
 sample source id: 1
 sample set for prediction study: 1
 sample section: 1
 sample rin: 1
 sample recovery type: 1
 sample prep: 1
 sample pooling protocol: 1
 sample pooling: 1
 sample pool name: 1
 sample point mid-log phase of growth: 1
 sample pair id: 1
 sample nr: 1
 sample note: 1
 sample molecule: 1
 sample medical procedure: 1
 sample lot number: 1
 sample isolation method: 1
 sample information: 1
 sample included in reference yes/no: 1
 sample included in reference pool: 1
 sample id short form for plotting: 1
 sample histology: 1
 sample group/subtype: 1
 sample digestion: 1
 sample designation/group: 1
 sample description 5: 1
 sample data and location: 1
 sample condition: 1
 sample collection time post virus infection: 1
 sample collection date: 1
 sample collected at time pt 17-23weeks 1, 27-33weeks 2: 1
 sample cohort: 1
 sample age group: 1
 sampe type: 1
 salt.score: 1
 salmonella challenge: 1
 salmon type: 1
 sall4 isoform expression: 1
 salivary gland domain: 1
 salinity (psu): 1
 saec permissiveness: 1
 sacrificed at: 1
 sacdate: 1
 sa key: 1
 s_tumor_size_mm: 1
 s_tumor_size20_0no_1yes: 1
 s_surgery_extended_0no_1yes: 1
 s_surgery_desc: 1
 s_spf_status_0low_1high: 1
 s_spf_percent: 1
 s_spf_nbr_pop: 1
 s_recurrence_0no_1yes: 1
 s_pgr_pos_neg: 1
 s_pgr_float: 1
 s_original_study_prog: 1
 s_original_study: 1
 s_meno: 1
 s_histology_type: 1
 s_hgrade_lokrec_tubules: 1
 s_hgrade_lokrec_pleomrph: 1
 s_hgrade_lokrec_mitotic_count: 1
 s_hgrade_lokrec: 1
 s_hgrade3_lokrec_0no_1yes: 1
 s_er_pos_neg: 1
 s_er_float: 1
 s_dnaind4: 1
 s_dnaind3: 1
 s_dnaind2: 1
 s_dnaind1: 1
 s_clinic_code: 1
 s_bioanalyzer_rin6_0no_1yes: 1
 s_bioanalyzer_rin: 1
 s_bioanalyzer_ratio: 1
 s_bioanalyzer_manual: 1
 s_bioanalyzer_area: 1
 s_bioanalyzer_28s: 1
 s_bioanalyzer_18s: 1
 s_age_year: 1
 s_age_above50year_0no_1yes: 1
 s_age_10year: 1
 s2 treatment: 1
 s/dmems or s/d/dmemd: 1
 s. uberis infection: 1
 s. marcescens genotype/variation: 1
 s): 1
 s status: 1
 s associated: 1
 runx1 mutation: 1
 run_date: 1
 run-type: 1
 run lane: 1
 run (microarray batch): 1
 rt primer with random barcode / index: 1
 rt enzyme: 1
 rsc1:: 1
 rs7956957 genotype: 1
 rs5995355 genotype: 1
 rs1333049 genotype: 1
 rrp6:: 1
 rrna status: 1
 rrna removal method: 1
 rrna depleted: 1
 rr: 1
 rqi: 1
 rpob mutation 2: 1
 rpob mutation 1: 1
 rpoS: 1
 rph1:: 1
 rpa class: 1
 rp symptomatic: 1
 route of infection: 1
 route of exposure: 1
 route of  administration: 1
 rounds of in vivo selection: 1
 rotation speed: 1
 ros: 1
 rop lasertherapy: 1
 rootstock: 1
 roche ct/ng pcr amplicor value: 1
 roche ct/ng amplicor pcr value: 1
 ro: 1
 rnase i fragmentation condition: 1
 rnaqc_pass: 1
 rnap mutant: 1
 rnai type: 1
 rnai target: 1
 rnai deletion: 1
 rnaextractedfrom: 1
 rna_source: 1
 rna_quality_rin: 1
 rna_integrity_number (as reported by the agillent bioanalyzer): 1
 rna_extraction_date: 1
 rna_concentration_ngpul: 1
 rna_260_280: 1
 rna-treatment: 1
 rna-seq library preparation kit: 1
 rna-seq id: 1
 rna yield (ug): 1
 rna volume ul: 1
 rna vendor: 1
 rna sybtype: 1
 rna storage: 1
 rna state: 1
 rna source type: 1
 rna size range & source: 1
 rna selection method: 1
 rna sample type: 1
 rna sample id: 1
 rna rin values before globin depletion: 1
 rna rin values after globin depletion: 1
 rna quantity s2: 1
 rna quantity ercc: 1
 rna processing batch: 1
 rna preparation protocol: 1
 rna prep batch: 1
 rna population: 1
 rna polyadenylation: 1
 rna per sample: 1
 rna isolation method: 1
 rna isolation also used for microarray analysis: 1
 rna isoaltion batch: 1
 rna interference: 1
 rna integrity rin: 1
 rna input amount: 1
 rna input: 1
 rna injected: 1
 rna extraction day: 1
 rna extraction batch: 1
 rna extract srckey: 1
 rna enrichment protocol: 1
 rna degradation time: 1
 rna concentration before globin depletion: 1
 rna concentration after globin depletion: 1
 rna cat. #: 1
 rna associated: 1
 rna amplification protocol: 1
 rna amount ug: 1
 rna amount ng: 1
 rna (ug/l): 1
 rn source key current: 1
 rmr1 genotype: 1
 rmpa signature: 1
 rmh lab code: 1
 rmax: 1
 rma outlier: 1
 risk score: 1
 risk group: 1
 rip type: 1
 rip antibody lot#: 1
 rip antibody information: 1
 rin value: 1
 rin score: 1
 ril: 1
 right ventricular systolic pressure (mmhg): 1
 right ventricle weight mg: 1
 rift valley fever virus: 1
 rice cultivar: 1
 ribosome-protected: 1
 ribosome stabilization agent: 1
 ribosomal protein rna abundance: 1
 rhizobia: 1
 rheumatoid factor positivity: 1
 rfsevent: 1
 rfs_time_days: 1
 rfs_event: 1
 rfs time in days: 1
 rfs status: 1
 rfs event: 1
 rfs: 1
 rfi value: 1
 rf-emf sar: 1
 rf: 1
 reverse side barcode: 1
 retrovirus infection: 1
 retrovirus expression: 1
 retroviral infection: 1
 retroviral expression vector: 1
 retroperitoneal g: 1
 retinopathy of prematurity (rop) group: 1
 retinopathy: 1
 retinoic acid treatment: 1
 retinal detachment: 1
 retina condition: 1
 ret/ptc rearrangements: 1
 ret mutation: 1
 resulting tumor: 1
 resulting embryoid body: 1
 restriction model: 1
 restriction enzymes: 1
 restriction digest: 1
 resting/stimuli: 1
 restimulation: 1
 rest levels: 1
 response to vaccine: 1
 response to therapy: 1
 response to the hormonal therapy: 1
 response to tetracycline as previously described in J Immunol 177: 1
 response to stimulus: 1
 response to sorafenib: 1
 response to preoperative chemoradiotherapy: 1
 response to infestation: 1
 response to docetaxel: 1
 response to dietary fa: 1
 response to chemoradiation: 1
 response to c. austroafricana infection: 1
 response recist pr or sd=1, pd=2: 1
 response rate: 1
 response at surgery: 1
 response at biopsy ii: 1
 response at biopsy i: 1
 responder-to-stimulator ratio: 1
 responder status usat last visit: 1
 responder status: 1
 responder pbmc cells: 1
 responder: 1
 respiratory chain complex deficiency in muscle: 1
 respiratory chain complex deficiency: 1
 respirations per minute: 1
 respiration phenotype: 1
 respectively: 1
 resp: 1
 resorted: 1
 resistance to synh: 1
 resistance to budworm: 1
 resistance of cells against alphavirus: 1
 resistance category: 1
 resion: 1
 residual tumor size r0 < 1 cm;  1 < r1 < 5 cm; r2 > 5cm: 1
 residual tumor: 1
 residual shear force nes: 1
 residual shear force es: 1
 residual feed intake: 1
 resection status (according to tnm classification 2002): 1
 resection: 1
 resected at: 1
 reps: 1
 reprogramming vector: 1
 reprogramming technique: 1
 reprogramming protocol: 1
 reprogramming method: 1
 reprogramming day: 1
 reprogrammed: 1
 reproductive status swine: 1
 reproductive status (cattle): 1
 reproductive phase: 1
 reproductive morph: 1
 reproductive mode: 1
 reproduction: 1
 repository source fibroblast id: 1
 reporter sorted for: 1
 reporter gene: 1
 reporter fluorescence: 1
 reponse to therapy: 1
 replication id: 1
 replication genotype: 1
 replicated: 1
 replicate type: 1
 replicate no: 1
 replicate #: 1
 replicat: 1
 reperfusion time: 1
 repeat set: 1
 repeat samples derived from dentical donors: 1
 repeat biological: 1
 rep. no.: 1
 rep tank within treatment: 1
 rep number: 1
 reoxygenated with: 1
 renal vein involvement: 1
 renal function: 1
 renal biopsy group: 1
 renal biopsy: 1
 remuzzi score inadequate tissue for pathology interpretation: 1
 remission at week 10: 1
 released co2 g/l: 1
 relative.neutrophils: 1
 relative.monocytes: 1
 relative.lymphocytes: 1
 relative.eosinophils: 1
 relative.basophils: 1
 relative vo2: 1
 relative liver cell nucleus size: 1
 relationship to proband: 1
 related mirna sample: 1
 related genome-wide dna analysis data available (geo id): 1
 related gene expression profiling (gep) data available (geo id): 1
 relapsed: 1
 relapse.metastasis.date: 1
 relapse.metastasis: 1
 relapse.local.date: 1
 relapse.local: 1
 relapse.date: 1
 relapse free survival time: 1
 relapse 1=yes: 1
 relA251: 1
 regulator_overexpressed: 1
 registry year: 1
 regional metastases: 1
 region of residence: 1
 region name: 1
 regimen: 1
 regeneration type: 1
 regeneration time: 1
 regeneration status: 1
 regeneration stage: 1
 regenerating stage: 1
 reference to clinical data: 1
 reference sample from accession gse30111 (rna source): 1
 reference sample components: 1
 reference rna vendor: 1
 reference rna source: 1
 reference rna composition: 1
 reference lot #: 1
 reference id: 1
 reference group: 1
 reference genome: 1
 reference dna vendor: 1
 reference dna cat. #: 1
 reference concentration: 1
 reference cell type: 1
 reference cell lines: 1
 reference cat. #: 1
 ref: 1
 reduction_auc: 1
 redox stress chemical: 1
 red cell distr. width %: 1
 recurrence-free time years: 1
 recurrence interval: 1
 recurrence free survival months (distant and local): 1
 recurrence and site: 1
 recurred: 1
 rectum tumor biopsy: 1
 recruitment site: 1
 recql5 status: 1
 recovery: 1
 reconstituted with: 1
 recombinant virus type: 1
 recombinant tgfb1: 1
 recombinant inbred line ril from: 1
 recombinant inbred line: 1
 reclassified histological subtype: 1
 recipients: 1
 recipient strain genotype: 1
 recipient strain gender: 1
 recipient mouse status: 1
 recipient mouse leukemia status: 1
 recipient mouse genotype: 1
 recipient mice: 1
 recipient ethnicity: 1
 recipient age: 1
 receptor status: 1
 receptor activation: 1
 receptive: 1
 receiving severe pecks: 1
 receiving gentle pecks: 1
 receiving aggressive pecks: 1
 rec.: 1
 rearrangement: 1
 rearing history: 1
 rearing environment: 1
 rearing condition: 1
 rearing: 1
 reanalysis: 1
 reagent/antibody company: 1
 reading primer sequence: 1
 read_length: 1
 read_depth: 1
 read type: 1
 reaction: 1
 re: 1
 rch: 1
 rcc subtype: 1
 rcb 0 i prediction: 1
 rc grade: 1
 rbv-sensitivity status: 1
 rbc 10e12/l: 1
 rb: 1
 raw data label: 1
 ratuniqueidentifier: 1
 ration size: 1
 ratio of monocytes to lymphocytes  whole blood: 1
 ratio delta1/delta2: 1
 ratio 28s/18s: 1
 ratio 260/280: 1
 ratio 260/230: 1
 rat weight: 1
 rat strain: 1
 rat line: 1
 ras-transformed: 1
 ras mutation status: 1
 ras module tertile: 1
 rapamycin sensitivity: 1
 rank of gfp retaining level: 1
 range: 1
 randomized to thal: 1
 randomized position: 1
 radiology group: 1
 radiology: 1
 radiological stenosis: 1
 radiological feature: 1
 radically operated: 1
 radiation.therapy: 1
 radiation timing: 1
 radiation protocol: 1
 radiated: 1
 rad9 status: 1
 race_a_carrib: 1
 race/ethnicity: 1
 race orientation: 1
 race composition: 1
 race : 1
 rabbit group: 1
 ra treatment: 1
 ra exposure: 1
 r70: 1
 r50: 1
 r1.fastq spacing: 1
 r-script file name match: 1
 r-hlh dosage: 1
 r-hfsh dosage: 1
 r: 1
 quorum sensing status: 1
 queen pairing: 1
 quantity ul: 1
 qualscores: 1
 quality.filtered: 1
 quality grade: 1
 quality control notes: 1
 quality control: 1
 quality: 1
 qft-git: 1
 qft: 1
 qc test: 1
 qc pass: 1
 pythium strain: 1
 pyrethroid-resistance status: 1
 pyrethroid susceptibility: 1
 pyrene ng/m3: 1
 pyr: 1
 pygfp: 1
 pyers: 1
 pvtify gene expresion: 1
 purpose: 1
 purified length: 1
 purification procedure: 1
 pupal survival: 1
 pulsotype: 1
 pulse/chase tet-off system: 1
 pulmonarycapillarywedgepressure: 1
 pulmonary artery pressure: 1
 pulldown: 1
 pull-down tag: 1
 pull: 1
 ptpn11: 1
 ptk7 surface abundance: 1
 ptensig score: 1
 ptensig poor: 1
 ptensig good: 1
 ptensig class abs0.2: 1
 pten mutant: 1
 pten module tertile: 1
 pten ihc: 1
 ptc translocation: 1
 pt number: 1
 psyllid vector: 1
 psts genotype: 1
 pstage iorii: 1
 psoriasis subtype: 1
 psoriasis duration: 1
 psf t: 1
 psf s: 1
 pseudomonas aeruginosa surrogate variable 1: 1
 psen1 mutation: 1
 psa-recurrence free survival outcome: 1
 psa-recurrence free survival (months): 1
 psa recurrence-free survival months: 1
 psa recurrence-free survival event: 1
 psa pre-chemotherapy: 1
 psa post-chemotherapy: 1
 psa ng/ml: 1
 psa level ng/ml: 1
 psa level: 1
 ps6 antibody: 1
 ps: 1
 pru value: 1
 prpf8-mutation: 1
 prox1gfp: 1
 protocols time of isolation: 1
 protocols polarization: 1
 protocols isolation method: 1
 protocols differentiation: 1
 protocol transfection: 1
 protocol transduced: 1
 protocol to block transcription: 1
 protocol modifications: 1
 protocol host: 1
 protocol genetic modification: 1
 protocol description: 1
 protocol (transfection): 1
 proteomics sv3: 1
 proteomics sv2: 1
 proteomics sv1: 1
 proteomics study: 1
 proteolytic activity: 1
 protein tag: 1
 protein production in the previous lactation for the first 100 days: 1
 protein mutated: 1
 protein line: 1
 protein immunoprecipitated: 1
 protein co-immunoprecipitation: 1
 protection maneuver against iri: 1
 prostatetissue: 1
 prostate tissue: 1
 prostate lobe: 1
 prostate cancer subtype: 1
 prostate cancer status: 1
 pros expression level: 1
 proportion of monocytes: 1
 proportion of lymphocytes: 1
 proportion of granulocytes: 1
 propagule: 1
 promoter strength: 1
 promoter contruct: 1
 prom1 status: 1
 prolireating vs maturing: 1
 prolificacy: 1
 proliferative?: 1
 proliferation index: 1
 proliferation: 1
 progression-free survival: 1
 progression free survival delay: 1
 progression free survival (years): 1
 progression 0=no, 1=yes: 1
 progression (1=yes, 0=no): 1
 prognostic: 1
 progesteronereceptorstatus: 1
 progesterone status: 1
 progesterone serum level: 1
 progesterone level: 1
 progesterone: 1
 progesteron receptor status: 1
 progeny strain: 1
 progenitor population: 1
 profiling lab: 1
 productivity: 1
 product used: 1
 processing quality group: 1
 processing date: 1
 process date: 1
 process: 1
 procedure status: 1
 procedure date: 1
 probiotic treatment: 1
 probiotic: 1
 probe set: 1
 probe: 1
 prmt5 expression: 1
 prior radiation: 1
 prior chemotherapy: 1
 prior anti.tnf: 1
 priming strategy: 1
 primer set: 1
 primer index truseq small rna sample kit: 1
 primary_tumor: 1
 primary_site_status: 1
 primary_site: 1
 primary/relapse: 1
 primary/metastatic biopsy: 1
 primary type: 1
 primary tumor/metas: 1
 primary tumor dimension cm: 1
 primary source: 1
 primary mutation: 1
 primary host: 1
 primary cell line: 1
 primary cell culture: 1
 primary cause of death: 1
 prhswk4: 1
 prhswk16: 1
 prhswk0: 1
 previously treated for nhl: 1
 previous diagnosis of tb: 1
 previous chemo yes or no: 1
 pretreatmentdose: 1
 pretreatment drug & dose: 1
 pretransplant diabetes: 1
 preterm delivery within 48 hours: 1
 pressure in kpa: 1
 pressure: 1
 preservation type: 1
 preservation method: 1
 presentation order: 1
 presence/absence of puffing disorder: 1
 presence or absence of uterine/pelvic pathology: 1
 presence of the novb2 protein: 1
 presence of small lymphocyte aggregates (0 = negative, 1 = positive, na = not evaluated for this individual): 1
 presence of seizure: 1
 presence of peptide nucleic acid clamp: 1
 presence of metastasis: 1
 presence of large lymphocyte aggregates (0 = negative, 1 = positive, na = not evaluated for this individual): 1
 presence of chd1-ume6 fusion: 1
 prepsa: 1
 prepost-pair: 1
 preparation of conidia: 1
 prep type: 1
 preopclinstage: 1
 preliminary diagnosis: 1
 pregnant_status: 1
 pregnant: 1
 pregnancy_status: 1
 pregnancy state: 1
 pregnancies: 1
 prednisolone sensitivity: 1
 predicted molecular subtype: 1
 precursor cell type: 1
 precursor: 1
 precipitation: 1
 pre/post treatment: 1
 pre/post therapy: 1
 pre-treated with: 1
 pre-transplant disease: 1
 pre-psa: 1
 pre-incubated with: 1
 pre-hypoxia-temperature: 1
 pre-enrichment: 1
 pre-amplification: 1
 pre transplant hypertension: 1
 pre t: 1
 pre or post treatment: 1
 pre n: 1
 pre mbng: 1
 prc210: 1
 prc110: 1
 prbid: 1
 prasugrel: 1
 pr3-anca u/ml: 1
 pr.ih: 1
 pr-ihc: 1
 pr status by ihc: 1
 pr ihc status: 1
 pr allred score: 1
 pr (%) by ihc: 1
 pr   1= positive, 0= negative: 1
 ppp staining: 1
 ppi therapy (currently): 1
 pparg translocation: 1
 ppard treatment: 1
 poxvirus strain: 1
 postmortem interval minutes: 1
 postmortem interval hours: 1
 postmortem interval (pmi): 1
 postmortem interval: 1
 postmortem delay hr: 1
 postinjury time point at tissue harvest: 1
 postharvest treatment: 1
 postharvest storage condition: 1
 postchemo type: 1
 post-treatment: 1
 post-surgery: 1
 post-stroke time: 1
 post-mortem-interval hrs: 1
 post-mortem interval: 1
 post-mortem control case: 1
 post-mixing time: 1
 post-injury time: 1
 post-infection time: 1
 post-induction bortezomib treatment response: 1
 post-hypoxia-temperature: 1
 post-dac treatment: 1
 post transplant diabetes: 1
 post serum time point: 1
 post mortem interval pmi: 1
 post mortem interval (pmi): 1
 post menopausal status: 1
 positive lymphnodes count: 1
 positive: 1
 position of sample in tree: 1
 position: 1
 posaconazole resistance: 1
 pos-harvest time: 1
 populations: 1
 population/ species group: 1
 population source: 1
 population name: 1
 population doubling level: 1
 population base: 1
 popliteal angle: 1
 pooled or single individual?: 1
 pooled from multiple samples: 1
 pool used: 1
 pool transplanted into: 1
 pool size n of cases used per rna sample: 1
 pool of x animals: 1
 pool of origin: 1
 pool construction: 1
 polyposis: 1
 polyomavirus mxpyv status: 1
 polyic treatment: 1
 polya enrichment: 1
 polya depletion: 1
 poly selection: 1
 poly I: 1
 pollutant sensitivity: 1
 polisomy-17: 1
 polarizing conditions: 1
 polarization: 1
 point of time post infection: 1
 point mutation status: 1
 podoplanin expression: 1
 podocyte: 1
 pod: 1
 pneumocystis colonization: 1
 pna: 1
 pn status: 1
 pma stimulated: 1
 pma sensitivity: 1
 pm2.5  ug/m3: 1
 pm stage: 1
 pluripotent: 1
 pluripotency state: 1
 pluripotency confirmed using teratoma assay: 1
 pluripotency: 1
 plt 10e9/l: 1
 plnd result: 1
 plavix: 1
 plau module tertile: 1
 platinum-sensitivity refractory or resistant: 1
 platinium sensitivity resistant: 1
 plating: 1
 platform_id_id design: 1
 platform: 1
 platelets x10^9/l: 1
 platelets 1000s/mm3: 1
 platelets: 1
 platelet_count_(x103/ul): 1
 platelet reactivity to 1.5 um epinephrine: 1
 platelet description: 1
 platelet (x10^3/mcl): 1
 plateid: 1
 plate batch: 1
 plasmodium infection: 1
 plasmids used for transduction: 1
 plasmid vector: 1
 plasmid transfected: 1
 plasmid backbone: 1
 plasmainsulinng/ml: 1
 plasmainsulinmu/l: 1
 plasma-testosterone: 1
 plasma-androstenone: 1
 plasma vitellogenin mg/ml: 1
 plasma testosterone ng/ml: 1
 plasma hiv-1 rna levels (copies/ml): 1
 plasma glucose mg per dl: 1
 plasma glucose area under the curve above basal ogtt mmol/l * min: 1
 plasma genistein ng/ml: 1
 plasma free fatty acids under the curve ogtt mmol/l * min: 1
 plasma estradiol ng/ml: 1
 plasma cortisol: 1
 plasma collected from: 1
 plaque stability: 1
 plaque histology: 1
 planting location: 1
 plant variety: 1
 plant number: 1
 plant material: 1
 plant info: 1
 plant height: 1
 plant growth conditions: 1
 plant cultivar: 1
 plant condition: 1
 plant: 1
 placental_gestation weeks: 1
 placenta_group: 1
 placed at: 1
 place of origin: 1
 pl alleles: 1
 pk/year: 1
 pk/day: 1
 pivka-ii: 1
 pik3ca.gene.mutation.status: 1
 pik3ca status: 1
 pik3ca mutation: 1
 pik3ca mutant: 1
 pik3ca module tertile: 1
 pik3ca aa: 1
 pik3ca: 1
 piglet group: 1
 piece: 1
 picture available: 1
 phytophtora inoculation: 1
 physiologycal status: 1
 physiology state: 1
 physiological status: 1
 physical exercise: 1
 physical activity level pal: 1
 physical activity: 1
 phylogeny of diet: 1
 phototypes: 1
 phototype: 1
 photosynthetic mode: 1
 photoactivatable ribonucleoside analog and crosslinking wavelength: 1
 phosphorus condition: 1
 phosphorus concentration: 1
 phosphate quantity: 1
 phosphate (um): 1
 phosphate: 1
 phonological stage: 1
 phob genotype: 1
 phillips subtype: 1
 pheophytin content (ug/l): 1
 phenoytpe: 1
 phenotyping group: 1
 phenotypical stage: 1
 phenotypic markers: 1
 phenotypic marker: 1
 phenotypes: 1
 phenotype/variation: 1
 phenotype regarding social experience: 1
 phenotype of the cells: 1
 phenotype of NK subsets: 1
 phenotype lignin: 1
 phenotype in plant: 1
 phenotype hemicellulose-lignin: 1
 phenotype hemicellulose xylose: 1
 phenotype group birth outcome: 1
 phenotype glucose: 1
 phenotype density-lignin: 1
 phenotype density-alpha cellulose: 1
 phenotype density: 1
 phenotype alpha cellulose-lignin: 1
 phenotype alpha cellulose-hemicellulose glucose-xylose: 1
 phenotype alpha cellulose: 1
 phenotype against ipnv infection: 1
 phenotyp: 1
 phenobarbital dose ppm: 1
 phenanthrene ng/m3: 1
 phase of growth: 1
 phase in phb production cycle: 1
 phase in pha production cycle: 1
 phase growth: 1
 pharmaceutical agent: 1
 phage: 1
 ph of the medium: 1
 pgc-1 alpha isoform expression: 1
 pgc number: 1
 pg: 1
 pfs.time: 1
 pfs.status: 1
 pfs time to event months: 1
 pfs time: 1
 pfs status: 1
 pfs months: 1
 pfs indicator: 1
 pfs event type 0 = censored: 1
 pfi days: 1
 pf299804: 1
 pet: 1
 person: 1
 persistent ps aer status: 1
 permissiveness to hcv: 1
 periventricular leukomalacia (pvl): 1
 peritoneal dissemination: 1
 perirenalfatg: 1
 peripheral blood cd4+ t cells (cells/ml): 1
 peripheral blood: 1
 perineural invasion: 1
 peri-nephric fat involvement: 1
 performance status corresponding to who criteria: 1
 percentage (%) of sp cells: 1
 percentage (%) of mp cells: 1
 percent marinade uptake at 24h post-slaughter: 1
 percent liver fat: 1
 percent liver: 1
 percent lactulose in urine: 1
 percent: 1
 per3 genotype: 1
 peptide treatment: 1
 peptide dosage: 1
 pepd status: 1
 pelvic lymph nodes: 1
 pecies: 1
 pecam status: 1
 peak vo2 ml/kg/min: 1
 peak vo2 l/min: 1
 peak velocity mph: 1
 peak ve l/min: 1
 peak transepitheilal electrical resistance ksr only: 1
 peak rr breaths/min: 1
 peak rr: 1
 peak power w: 1
 peak inclination %: 1
 peak hr bpm: 1
 peak duration %: 1
 pe pcr primer r: 1
 pe pcr primer f: 1
 pdgf-bb: 1
 pdac sample identifier: 1
 pctgastrap_slicer: 1
 pctemph_slicer: 1
 pcrrcb1: 1
 pcr/virus isolation: 1
 pcr 1 vs rd 0: 1
 pca status: 1
 pc20 (mg/ml): 1
 pc1 expression level: 1
 pbrm1 status: 1
 pbmc isolation method: 1
 pbde dose: 1
 pax-foxo1 fusion status: 1
 pavm: 1
 pattern of  cancer growth: 1
 patients cohort (sample set): 1
 patientcodeoncologistms: 1
 patient_replicate: 1
 patient_number: 1
 patient/tissue id: 1
 patient/line: 1
 patient/donor number: 1
 patient/control id: 1
 patient.smoker: 1
 patient.number: 1
 patient.nodal.status: 1
 patient's tumor: 1
 patient treatment status: 1
 patient treatment plan: 1
 patient treatment: 1
 patient survival status: 1
 patient stage: 1
 patient sex: 1
 patient sample type: 1
 patient sample id: 1
 patient sample: 1
 patient race: 1
 patient prognosis: 1
 patient mm stage: 1
 patient last status: 1
 patient identification: 1
 patient group and tissue group: 1
 patient glucold study id: 1
 patient diagnosis: 1
 patient description: 1
 patient code name: 1
 patient alive: 1
 patient age at stage iii sample banked years: 1
 patient age at primary dignosis years: 1
 patient age at diagnosis: 1
 patient age (yrs): 1
 patient 2 yr disease free survival outcome: 1
 patient #: 1
 pathway: 1
 pathovar: 1
 pathology diagnosis: 1
 pathological_stage: 1
 pathological t: 1
 pathological staging: 1
 pathological response to preoperative chemoradiotherapy: 1
 pathological response to crp: 1
 pathological n: 1
 pathological diagonosis: 1
 pathological diagnostic: 1
 pathological diagnosis: 1
 pathological complete response: 1
 pathologic tnm staging: 1
 pathologic status: 1
 pathologic response rcb class: 1
 pathologic response pcr rd: 1
 pathologic response pcr ncr: 1
 pathogen treatment: 1
 pathogen isolates: 1
 pathogen infection intensity zoospore equivalents for subject: 1
 pathogen infection: 1
 pathogen genotype/variation: 1
 pathogen genotype: 1
 pathogen challenge: 1
 path. review % of tumour cells: 1
 path cr: 1
 paternal ril: 1
 paternal age: 1
 patent: 1
 passive siga in mother's milk: 1
 passes qc checks: 1
 passedqc: 1
 passaged culture: 1
 passage state: 1
 passage post cre infection: 1
 passage of cell line: 1
 passage nr.: 1
 passage day: 1
 pasi75_w12: 1
 pasi (baseline): 1
 pasi (after): 1
 particle/vesicle: 1
 particle: 1
 participants group: 1
 partial hepatectomy time point: 1
 parthenocarpy: 1
 paris age at diagnosis: 1
 parents: 1
 parentality: 1
 parentalcopd: 1
 parental/progeny: 1
 parental mouse strain for cell line: 1
 parental mouse strain background for cell line: 1
 parental mouse gender for cell line: 1
 parental mouse age for cell line: 1
 parental isolate: 1
 parental growth temperature: 1
 parental genotype/variation: 1
 parental duplication of  distal chr7: 1
 parental duplication of  distal chr15: 1
 parental cells: 1
 parental cell type: 1
 parental cell line id: 1
 parentage: 1
 parent-of-origin: 1
 parent of origin of y chr: 1
 parent of origin: 1
 parasite isolate: 1
 parasite genotype/variation: 1
 parasite dose: 1
 parasite clearance halflife upon artemisinin treatment h: 1
 paraquat exposure: 1
 paraprotein type and level: 1
 paradigm: 1
 par4 agonist response score: 1
 paquet.et.al: 1
 papillomas: 1
 panobinostat treatment: 1
 panicle length: 1
 pancreatic cell type: 1
 pancreatic cancer: 1
 pancreasg: 1
 pam50.intrinsic.subtype: 1
 pam50 subtype assignment: 1
 pam50 subtype: 1
 pam50 est: 1
 pam50 correlation: 1
 pam50 class: 1
 pairing of samples: 1
 pairing: 1
 paired_or_unpaired: 1
 paired sample id: 1
 paired or single-end: 1
 paired microarray: 1
 paired material support: 1
 pair_number: 1
 pair_index: 1
 packyrs: 1
 packs: 1
 pack-years: 1
 pacemaker: 1
 paa: 1
 p_treat_radio_0no_1yes: 1
 p_treat_horm_0no_1yes: 1
 p_treat_chemo_0no_1yes: 1
 p_local_recurrence_desc: 1
 p_local_recurrence_0no_1yes: 1
 p_dead_followup_0no_1yes: 1
 p_days_to_recurrence: 1
 p_days_to_distant_recurrence: 1
 p_days_to_death: 1
 p_days_followup: 1
 p_cause_of_death: 1
 pT_of_TMN_Staging_System: 1
 pTNM: 1
 pT: 1
 pStage: 1
 pN_of_TMN_Staging_System: 1
 pN: 1
 pM_of_TMN_Staging_System: 1
 pM: 1
 pH: 1
 pGAL1: 1
 p63 staining status: 1
 p63 expression: 1
 p53ihc: 1
 p53.ihc: 1
 p53 stimulator: 1
 p53 positive ihc: 1
 p53 positive (IHC): 1
 p53 nucl.accum.: 1
 p53 ihc status: 1
 p53 ihc: 1
 p53 Status: 1
 p53 Model: 1
 p53 Genotype: 1
 p53 Genoty: 1
 p210_bcr-abl1: 1
 p190_bcr-abl1: 1
 p16 restoration: 1
 p10date: 1
 p. yoeli infection strain control=n: 1
 p-cadherin overexpression: 1
 ozone sensitivity: 1
 ozone exposure ppb: 1
 oyster line: 1
 oxytocin: 1
 oxygen stress: 1
 oxygen status: 1
 oxygen regime: 1
 oxygen percentage: 1
 oxygen levels: 1
 oxygen availability: 1
 oxygen 36 weeks postmenstrual age (wpma): 1
 oxygen 28 days: 1
 oxygen (mg/l): 1
 ovulation: 1
 overproduction: 1
 overexpresson: 1
 overexpression status: 1
 overexpression product: 1
 overexpression induced with doxycline: 1
 overexpressing: 1
 overallsurvival_months: 1
 overall.survival..days.: 1
 overall survival status: 1
 overall survival low_<or=median=1, high_>median=2: 1
 overall survival (days): 1
 overall survival (censored): 1
 overall survival (censored 1=event)): 1
 overall stage: 1
 overall metastasis: 1
 overall azole resistance: 1
 over-expression: 1
 ovarian cycle status: 1
 outlier: 1
 outgrowth: 1
 other_id: 1
 other positive results: 1
 other markers: 1
 other illnesses: 1
 osteo-induced: 1
 osmostress treatment: 1
 osccdeath: 1
 os_time_days: 1
 os_event: 1
 os.event: 1
 os.delay: 1
 os years: 1
 os time to event months: 1
 os t: 1
 os s: 1
 os months: 1
 os indicator: 1
 os event type 0 = censored: 1
 os days: 1
 os censored: 1
 os - overall survival days: 1
 original tumor type: 1
 original tumor status: 1
 original tumor: 1
 original sample id: 1
 original place: 1
 original pipeline: 1
 original geo sample id: 1
 original genechip type: 1
 original cell type: 1
 original cell line: 1
 origin of the colony: 1
 origin of specimen: 1
 origen of cultured cells: 1
 organsim part: 1
 organs: 1
 organoid stage: 1
 organisms: 1
 organismPart: 1
 organism(s): 1
 organism weight: 1
 organism structure: 1
 organism part(tissue): 1
 organism isolated from: 1
 organism germplasm accession: 1
 organic substrate: 1
 organ_or_cell_type: 1
 organ site at which tumor arose: 1
 organ site: 1
 organ part: 1
 organ culture batch: 1
 organ and cell type: 1
 orf encoding protein: 1
 ord_id: 1
 orally gavaged (for 3 days): 1
 oral cancer-free survival time (years): 1
 or hras mutation: 1
 or cell line: 1
 optimal: 1
 optical density 600nm: 1
 operability: 1
 opdat: 1
 op: 1
 oocytes in metaphase ii: 1
 oocyte stage: 1
 oocyte maturity 3: 1
 oocyte maturity 2: 1
 oocyte maturity: 1
 oocyte maturation stage: 1
 oocyte genotype/variation: 1
 oocyte genotype: 1
 oocyte chromatin configuration: 1
 oocyst prevalence: 1
 onset week: 1
 onset of asthma age: 1
 onset: 1
 one of 3 rna pools, 6 animals each: 1
 oncogenic overexpression: 1
 oncogene expression: 1
 on the third day: 1
 on slide: 1
 on antibiotics at time of sample: 1
 omega 3 supplement level: 1
 olt model: 1
 oligonucletides used for chirp: 1
 oligo treatment: 1
 oligo transfection: 1
 oligo set: 1
 olfactory stimuli: 1
 oil concentration: 1
 oht: 1
 ogtt fasting plasma glucose mmol/l: 1
 ogtt fasting plasma free fatty acid mmol/l: 1
 ogtt 30 min plasma proinsulin pm/l: 1
 ogtt 30 min plasma insulin mu/l: 1
 ogtt 30 min plasma glucose mmol/l: 1
 ogtt 30 min plasma free fatty acid mmol/l: 1
 ogtt 120 min plasma proinsulin pm/l: 1
 ogtt 120 min plasma insulin mu/l: 1
 ogtt 120 min plasma glucose mmol/l: 1
 ogtt 120 min plasma free fatty acid mmol/l: 1
 offspring_diet: 1
 offspring diet: 1
 of the cells to survive): 1
 of nuclei): 1
 of cells counted): 1
 od600 nm: 1
 od 600: 1
 octn2: 1
 octn1: 1
 oct4: 1
 obtention: 1
 observation: 1
 obligate intracellular bacterium: 1
 obese: 1
 nymphal stage: 1
 nyha: 1
 nutrients: 1
 nutrient supplement: 1
 nutrient state: 1
 nutrient source: 1
 nutrient limitation or pulse: 1
 nutrient: 1
 nup214-abl1: 1
 number.of.invaded.lymph.nodes..on.total.investigated.lymph.nodes: 1
 number passages: 1
 number of vessels cad: 1
 number of tumors: 1
 number of trouts per group: 1
 number of treatments: 1
 number of transfer methanol 2%: 1
 number of tissues: 1
 number of the worker bee: 1
 number of siv challenge to infection: 1
 number of relapses during the year prior to treatment: 1
 number of relapses during 5-year follow-up: 1
 number of relapses during 2-year follow-up: 1
 number of relapses during 2-month follow-up: 1
 number of relapses during 12-month follow-up: 1
 number of relapses during 1-year follow-up: 1
 number of rats per group: 1
 number of primary melanomas: 1
 number of pooled tissues: 1
 number of pooled samples: 1
 number of plants harvested: 1
 number of patients: 1
 number of motifs sung: 1
 number of lymphnodes resected: 1
 number of lymph node metastasis: 1
 number of lung tumors: 1
 number of insertion sites: 1
 number of individulas per sample: 1
 number of individuals per sample: 1
 number of immunization boost: 1
 number of fish in group: 1
 number of doses: 1
 number of bees: 1
 number of aortic cusps: 1
 number of animals pooled per array: 1
 number of animal per cage: 1
 number cells in sample: 1
 num_cells: 1
 num. cells: 1
 nuicc: 1
 nugent score: 1
 nuclide: 1
 nucleus polymorphy grade: 1
 nuclear receptor agonist type: 1
 nuclear pleomorphism: 1
 nuclear condition: 1
 nsaid treatment: 1
 nrti treatment status: 1
 nras status: 1
 nras mutation status: 1
 npod id: 1
 npm1 status: 1
 npm status: 1
 npc culture propagated from: 1
 notch1 status: 1
 notch signaling pathway activation: 1
 not progressed: 1
 nos2 expression: 1
 normalizedsmokinghistoryinpackyears: 1
 normalization: 1
 normal/tumor: 1
 normal pancreas vendor: 1
 normal pancreas pool for between-slide normalization: 1
 normal or tumor: 1
 normal donor: 1
 non-silent mutation rate per mb wes: 1
 non-reading primer sequence: 1
 non rejection: 1
 nomogram score: 1
 nominal dose: 1
 nodrecurdt: 1
 node status (1=pos): 1
 node involvement (n): 1
 nodalrecur: 1
 nodal-count: 1
 nodal status at surgery: 1
 nodal status (according to tnm classification 2002): 1
 nodal status (0=negative, 1=positive, na=not applicable): 1
 nodal involvement: 1
 nod 908: 1
 nod 702: 1
 nod 1007 fs: 1
 no3 added on day 9: 1
 no. of total reads: 1
 no. of pulmonary metastases: 1
 no. of embryos/cells: 1
 no): 1
 no of uniquely mapped reads: 1
 no of glomeruli: 1
 no inhibitor: 1
 no evidence of disease (ned) or failed: 1
 nmr lean: 1
 nmr fat: 1
 nkc state: 1
 nk depletion: 1
 nk cells mrna mass ng: 1
 nitrogen_level: 1
 nitrogen starvation time: 1
 nitrogen source in growth media: 1
 nitrogen requirements: 1
 nitrogen level: 1
 nitrogen concentration: 1
 nitrogen: 1
 nitrate (um): 1
 nik pathway mutation: 1
 nih registry number: 1
 night duration: 1
 nicotine exposure: 1
 niche: 1
 nhl or chl: 1
 nh3 availability: 1
 ngn3 transfection stage: 1
 nf1-associated: 1
 nf-1 clinical manifestation: 1
 nf value: 1
 neutrophils x10^9/l: 1
 neutrophils mrna mass ng: 1
 neutrophil subset: 1
 neutrophil differentiation stage: 1
 neutrophil count: 1
 neutrophil: 1
 neuropathy > 2: 1
 neuropathological data braak stage: 1
 neuropathological category: 1
 neuronal age: 1
 neuron subtype: 1
 neuron species: 1
 neuron age: 1
 neuron: 1
 neurocognitive disorder: 1
 neurocognitive abnormal: 1
 neural tube morphology: 1
 neu 10e9/l: 1
 net-seq antibody: 1
 net insr expression by facs: 1
 nert: 1
 neoplasia type: 1
 neonate: 1
 neonatal maternal separation nms: 1
 neoadjuvant chemotherapy response: 1
 nematode: 1
 necrosis score: 1
 necrosis level (linkon): 1
 necrosis level (ekl): 1
 necrosis class: 1
 near isogenic lines: 1
 ndrg1 genotype: 1
 ncat: 1
 nb reads: 1
 nb multiplexed samples: 1
 natural killer cell subset: 1
 native mir196a expression: 1
 nass: 1
 nas: 1
 naphthalene ng/m3: 1
 nanomaterial: 1
 nanog: 1
 nanodrop 260/280: 1
 nanodrop 260/230: 1
 nagative: 1
 nafld status: 1
 na: 1
 n0: 1
 n/k-ras: 1
 n-3LCPUFA_Flesh: 1
 n-3 pufa intake g/day: 1
 n tnm score: 1
 n lymph node metastasis: 1
 n (tnm stage): 1
 myometrial invasion: 1
 myofibroblast source: 1
 myofiber type: 1
 myocardial sample: 1
 myoblast culture: 1
 myeloperoxidase activity (u/mg): 1
 mycn expression: 1
 myc_copy: 1
 myc translocation: 1
 myc module tertile: 1
 mutational.status: 1
 mutational status: 1
 mutation, hgvs: 1
 mutation status of dicer1 or drosha: 1
 mutation status esr1: 1
 mutation induction age: 1
 mutation group: 1
 mutation description: 1
 mutatio type: 1
 mutated tumor suppressor: 1
 mutant state: 1
 mutant line: 1
 mutant allele: 1
 mut: 1
 musk expression: 1
 muscular dystrophy type: 1
 muscles: 1
 muscle name: 1
 muscle mass %: 1
 muscle invasion: 1
 muscle innervation: 1
 muscle hypertrophy: 1
 multiplex index: 1
 multiplex adapters: 1
 multiple p53 mutation: 1
 multiple organ dysfunction: 1
 multifocality: 1
 multifocal: 1
 multicentric occurrence-free survival days: 1
 mts_type: 1
 mtor inhibitor treatment?: 1
 mths_to_last_clinical_assessment: 1
 mtdna haplogroup: 1
 mtdna genotype: 1
 mtdna from: 1
 mtap: 1
 msx1 expression: 1
 mss/msi status: 1
 mskcc: 1
 msi.status mismatch repair status: 1
 msc type: 1
 msc treatment: 1
 msc transplantation: 1
 msc culture: 1
 ms treatment: 1
 mrna type: 1
 mrna targeted by 2nd sirna: 1
 mrna targeted by 1st sirna: 1
 mrna synthesis: 1
 mrna input: 1
 mrna enrichment: 1
 mri t2 value: 1
 mrd: 1
 mpo-anca u/ml: 1
 mplw51: 1
 mouse_no: 1
 mouse.id: 1
 mouse's organs with engrafted tumors: 1
 mouse weight: 1
 mouse status: 1
 mouse rna input quantity: 1
 mouse portion %: 1
 mouse model gender: 1
 mouse model age: 1
 mouse line abbreviation: 1
 mouse group: 1
 mouse genome informatics (mgi) strains: 1
 mouse genetic background: 1
 mouse developed tumors: 1
 mouse cross to generate experimental fetus: 1
 mouse background: 1
 mouse #: 1
 mother_diet: 1
 mother number: 1
 mother bc: 1
 mortality: 1
 morphology of papillary carcinomas: 1
 morphological stage: 1
 morphological phase: 1
 morphological diagnosis: 1
 morpholino injection at 1-cell stage: 1
 morpholino: 1
 months_to_last_contact_or_death: 1
 months_to_first_progression: 1
 months]: 1
 months total f/u: 1
 months to relapse: 1
 months to bcr: 1
 months from dg to r: 1
 months before relapse/censor: 1
 months: 1
 month of sampling: 1
 monozygotic twin relationship: 1
 monocytes x10^9/l: 1
 monocytes mrna mass ng: 1
 monocytes: 1
 monocyte subtype: 1
 monocyte derived dendritic cell: 1
 monocyte: 1
 monocolonized host: 1
 monoclonal component: 1
 mono 10e9/l: 1
 molt stage: 1
 molecute subtype: 1
 molecular tumor subtype: 1
 molecular subtype according to sorlie et al., pnas 100, 8418-23 2003: 1
 molecular classification: 1
 molar concentration: 1
 modus operandi: 1
 modulation mg: 1
 modulation: 1
 modifiers: 1
 modified nucleotide: 1
 modified mankin score: 1
 modifications: 1
 model number: 1
 model id: 1
 mode of inheritance: 1
 mode of gowth: 1
 mode of delivery: 1
 moap-1: 1
 mnssl: 1
 mnet-seq antibody: 1
 mnase digestion: 1
 mmse: 1
 mm subtype: 1
 mm stage: 1
 mm no3-: 1
 mm mesangial matrix expansion: 1
 mll_translocation: 1
 mll_par: 1
 mll_ind: 1
 mll-rearranged(11q23): 1
 mll-ptd: 1
 mll status: 1
 mll fusion: 1
 ml) at RRP: 1
 ml peptidoglycan: 1
 mixing ratio: 1
 mixed rna: 1
 mixed race: 1
 mix: 1
 mitotic rate of tumor: 1
 mitotic rate: 1
 mitotic cycle: 1
 mitotic count: 1
 mitosis grade: 1
 mitochondrial status: 1
 mit1:: 1
 mirna construct: 1
 mira: 1
 mir142 genotype: 1
 mir-34a expression: 1
 mir-31 transfection: 1
 mir-222 overexpression: 1
 mir-150 level: 1
 mir-146a expression: 1
 minutes after dawn day 4: 1
 minor.gleason: 1
 mininal stage grouping: 1
 minimal sugar medium: 1
 min): 1
 min: 1
 mimicked developmental phase: 1
 miller-payne response: 1
 milking status: 1
 milk performance in the previous lactation for the first 100 days: 1
 milan criteria: 1
 mii): 1
 migration model: 1
 mif status: 1
 midgut region: 1
 microvascular invasion: 1
 microvascular density (mvd): 1
 microsattelite instability: 1
 microsattelite: 1
 microsatellite status: 1
 microsatellite phenotype: 1
 microrna mimic: 1
 microinjected with: 1
 microglia isolation method: 1
 microenvironment_cd8positive_cell_number: 1
 microenvironment_cd4positive_cell_number: 1
 microdeletion: 1
 microbial status: 1
 microarraychip: 1
 microarray_batch: 1
 microarray#: 1
 microarray study: 1
 microarray slide number: 1
 microarray slide half number unique within slide: 1
 microarray slide array number unique within slide half: 1
 microarray id: 1
 microarray data quality: 1
 microarray: 1
 microRNA-based subclass: 1
 micro array id: 1
 mice no.: 1
 mic status: 1
 mic: 1
 miRNA spike in amount: 1
 miRNA mimic: 1
 mi63 treatment: 1
 mi type: 1
 mhc: 1
 mgmt status: 1
 mg2+: 1
 mg/etoh treatment: 1
 mg ethephon: 1
 mfsdel (month): 1
 mfs days: 1
 mfs: 1
 mfolfox6: 1
 mets_dd_after_diagnosis: 1
 mets_count: 1
 mets: 1
 methylation barcode: 1
 methylation: 1
 methotrexate sensitivity: 1
 method subtype: 1
 method of termination: 1
 method of induction: 1
 methacholine inhalation challenge: 1
 meth_brca2: 1
 meth_brca1: 1
 metformin added: 1
 metatastic tissue: 1
 metastatic site preference: 1
 metastatic progression: 1
 metastatic phenotype: 1
 metastatic group: 1
 metastatic event: 1
 metastasis stage: 1
 metastasis site: 1
 metastasis level: 1
 metastasis growth phase: 1
 metastasis free interval (months): 1
 metastasis class: 1
 metastasis (1: 1
 metal accumulation and tolerance: 1
 metabolism: 1
 metabolic state: 1
 metabolic equivalents: 1
 metabolic class: 1
 meta: 1
 mesentericfatg: 1
 mesenteric g: 1
 mescs: 1
 mesangium ig: 1
 merkel cell polyomavirus status dna and rna: 1
 merged_sample: 1
 meoh-fixed: 1
 menstrual cycle phase: 1
 menstral cycle phase: 1
 menstral cycle day: 1
 menopause status 0=pre, 1=post: 1
 menopause status: 1
 menopausal status: premenopause race: 1
 menopausal status: premenopausal race: 1
 menopausal status at start therapy: 1
 menopausal state post=1\pre=0: 1
 menopausal   status: 1
 menopausal: 1
 menop: 1
 meningioma type: 1
 meld: 1
 melanoma type: 1
 melanoma subtype: 1
 melanoma cell type: 1
 meiotic time point: 1
 meiotic fraction: 1
 mefs: 1
 medium/substrate: 1
 medium used for es cells: 1
 medium supplements: 1
 medium ph: 1
 medium of growth: 1
 medip antibody lot#: 1
 medip antibody catalog#: 1
 medication regimen: 1
 medication: 1
 medical procedure: 1
 medical examiner office: 1
 median tin score: 1
 median age: 1
 media ypd, synh -hts, synh: 1
 media supplement: 1
 media stimulation: 1
 media culture: 1
 media additions: 1
 media adaptation: 1
 med12 status: 1
 meconium ileus surrogate variable 9: 1
 meconium ileus surrogate variable 8: 1
 meconium ileus surrogate variable 7: 1
 meconium ileus surrogate variable 6: 1
 meconium ileus surrogate variable 5: 1
 meconium ileus surrogate variable 4: 1
 meconium ileus surrogate variable 3: 1
 meconium ileus surrogate variable 26: 1
 meconium ileus surrogate variable 25: 1
 meconium ileus surrogate variable 24: 1
 meconium ileus surrogate variable 23: 1
 meconium ileus surrogate variable 22: 1
 meconium ileus surrogate variable 21: 1
 meconium ileus surrogate variable 20: 1
 meconium ileus surrogate variable 2: 1
 meconium ileus surrogate variable 19: 1
 meconium ileus surrogate variable 18: 1
 meconium ileus surrogate variable 17: 1
 meconium ileus surrogate variable 16: 1
 meconium ileus surrogate variable 15: 1
 meconium ileus surrogate variable 14: 1
 meconium ileus surrogate variable 13: 1
 meconium ileus surrogate variable 12: 1
 meconium ileus surrogate variable 11: 1
 meconium ileus surrogate variable 10: 1
 meconium ileus surrogate variable 1: 1
 meconium ileus status: 1
 meat condition: 1
 measurable disease check if it's measurable: 1
 mean wiener entropy: 1
 mean tethered flight distance: 1
 mean steroid levels from phenotypes: 1
 mean size: 1
 mean pitch goodness: 1
 mean pitch: 1
 mean number of oocysts: 1
 mean insert size: 1
 mean frequency modulation: 1
 mean edss ms csf: 1
 mean cell volume fl: 1
 mean cell hb pg: 1
 mean cell hb conc. g/l: 1
 mean arterial pressure mmhg: 1
 mean: 1
 meal type: 1
 mdv-infection susceptibility: 1
 mdrd: 1
 mcv_status: 1
 mcherry: 1
 mch pc20 mg/ml at pre-challenge: 1
 mch pc20 mg/ml at post-challenge: 1
 mcam: 1
 mc6 medical history: 1
 mc6 gender: 1
 mc6 cause of death: 1
 mc6 age: 1
 mc5 medical history: 1
 mc5 gender: 1
 mc5 cause of death: 1
 mc5 age: 1
 mc4 medical history: 1
 mc4 gender: 1
 mc4 cause of death: 1
 mc4 age: 1
 mc3 medical history: 1
 mc3 gender: 1
 mc3 cause of death: 1
 mc3 age: 1
 mc2 medical history: 1
 mc2 gender: 1
 mc2 cause of death: 1
 mc2 age: 1
 mc1r: 1
 mc1 medical history: 1
 mc1 gender: 1
 mc1 cause of death: 1
 mc1 age: 1
 mc mesangial cell increase: 1
 mc: 1
 maximum time of rapamycin exposure: 1
 max work watts: 1
 max work (watts): 1
 max expression: 1
 maturity stage: 1
 maturation stage: 1
 maturation method: 1
 matrix stiffness: 1
 matingstatus: 1
 mating relationship: 1
 mating behavior: 1
 mating: 1
 maternal status: 1
 maternal ril: 1
 maternal plane of nutrition: 1
 maternal mouse info: 1
 maternal ethnicity: 1
 maternal bmi: 1
 material_source: 1
 material property: 1
 matching input raw data file: 1
 matching group: 1
 matching expression data: 1
 matching: 1
 matched_tumor_array: 1
 matched_tail_array: 1
 matched/unmatched: 1
 matched pair: 1
 match to domesticated: 1
 mat: 1
 master set: 1
 mast cell engraftment: 1
 massage leg: 1
 mass mg: 1
 marker phenotype short name: 1
 marker phenotype: 1
 marker expression and plasticity: 1
 marginal: 1
 margin_status: 1
 mare#: 1
 mapped to genes before filtering: 1
 mapped to genes after filtering: 1
 mapped reads: 1
 mapki treatment: 1
 mapki sensitivity: 1
 mapk-inhibitor: 1
 mapk module tertile: 1
 mapk hit: 1
 mapi inadequate tissue for pathology interpretation: 1
 manufacturer/source: 1
 manufacture: 1
 mantle cell lymphoma mcl line: 1
 mammary gland stage: 1
 malocclusion classification: 1
 malignity: 1
 malignant potential: 1
 malignancy state: 1
 malignancy grade: 1
 malignacy: 1
 malign: 1
 male/female ratio: 1
 male.population: 1
 male): 1
 male or female: 1
 malaria status: 1
 malaria retinopathy: 1
 major.gleason: 1
 major tissue: 1
 major cell type: 1
 maize inbred line: 1
 mahpic non human primate individual id: 1
 magnetic beads: 1
 maf: 1
 madbid: 1
 macs antibody: 1
 macrophages: 1
 macrophage subtype: 1
 macrophage pool: 1
 macrophage: 1
 macronutrient in p/c/f: 1
 macroh2a genotype: 1
 macrochip: 1
 macro-area of verdona region: 1
 machine: 1
 mab: 1
 ma6 medical history: 1
 ma6 gender: 1
 ma6 cause of death: 1
 ma6 age: 1
 ma5 medical history: 1
 ma5 gender: 1
 ma5 cause of death: 1
 ma5 age: 1
 ma4 medical history: 1
 ma4 gender: 1
 ma4 cause of death: 1
 ma4 age: 1
 ma3 medical history: 1
 ma3 gender: 1
 ma3 cause of death: 1
 ma3 age: 1
 ma2 medical history: 1
 ma2 gender: 1
 ma2 cause of death: 1
 ma2 age: 1
 ma1 medical history: 1
 ma1 gender: 1
 ma1 cause of death: 1
 ma1 age: 1
 mAdbID: 1
 m9 minimal media supplemented with: 1
 m5c antibody vendor: 1
 m5c antibody cat.#: 1
 m5c antibody: 1
 m3 cadi: 1
 m2): 1
 m2: 1
 m12 cadi: 1
 m0: 1
 m. tuberculosis strain: 1
 m. smegmatis infection status: 1
 m-stage: 1
 m-csf: 1
 m): 1
 m type: 1
 m tnm score: 1
 m stage: 1
 m (tnm stage): 1
 lynch.syndrom: 1
 lymphovascular invasion: 1
 lymphoma subtype: 1
 lymphocytes x10^9/l: 1
 lymphocyte.reaction: 1
 lymphocyte percentage: 1
 lymphocyte count: 1
 lymphocyte: 1
 lymph.cluster: 1
 lymph node status n: 1
 lymph node status (0: 1
 lymph node positive: 1
 lymph node location relative to tumor: 1
 lym 10e9/l: 1
 ly6c expression: 1
 ly-6d: 1
 lvad support: 1
 lvad status: 1
 lvad device: 1
 lung.metastasis.in.mice: 1
 lung weight mg: 1
 lung source: 1
 lung metastasis: 1
 lung lobe: 1
 lung disease: 1
 lung cancer type: 1
 lumb_brca2-like_pred: 1
 ltindex: 1
 lrpprc expression vs. control: 1
 lps_concentration: 1
 lps treatment (time): 1
 lps treatment: 1
 lps stimulation: 1
 lps exposure time: 1
 lps addition: 1
 lower_protocol: 1
 low ejection fraction: 1
 lot/catalog#: 1
 lot/batch number: 1
 loss of function method: 1
 loop content: 1
 longitudinal zone: 1
 longissimus dorsi muscle, animal: 1
 log2 estimated glomerular filtration rate using modification of diet in renal disease egfr_mdrd: 1
 log10 urinary albumin excretion rate ug/min: 1
 log10 total triglycerides mmol/l: 1
 log10 total cholesterol mmol/l: 1
 log10 serum bilirubin umol/l: 1
 log10 serum apob g/l: 1
 log10 serum apoa1 g/l: 1
 log10 serum alanine aminotransfrase u/l: 1
 log10 plasma glucose area under the curve ogtt mmol/l * min: 1
 log10 ogtt fasting plasma proinsulin pm/l: 1
 log10 ogtt fasting plasma insulin mu/l: 1
 log10 matsuda insulin sensitivity index: 1
 log10 ldl cholesterol mmol/l: 1
 log10 insulin area under the curve ogtt pmol/l * min: 1
 log10 insulin area under the curve above basal ogtt pmol/l * min: 1
 log10 il1 receptor antagonist pg/ml: 1
 log10 il1 beta pg/ml: 1
 log10 homais insulin secretion index based on homa: 1
 log10 homair insulin resistance index based on homa: 1
 log10 hdl cholesterol mmol/l: 1
 log10 estimated creatinine clearance rate using cockfcrot-gault formulaa egcr: 1
 log10 creatinine umol/l: 1
 log10 body mass index: 1
 log10 bioimpedance reactance: 1
 log10 bioimpedance: 1
 log10 basal metabolic rate kcal: 1
 log triglycerides: 1
 log trehalose: 1
 log ktrans week 14: 1
 log ktrans week 0: 1
 log homa_1 ir: 1
 locrecurdt: 1
 locomotion phenotype: 1
 locations of metastatic tumor specimens: 1
 location of tumors: 1
 location isolated: 1
 location in tumor nodule: 1
 location in epididymis: 1
 location generated: 1
 localrecur: 1
 localization group: 1
 localisation of metastases: 1
 local therapy: 1
 local recurrence: 1
 local origin: 1
 local cd8 il-33 expression level: 1
 lobe of the lung where sample was taken from: 1
 lnratio: 1
 ln_status: 1
 ln_positive: 1
 ln_examined: 1
 lmp2a: 1
 lmp1-mrfp expression level: 1
 lmp1 expression: 1
 ll: 1
 lkidg: 1
 lkb1: 1
 liveweight: 1
 livernmrlean g: 1
 livernmrfat g: 1
 liverg: 1
 liver metastasis: 1
 liver histology: 1
 liver fibrosis stage: 1
 live weight: 1
 live births: 1
 litterid: 1
 litter_id: 1
 litter number: 1
 lithium treated: 1
 listeria strain: 1
 linker 5'->3': 1
 linfonode: 1
 line/stock: 1
 line type: 1
 line source: 1
 line number: 1
 line background: 1
 line and replicate: 1
 lin28b: 1
 lims src id: 1
 lims hyb id: 1
 limb region: 1
 lighttreatment: 1
 lightl/darkd: 1
 light/dark-cycle: 1
 light/dark cycle: 1
 light/dark: 1
 light-dark cycle/dark: 1
 light sources: 1
 light level: 1
 light induction time point: 1
 lifleukemia inhibitory factor status: 1
 lifestyle: 1
 lifecycle stage: 1
 life_stage: 1
 life-cyle_stage: 1
 life status (censoring day): 1
 life cycle form: 1
 lif: 1
 library-type: 1
 library preparation protocol: 1
 library preparation method: 1
 library prep protocol: 1
 library prep method: 1
 library prep: 1
 library date: 1
 library construction batch: 1
 library concentration (pm): 1
 library adapter: 1
 lg10 serum c-reactive protein mg/l: 1
 lg10 plasma adiponectin mg/l: 1
 level_of_reaction: 1
 leukotoxin level: 1
 leukocytes x10^9/l: 1
 leukocyte count: 1
 leukemic_state: 1
 leukemia subtype: 1
 leukemia mouse model: 1
 leukemia class: 1
 leukemia cell line: 1
 leukaemic stem cells: 1
 lethality stage: 1
 lesion stage: 1
 lesion site: 1
 lesion number: 1
 lesion formation: 1
 leptin: 1
 leprosy type: 1
 lentviral vector: 1
 lentiviruses: 1
 lentivirus-introduced modification: 1
 lentivirus isoform: 1
 lentiviral transgenes: 1
 lentiviral shrna: 1
 lentiviral plasmids: 1
 lenolidamide treatment: 1
 length of treatment (days): 1
 length of knockdown: 1
 length of infection: 1
 length of exposure: 1
 length of egg to adult development time: 1
 length of differentiation: 1
 length of columnar mucosa (cm): 1
 length feii shock: 1
 leishmania strain: 1
 leishmania major infected: 1
 leg: 1
 lectin treatment: 1
 leaves: 1
 leaf type: 1
 leaf stage: 1
 leaf sections: 1
 leaf region: 1
 leaf order: 1
 leaf location: 1
 leaf length: 1
 leaf color: 1
 lead exposure level: 1
 ldl-c (mg/dl): 1
 ldh increased: 1
 ldh: 1
 ld: 1
 lcmv infection type: 1
 lcm_location: 1
 lcap: 1
 layer of epithelium: 1
 layer line: 1
 layer: 1
 lauren histology: 1
 latest mdd visit: 1
 latation number: 1
 lastnews or death.date: 1
 lastfudt: 1
 last known status: 1
 last followup date: 1
 last follow up: 1
 laser-dissected: 1
 larval survival: 1
 larval instar: 1
 larval diet: 1
 larvae: 1
 largest.dimension.ln.metastasis..cm.: 1
 largest.dimension..primary.tumor..cm.: 1
 lar: 1
 lane number: 1
 lactation stage: 1
 lactation: 1
 lactate measurement: 1
 lactate dehydrogenase measurement: 1
 lactate and nahco3 as carbon source: 1
 lacZ4787(: 1
 lac phenotype: 1
 labour status: 1
 labor status: 1
 labor: 1
 labelling: 1
 labelled extract concentration: 1
 labeling_batch: 1
 labeling time: 1
 labeling protocol: 1
 labeling method: 1
 labeling batch: 1
 labeling: 1
 labeled molecule: 1
 labeled by: 1
 labelblock: 1
 labelbatch: 1
 label protocol: 1
 label dilution: 1
 lab-passage number: 1
 lab or wild strain: 1
 lab of origin: 1
 lab data id: 1
 l-dopa treatment: 1
 l - log2 transformed: 1
 kupffer cell vacuolation: 1
 ksp status: 1
 kras37bp marker genotype: 1
 kras.gene.mutation.status: 1
 kras g12d allelic frequency by ddpcr: 1
 kras expression: 1
 kr-72 treatment: 1
 knocked out gene: 1
 knockdown target: 1
 knockdown condition: 1
 knockdown chemistry: 1
 knock-in: 1
 knock-down: 1
 klf1k288x mutation: 1
 kj-pyr-9 treatment: 1
 kit used: 1
 kit mutation status: 1
 kit information: 1
 kinship: 1
 kill time: 1
 kidney zone: 1
 kidney transplant recipient: 1
 kidney status: 1
 kidney injury: 1
 kidney: 1
 ki67wk4: 1
 ki67wk16: 1
 ki67wk0: 1
 ki67-6.1: 1
 ki67-2: 1
 ki67-1: 1
 ki67%: 1
 ki67 status: 1
 ki67 reduction: 1
 ki67 proliferation index: 1
 ki67 ihc status: 1
 ki67 expression level: 1
 ki67 %: 1
 ki-67: 1
 ki: 1
 kg): 1
 kg body weight: 1
 ketoprofen concentration: 1
 kept in: 1
 kdri: 1
 kd batch id: 1
 kcl treatment time (hours): 1
 karyotype and igh status: 1
 karnofsky performance status kps: 1
 kaplan meier days: 1
 kairomone: 1
 k-ras mutation: 1
 k-ras dependence: 1
 k: 1
 joint problems: 1
 joint location: 1
 jmjd1a mutant allele: 1
 jejuni-susceptibility: 1
 jcv replication rate: 1
 jak2v617f: 1
 jak2 v617 neutrophil burden %: 1
 j2 fibroblast status: 1
 ix: 1
 iw: 1
 ivt rna input quantity: 1
 ivf procedure: 1
 ivf outcome: 1
 ivf condition: 1
 iss stage: 1
 isotype switching: 1
 isopropanol concentration: 1
 isolation protocol: 1
 isolation beads: 1
 isolated rna: 1
 isolated from: 1
 isolated by: 1
 isolate region: 1
 isolate number: 1
 isolate characteristics: 1
 isogenic_group: 1
 isogenic variation: 1
 isoform purified from: 1
 isofemale line: 1
 iso/allo: 1
 islet donor strain: 1
 island of origin: 1
 ishak fibrosis: 1
 ischemic time (days): 1
 ischemic event: 1
 ischemia protocol: 1
 is.back.anagen: 1
 irs stage: 1
 irradiated with: 1
 irradiated: 1
 iron stock: 1
 iron concentration: 1
 iron: 1
 irish score: 1
 irf4 shrna expression: 1
 ir dose: 1
 iptg conc.: 1
 ipsc clone number: 1
 ip_date: 1
 ip/input: 1
 ip-antibody: 1
 ip rna amount: 1
 ip method: 1
 ip antibody/beads information: 1
 ip antibody provider: 1
 ip antibody lot #: 1
 ip antibody info: 1
 ip antibody cat #: 1
 ip ab: 1
 iodine treatment: 1
 involution: 1
 inventory sample name: 1
 invasive tumour type: 1
 invasive behavior: 1
 invasive b-r grade: 1
 invasion behavior: 1
 invasion: 1
 inv.type: 1
 inv(3)(q21q26)/t(3;3)(q21;q26): 1
 inv(16)(p13q22): 1
 intrustion treatment: 1
 intrusion treatment: 1
 introduced construct: 1
 intrinsic subtype: 1
 intranasal  1: 1
 intramuscular fatty acid composition: 1
 intracellular transfer: 1
 intracellular domain of notch1 (icn1) status: 1
 intra-muscular injection (on the third day): 1
 intiial time point: 1
 intestinal colonization: 1
 intervention status: 1
 intervention shake: 1
 interstitial pneumonia: 1
 intersex index: 1
 internvention: 1
 international prognostic score (ips): 1
 internal_id: 1
 internal strain reference: 1
 internal reference: 1
 internal ^sample: 1
 interferon score: 1
 intensive monitoring: 1
 intensity: 1
 integrin: 1
 integrative analysis: 1
 integrated vector: 1
 integrated sequence: 1
 intact t: 1
 insulin uiu per ml: 1
 insulin sensitivity - m value: 1
 institutional tumor diagnosis: 1
 insgenin insulinogenic index: 1
 insertlength description: 1
 insert standard deviation: 1
 insert size: 1
 insert length standard deviation: 1
 insert length mean: 1
 insemination: 1
 insecticide: 1
 insect strain: 1
 insect cell line: 1
 input regime: 1
 input material: 1
 input kras mutations: 1
 input amount: 1
 inpp4b mrna: 1
 inoculum route: 1
 inoculation type: 1
 inoculation density: 1
 inoculated tumor: 1
 inoculated into: 1
 inoculated fungi: 1
 inoculated from: 1
 innoculation: 1
 injury type: 1
 injury stage: 1
 injury severity score: 1
 injury model: 1
 injury level: 1
 injection timepoint: 1
 injection time: 1
 injection site: 1
 injection position: 1
 injection dose: 1
 injection age: 1
 injected timepoint: 1
 injected mrna: 1
 injected construct: 1
 injected cells: 1
 injected cell line: 1
 initial tumour onset (days): 1
 initial tumor volume: 1
 initial tcdd dose: 1
 initial processing lab: 1
 initial patient nfkb level: 1
 initial p. aeruginosa isolate source: 1
 initial isolate source: 1
 initial distant metastases: 1
 initial differentiation: 1
 initial dap concentration: 1
 initial age infection day: 1
 inhibitor exposure: 1
 inhibition rate relative to control sirna: 1
 inhibition: 1
 inhaled medications: 1
 infusion of crystalloid or colloid solution diluted in physiological saline: 1
 infrequent clonal strain code: 1
 informatic analysis group: 1
 influenza virus strain: 1
 influenza a virus titer: 1
 inflammatory cytokines used: 1
 inflammatory: 1
 inflammation_status: 1
 inflammation level: 1
 infertility: 1
 inferred trophectoderm subpopulation: 1
 inferred pseudo-time: 1
 inferred lineage: 1
 inferior vena cava involvement: 1
 infective status: 1
 infectious haematopoietic necrosis virus vaccination: 1
 infectioncode: 1
 infection_status: 1
 infection/ in vitro stimulation: 1
 infection with: 1
 infection virus strain: 1
 infection time point: 1
 infection time (min): 1
 infection susceptibility: 1
 infection state: 1
 infection stage: 1
 infection route: 1
 infection reagent: 1
 infection protocol: 1
 infection physiological condition: 1
 infection of mice: 1
 infection model isolate source: 1
 infection microorganism: 1
 infection frog virus 3: 1
 infection dose and wk p.i.: 1
 infection dose: 1
 infection day: 1
 infection class: 1
 infection by nematode: 1
 infection (virus strain): 1
 infecting virus: 1
 infecting serotype: 1
 infected with sgrna: 1
 infected with retroviral vector to express: 1
 infected with bacterial strain: 1
 infected host tissue: 1
 infected host plants: 1
 infected cells: 1
 infected cell line: 1
 infected cell: 1
 infected  with: 1
 infant age: 1
 induction time (h): 1
 induction of mir-221: 1
 induction date: 1
 inducible shrna: 1
 inducible protein: 1
 inducible gene: 1
 inducible expression: 1
 induced to express: 1
 induced shrna: 1
 induced overexpression: 1
 induced genes: 1
 induced by: 1
 induce condition: 1
 indivisual id: 1
 individuum: 1
 individul: 1
 individuals/year/stage: 1
 individuals: 1
 individual_identifier: 1
 individual_id: 1
 individual/probe/cow number: 1
 individual type: 1
 individual number: 1
 individual no: 1
 individual identifier 2: 1
 individual genotype: 1
 individual genetic characters: 1
 individual condition: 1
 individual characteristics: 1
 individual ID: 1
 indictation for procedure: 1
 indication for caesarean section: 1
 index primer used for pcr: 1
 index 2: 1
 index 1: 1
 indeno1,2,3-cdpyrene ng/m3: 1
 incubation_time: 1
 incubation time days before harvest: 1
 incubation time at secondary media ph 7: 1
 incubation on brain section: 1
 incubation hours: 1
 incubation condition: 1
 incubated with 4su for: 1
 incubated in: 1
 incubated fatty acid: 1
 incubated: 1
 inclusion markers: 1
 inclusion criteria: 1
 incidence: 1
 inbred/open pollinated: 1
 inbred strain: 1
 inbred: 1
 in.situ: 1
 in-vitro treatment: 1
 in vivo treatment with: 1
 in vivo phenotype: 1
 in vivo fed/fasted state: 1
 in vitro stage: 1
 in vitro or in vivo: 1
 in vitro maturation conditions: 1
 in vitro differentiation days: 1
 in vitro culture conditions: 1
 imwg stratification: 1
 improvementtpssatw12: 1
 improvementpasiatw12: 1
 imprkrt16w12_75: 1
 imprkrt16w12: 1
 imprining of igf2: 1
 imprepi.thickness: 1
 implantation site: 1
 implant dose: 1
 immuophenotype: 1
 immunosuppressors: 1
 immunosuppression treatment: 1
 immunoprecipitation reagent: 1
 immunoprecipitation antibody: 1
 immunoprecipitation: 1
 immunoprecipiated with: 1
 immunophenotypic definition: 1
 immunopathological classification: 1
 immunomagnetic bead-selected fraction: 1
 immunological status: 1
 immunohistochemistry subgroup: 1
 immunohistochemistry straining for estrogen receptor positive: 1
 immunohistochemistry staining with ki67 antibody positive: 1
 immuno-activated: 1
 immunization status: 1
 immunization outcome: 1
 immunization: 1
 immune strain/background: 1
 immortalized: 1
 immitis-infection susceptibility: 1
 immitis: 1
 immersed in: 1
 imatinib treatment: 1
 illumina_index: 1
 illumina truseq rna index: 1
 illumina rna-seq bar codes: 1
 illumina protocol: 1
 illumina index: 1
 illumina barcode: 1
 illumina adapter barcode: 1
 illumina 3' index number: 1
 illumina 3' index: 1
 ild subtype: 1
 il7r haplotype: 1
 il4r genotype: 1
 il4 stimulation time: 1
 il4 stimulation: 1
 il4: 1
 il10 status: 1
 il10 staining: 1
 il-23 responsiveness: 1
 il-2 ifn index: 1
 ikk2 status: 1
 ii interstitial inflammation: 1
 ihprna construct: 1
 ihnv status: 1
 ihc_pr: 1
 ihc_her2: 1
 ihc_er: 1
 igvh status: 1
 igvh mutation status: 1
 igr2230: 1
 igr2198: 1
 igr2096: 1
 igh translocation: 1
 igf1r ihc status: 1
 igf1 module tertile: 1
 igf response: 1
 ige level: 1
 iga: 1
 ifng: 1
 ifn-a2b: 1
 ifn type1: 1
 ifn pre-treatment: 1
 if yes chemo protocol: 1
 if interstital fibrosis: 1
 if: 1
 idh2.gene.mutation: 1
 idh2: 1
 idh1/h3f3a mutation status: 1
 idh1.gene.mutation: 1
 idh mutational status at the mrna level: 1
 ideotype: 1
 identity: 1
 identfier: 1
 idd related disease: 1
 id_in_files: 1
 id3-yfp expression: 1
 id1: 1
 icu_day: 1
 iclip barcode: 1
 iclip antibody vendor: 1
 iclip antibody cat. #: 1
 icd-o 3 diagnosis text: 1
 icd-o 3 code: 1
 ibd affected relatives: 1
 ibc vs non-ibc: 1
 iPSs risk category: 1
 iPSs: 1
 iPScs derived from: 1
 iPSc/esc line: 1
 iPSc group: 1
 iPSc: 1
 iPS origin: 1
 iPS cell-line name: 1
 iPS cell line: 1
 i.p.injection: 1
 i-ifta grade: 1
 hysterectomy indication: uterine prolapse stage 2 menopausal status: postmenopause race: 1
 hysterectomy indication: uterine bleeding menopausal status: premenopause mixed race: 1
 hysterectomy indication: 1
 hypoxia or normoxia group: 1
 hypoxia exposure: 1
 hypereosinophilic condition: 1
 hygromycin treatment: 1
 hygrometry: 1
 hydronephrosis degree: 1
 hydrogen production: 1
 hydrogen peroxide treatment: 1
 hybridoma subclone: 1
 hybridizebatch: 1
 hybridizaton: 1
 hybridization_date: 1
 hybridization set : 1
 hybridization batch id: 1
 hybridisation temperature: 1
 hybridisation day: 1
 hybridisation date (second array): 1
 hybridisation date (first array): 1
 hybridisation batch: 1
 hybridation: 1
 hybrid line: 1
 hybrid cell line: 1
 hyborder: 1
 hybblock: 1
 hyb_date: 1
 hyb_block: 1
 hyb. date: 1
 hx smoking: 1
 human umbilical cord blood cells: 1
 human sci: 1
 human portion %: 1
 human loading: 1
 human leukemia cell line: 1
 human epidermal growth factor 2 receptor status: 1
 human donor: 1
 human cytomegalovirus strain: 1
 human cell line: 1
 hu subtype best: 1
 hu normal: 1
 hu lumb: 1
 hu luma: 1
 hu her2: 1
 hu best correlation: 1
 hu basal: 1
 htt status: 1
 htt cag repeat length longer allele: 1
 htn: 1
 htlv1 infection: 1
 htlv infection: 1
 htert.gene.mutation: 1
 htert status: 1
 ht: 1
 hstlo_s: 1
 hspc supporting capacity: 1
 hsf1 kd: 1
 hsf1: 1
 hsc support: 1
 hsc stage: 1
 hrs post treatment: 1
 hras status: 1
 hr bpm: 1
 hpv-status: 1
 hpv type: 1
 hpv: 1
 hpi: 1
 hpfh: 1
 hpa: 1
 hoxb4 overexpression: 1
 housing environment: 1
 hoursawake: 1
 hours since last treatment: 1
 hours since division: 1
 hours post-treatment: 1
 hours post-mating: 1
 hours post-infection hpi: 1
 hours post-infection: 1
 hours post root tip decapitation: 1
 hours post irradiation: 1
 hours post invasion (hpi): 1
 hours post inoculum: 1
 hours post inoculation: 1
 hours post infection hpi: 1
 hours post amputation: 1
 hours past infection: 1
 hours of recovery: 1
 hours h2o2: 1
 hours at restrictive temperature: 1
 hours at 37 degrees: 1
 hours after transfection: 1
 hour post serum-switch: 1
 hour post infection hpi: 1
 host/mouse strain: 1
 host/mouse genotype: 1
 host type given: 1
 host treatment: 1
 host strain genotype: 1
 host strain gender: 1
 host strain age: 1
 host status: 1
 host species: 1
 host soybean genotype: 1
 host organism for xenografts only: 1
 host organ stage: 1
 host organ: 1
 host mouse treatment: 1
 host mouse genotype: 1
 host genotype: 1
 host fed with: 1
 host developmental stage: 1
 host cells: 1
 host cell fraction: 1
 host age yr: 1
 hospotal id: 1
 horse number: 1
 horn type: 1
 hormonetreatment: 1
 hormone status: 1
 hormone receptor status: 1
 hormone exposure time: 1
 hormonal treatment: 1
 hormonal contraceptive treatment: 1
 hormo: 1
 homogenization: 1
 homa-ir: 1
 hmc1 subclone: 1
 hla status: 1
 hla expression: 1
 hiv-1 isolate: 1
 hiv-1 infection status: 1
 hiv virus status: 1
 hiv patient class: 1
 hiv infection status: 1
 hiv infection: 1
 hiv disease status: 1
 hiv: 1
 hits-clip antibody: 1
 histtype: 1
 history of keloid: 1
 history of breast cancer: 1
 history of asthma: 1
 histophatological type of tumor: 1
 histopatological description: 1
 histology_grade: 1
 histology type: 1
 histology at baseline (hyperplasia versus dysplasia): 1
 histology at baseline (breakdown): 1
 histologics: 1
 histological..subtype: 1
 histological variant: 1
 histological tumour type: 1
 histological grade of inflammation: 1
 histological findings of renal specimen: 1
 histologic_grade: 1
 histol information: 1
 histochemistry: 1
 histo: 1
 histlogical type: 1
 hist.score: 1
 hist: 1
 hinae cell: 1
 highest education: 1
 high risk: 1
 hierarchical cluster: 1
 hgf treatment: 1
 hg g/dl: 1
 hf progression: 1
 hev load: 1
 heteroplasmy: 1
 heterophils encountered: 1
 hes5 status: 1
 hereditary status: 1
 hereditary nature of hpps: 1
 herd no.: 1
 herceptin: 1
 herbage allowance: 1
 her2status: 1
 her2stat: 1
 her2ihc: 1
 her2hsw4: 1
 her2hsw0: 1
 her2fishbin: 1
 her2fish: 1
 her2amp: 1
 her2.status: 1
 her2-ihc: 1
 her2-: 1
 her2+: 1
 her2 status ihc (and fish): 1
 her2 status fish: 1
 her2 positive vs negative: 1
 her2  1=positive, 0=negative: 1
 her-2/neu ihc: 1
 hepatotoxicity status: 1
 hepatomegaly: 1
 hepatocellular carcinoma cell line: 1
 hepatic cyp3a activity: 1
 hepatectomy: 1
 heparin/lovenox: 1
 hemoglobin measurement: 1
 hemoglobin level: 1
 hemoglobin hb: 1
 hemoglobin g/l: 1
 hemoglobin (g/dl): 1
 hemoconcentration (hematocrit >20%): 1
 hematuria: 1
 hematocrite ht: 1
 hematocrit l/l: 1
 heliobacter pylori: 1
 height(cm): 1
 height (cm): 1
 heifer status: 1
 heat-shock: 1
 heat tolerance: 1
 heat stress time: 1
 heat sensitivity: 1
 heartg: 1
 heart subregion: 1
 heart size: 1
 heart rate bpm: 1
 heart rate (bpm): 1
 heart rate: 1
 heart failure onset: 1
 heart failure: 1
 heart compartment: 1
 healthy adult: 1
 head space: 1
 hdl chol mg per dl: 1
 hcv-ab: 1
 hcv virus status: 1
 hcv viral load: 1
 hcv status: 1
 hcv infection susceptibility: 1
 hcv infection status: 1
 hcv infection model: 1
 hcv infected: 1
 hcv genotype: 1
 hcv: 1
 hct116 mrna mass ng: 1
 hct %: 1
 hcmv strain: 1
 hcg dosage: 1
 hcc risk group: 1
 hbv status: 1
 hbf level (%): 1
 hbeag: 1
 hba1c mmol/mol: 1
 hb_(g/dl): 1
 hatchability: 1
 harvested tissue type: 1
 harvested time after dose: 1
 harvested on which day of the normal photoperiod: 1
 harvested at what time: 1
 harvest time/stage: 1
 harvest time(hours after daybreak): 1
 harvest time point along the psa curve: 1
 harvest time p.i.: 1
 harvest time after the first injection: 1
 harvest technique: 1
 harvest protocol: 1
 harvest phase: 1
 harvest od: 1
 harvest day: 1
 harvest: 1
 harmfulness: 1
 hapmap: 1
 hans classifier: 1
 handling time: 1
 handing time: 1
 hamilton depression rating scale with 17 items hdrs-17: 1
 hairpin rna: 1
 haired or bald: 1
 hair stage: 1
 hair growth phase: 1
 hai-1 expression: 1
 hadzi-vonsattel striatal score: 1
 hadzi-vonsattel cortical score: 1
 h3.3_status: 1
 h3.3 induction hour: 1
 h2o2 treatment: 1
 h2b status: 1
 h2a genotype: 1
 h-ras: 1
 gxbdataset_biirinternal: 1
 gsh localization: 1
 gsc line validated for self-renewal by neurosphere formation: 1
 growthphase: 1
 growth_temp: 1
 growth/development stage: 1
 growth/culture condition: 1
 growth time points: 1
 growth tempature: 1
 growth stages: 1
 growth stage source - paradigm genetics: 1
 growth source: 1
 growth replicate: 1
 growth protocol iron conditions: 1
 growth protocol carbon source: 1
 growth proptocol: 1
 growth plate zone: 1
 growth plate: 1
 growth phase/media: 1
 growth ph: 1
 growth performance: 1
 growth pattern: 1
 growth passage: 1
 growth on bacteria: 1
 growth od: 1
 growth nutrient: 1
 growth method: 1
 growth medium type: 1
 growth form: 1
 growth factor treatment: 1
 growth factor: 1
 growth cycle: 1
 growth culture: 1
 growth condtiion: 1
 growth condition and treatment: 1
 growth condition 2: 1
 growth chararceristics: 1
 growth characteristics: 1
 grown with: 1
 grown temperature: 1
 grown on bacteria expressing: 1
 grown in the presence of: 1
 growing year: 1
 growing region: 1
 growing conditions: 1
 groups with 10 and more replicates: 1
 groupname: 1
 grouping according to hpv dna physical status: 1
 grouping: 1
 group stage: 1
 group assignment: 1
 grna: 1
 greenhouse year: 1
 greenhouse: 1
 greater chemo sensitive: 1
 gravity type: 1
 gravity: 1
 grandparent growth temperature: 1
 grain number per panicle: 1
 grain number: 1
 grafting: 1
 graft duration months: 1
 grading and morphology: 1
 grade sbr: 1
 grade of acute and late toxicity to radiotherapy: 1
 grade histo: 1
 grade fuhrman: 1
 grade (12: 1
 gr-status: 1
 gpiib/iiia: 1
 gp120 treatment: 1
 gp: 1
 gowth conditions: 1
 gonads: 1
 gonadosomatic index: 1
 gonadal somatic index %: 1
 gonadal g: 1
 gonad wet wt g: 1
 gonad: 1
 gne mrna: 1
 gmfcs: 1
 gm: 1
 glyphosate: 1
 glycemic state: 1
 gly: 1
 glutamine synthetase: 1
 glutamine: 1
 glucosemmol: 1
 glucose mmol/l: 1
 glucose metabolism: 1
 glucose availability: 1
 glomerulosclerosis  inadequate tissue for pathology interpretation: 1
 glomerulosclerosis: 1
 globin expression status: 1
 glioma type: 1
 gleason_grade: 1
 gleason sum score surgical: 1
 gleason sum score biopsy: 1
 gleason sum: 1
 gleason pattern: 1
 gilt id: 1
 ghrelin staining: 1
 ghk: 1
 ggi class: 1
 gg: 1
 gfra1 status: 1
 gfr: 1
 gfpmyc status: 1
 gfp/cre-infected: 1
 gfp-reporter: 1
 gfp reporter: 1
 gfp marker: 1
 gfp level: 1
 gfp label: 1
 gfp expression: 1
 gfp detection: 1
 gfi1 ex4-5 status: 1
 gf: 1
 gestational week: 1
 gestational history: 1
 gestational age of subject in weeks: 1
 gestational age of pups: 1
 gestational age at delivery: 1
 gestational age (weeks, days): 1
 gestational age (weeks): 1
 gestational age (w+d): 1
 gestation week: 1
 gest age at sampling weeks: 1
 gest age at delivery weeks: 1
 germline mutation: 1
 germline knockdown and other transgenes: 1
 germline: 1
 germination: 1
 germinal zone: 1
 gep70 score: 1
 geonotype/variation: 1
 geographical origin: 1
 geographic source: 1
 geographic region: 1
 geo sample: 1
 gentype/variation: 1
 gentotype/variation: 1
 gentotype: 1
 gentle  feather pecking: 1
 genoype: 1
 genotype_mvb1: 1
 genotype: prototroph 670.20del: 1
 genotype: prototroph 555.11del: 1
 genotype: Tn7: 1
 genotype: Arabidopsis thaliana (wassilewskija); age: 1
 genotype: Arabidopsis thaliana (wassilewskija)  mutant (ss4-); age: 1
 genotype: Arabidopsis thaliana (wassilewskija)  mutant (ss4- phs1-); age: 1
 genotype: Arabidopsis thaliana (wassilewskija)  mutant (phs1-); age: 1
 genotype: Arabidopsis thaliana (wassilewskija)  mutant (adg1-); age: 1
 genotype: Arabidopsis thaliana (wassilewskija)  mutant (adg1- be2- be3-); age: 1
 genotype: Arabidopsis thaliana (col-0); age: 1
 genotype: Arabidopsis thaliana (col-0)  mutant (ss4-); age: 1
 genotype: Arabidopsis thaliana (col-0)  mutant (ss3-); age: 1
 genotype: Arabidopsis thaliana (col-0)  mutant (ss3- ss4-); age: 1
 genotype: 670.20del: 1
 genotype: 555.11del: 1
 genotype/variatoin: 1
 genotype/variation: alg-2; ALG-2:: 1
 genotype/variation of offspring: 1
 genotype/variation of mother: 1
 genotype/variation for tissue: 1
 genotype/variation animal: 1
 genotype/variation (cebpa single mutant, cebpa double mutant): 1
 genotype/vairation: 1
 genotype/strain: 1
 genotype/phenotype: 1
 genotype/ecotype: 1
 genotype/disease state: 1
 genotype/background: 1
 genotype.variation: 1
 genotype-variation: 1
 genotype(breed): 1
 genotype pc7: 1
 genotype pc6: 1
 genotype pc5: 1
 genotype pc4: 1
 genotype pc3: 1
 genotype pc2: 1
 genotype pc1: 1
 genotype of s. pombe cells: 1
 genotype of s. cerevisiae cells: 1
 genotype of pombe cells: 1
 genotype of pollen: 1
 genotype of cerevisiae cells: 1
 genotype mutant (asense: 1
 genotype hdh cag repeat length: 1
 genotype description: 1
 genotype correction status: 1
 genotype code: 1
 genotype background: 1
 genotype and mouse id: 1
 genotype across subcongenic segment: 1
 genotype (transgenic line): 1
 genotyp/variation: 1
 genotyp: 1
 genotpye: 1
 genotoxic (g) or non-genotoxic (ng): 1
 genomic mycn status: 1
 genomic modification: 1
 genomic grade: 1
 genome type: 1
 gennetic background: 1
 genetotype: 1
 genetically engineered mouse model: 1
 genetic/variation: 1
 genetic sub-line: 1
 genetic strain: 1
 genetic source of colony performance: 1
 genetic reporter: 1
 genetic modifications: 1
 genetic model: 1
 genetic markers: 1
 genetic manupulation: 1
 genetic factors: 1
 genetic characteristics: 1
 genetic category ci-fish: 1
 genetic backround: 1
 genetic background/npr-1 allele: 1
 genetic background strain: 1
 generation of germ cell: 1
 generation of cells: 1
 generation method: 1
 generation in xenograft model: 1
 generated by immunization of rabbits with the peptide mRXRa: 1
 generated by immunization of rabbits with the peptide mRARg: 1
 general control: 1
 geneder: 1
 genechipid: 1
 genechip assay site: 1
 gene treatment: 1
 gene transduction: 1
 gene therapy: 1
 gene reported: Tg(Sry-EGFP)92Ei/MGI: 1
 gene reported: Tg(Sox9-ECFP)2Capl / PMID: 1
 gene reported: Tg(Pou5f1-EGFP)2Mnn/MGI: 1
 gene reported: Tg(Kdr-mCherry)1Medi/MGI: 1
 gene reported: Tg(Acta2-EYFP)Jll / PMID: 1
 gene reported: Mafbtm1Jeng / MGI: 1
 gene modulation status: 1
 gene knockdown: 1
 gene fusion: 1
 gene expression profiling subgroup: 1
 gene alteration status: 1
 gender/age: 1
 gender type: 1
 gender of the clone: 1
 gender of offspring: 1
 gender of mice: 1
 gender of donor: 1
 gender of baby: 1
 gender ms csf: 1
 gender male or female: 1
 gender m=1, f=2: 1
 gender donor: 1
 gender composition: 1
 gender and age: 1
 gender 1=male, 2=female: 1
 gender : 1
 genbank synonym: 1
 gemcitabine sensitivity: 1
 gem model of prostate cancer: 1
 gefitinib-resistant: 1
 gc sensitivity: 1
 gbv-c virus status: 1
 gavaged with: 1
 gata4gr induction: 1
 gata1 transgene: 1
 gastrocnemius ablation ga: 1
 gastric cancer patient: 1
 gas in headspace: 1
 gander: 1
 gamma to beta globin switching phase: 1
 gamma secretase activity level: 1
 gametes: 1
 galassi grade: 1
 gain1q: 1
 ga days: 1
 ga: 1
 g2 checkpoint (the percentage of cells that arrest in g2 after irradiation): 1
 g1 checkpoint  (percentage of the cells that arrest in g1 after irradiation): 1
 g/c array: 1
 g lipid - log2 transformed: 1
 g level: 1
 g crt - log2 transformed: 1
 g - log2 transformed: 1
 fzf1 allele: 1
 fvp: 1
 fvc (% predicted): 1
 futime: 1
 fusion protein: 1
 fusion gene: 1
 fup.month: 1
 fup interval: 1
 funnel_id: 1
 fungus: 1
 fungicide-phenotype: 1
 fungal type: 1
 fungal strain: 1
 fungal pathogen isolate: 1
 fungal pathogen: 1
 function: 1
 fumonisin producer: 1
 fumnd: 1
 fully anonymized: 1
 full time pregancy: 1
 full genotype: 1
 full: 1
 fuel type: 1
 fu time: 1
 fstl-1 ng/ml: 1
 fstage: 1
 fsc: 1
 fruit acidity: 1
 frip antibody: 1
 fresh tissue sample/time in culture: 1
 frequency of incorporation of cy5 dye (foi): 1
 frequency of incorporation of cy5 dye: 1
 free testosterone: 1
 free fatty acids mg per dl: 1
 fragmentsize: 1
 fragmentation method: 1
 fragmentation batch: 1
 fragment length: 1
 fraction sub-pool: 1
 fraction size: 1
 fraction in sucrose gradient: 1
 foxp3 status: 1
 foxp1 expression by ihc: 1
 foxp rearrangement: 1
 foxa1 ihc status: 1
 fox3 expression: 1
 foundress origin: 1
 foundress number: 1
 forward side barcode: 1
 form: 1
 forced vital capacity fvc percent predicted: 1
 forced expression: 1
 force: 1
 food source: 1
 food group: 1
 followup total: 1
 followup time months: 1
 followup splen flex: 1
 followup rectum: 1
 followup recto sigmoid: 1
 followup months: 1
 followup hep flex: 1
 follow_up_duration (years): 1
 follow-up: 1
 follow up time months: 1
 follow up time (months): 1
 follow up period (months): 1
 follow up months: 1
 follow up month: 1
 follow up (years): 1
 follicular maturation stage: 1
 follicle size: 1
 folding and cutting temperature: 1
 folate treatment: 1
 foi dye/1000 bases: 1
 foal id: 1
 fna level: 1
 fly/stock id: 1
 fly source: 1
 fly line: 1
 fluticasone 6 months and then placebo for the remaining 24 months of the study: 1
 fluorescent cell marker: 1
 fluorescence sorted cell population: 1
 fluorene ng/m3: 1
 fluoranthene ng/m3: 1
 fluidic_station: 1
 flt3/itd mutation status: 1
 flt3-tkd: 1
 flt3-mutation: 1
 flt3 status: 1
 flt3 mutation: 1
 flower length: 1
 flowcell info id: 1
 flowcell id: 1
 flow-sorted cell type: 1
 flow strategy: 1
 flow sorting parameters of tumor associted macrophages: 1
 flow cytometry fraction: 1
 flow cell id: 1
 flock: 1
 flattop status: 1
 flagged: 1
 flagbothtissues: 1
 flag ip: 1
 flag immunoprecipitation: 1
 flag: 1
 fixed and unfixed: 1
 fiv-transduced: 1
 first_progression_or_relapse: 1
 first trimester losses: 1
 first or second vaccination, 14 day interval: 1
 first or second vaccination at 14 days interval: 1
 first intervention: 1
 first cutter and restriction site sequence: 1
 first apc mutation: 1
 finalgold: 1
 final.pat.stage: 1
 final morphology: 1
 final gtf2i mutation status: 1
 final age at death: 1
 fillet firmness: 1
 filenumber: 1
 file identifier: 1
 file accn: 1
 figo_stage: 1
 field replicate: 1
 fibrotic response: 1
 fibrosis: 1
 fibroblast sample id: 1
 fibroblast sample histological grade: 1
 fibroblast cell strain: 1
 fiber type: 1
 fgfr1: 1
 fgf2 and egf addition frequency: 1
 fgf-2: 1
 ffpe quality: 1
 fever days or defervescent df days: 1
 fev1pp_utah: 1
 fev1fvc: 1
 fev1_fvc_utah: 1
 fev1 predicted: 1
 fev1 (% predicted): 1
 fev1 %predicted: 1
 fetus genotype: 1
 fetal number: 1
 fertilization rate: 1
 fertilization method: 1
 fertility stutus: 1
 fertility diagnosis: 1
 fertility class: 1
 fermentor scale: 1
 fermentation run: 1
 fermentation conditions: 1
 fermentation batch: 1
 ferility class: 1
 female.population: 1
 female.pop: 1
 female, age: 1
 female strain: 1
 female gender: 1
 feii concentration: 1
 feibig stage: 1
 feeding type: 1
 feeding level: 1
 feeding group: 1
 feeding duration: 1
 feeding condition: 1
 feeding barn: 1
 feeding after surgery: 1
 feeder: 1
 feed restricted: 1
 feed media: 1
 feed gain and intake group: 1
 feed efficiency: 1
 fed-fasted state: 1
 fed on: 1
 fed: 1
 febrile seizure: 1
 features: 1
 featureextractiontime: 1
 feature extraction software update: 1
 fdg uptake: 1
 fd: 1
 fchl status: 1
 fbs: 1
 fatty acid: 1
 fatigue status: 1
 father name: 1
 fat-androstenone: 1
 fat production in the previous lactation for the first 100 days: 1
 fat mass %: 1
 fat in diet: 1
 fastqs from: 1
 fasting status: 1
 fasting prior sacrifice: 1
 fasting insulin pmol/l: 1
 fasting insulin (iv0inavg): 1
 fasting glucose (ogtt): 1
 fasting glucose (iv0gavg): 1
 fasting blood glucosemmol/l: 1
 fasting blood glucose levels: 1
 fasting  glucose mmol/l: 1
 family_id: 1
 family number: 1
 family member: 1
 family identifier: 1
 family history of breast cancer (1=familial case, 0=sporadic case): 1
 family father/mother: 1
 family ID: 1
 familial mutation: 1
 fall: 1
 failure free survival: 1
 failure free event: 1
 factors using in making ips cells: 1
 factor inducing monocyte differentiation: 1
 facs-sorting: 1
 facs-sortedcell type: 1
 facs-sorted cell population: 1
 facs-sort: 1
 facs-isolated clone: 1
 facs-isolated cell type: 1
 facs sorting criteria: 1
 facs profile: 1
 facs population: 1
 facs marker: 1
 facs gating strategy: 1
 facs gating: 1
 facs enrichment: 1
 facial symmetry: 1
 fab/who: 1
 fab-subtype: 1
 fab type: 1
 f3-generation of: 1
 f1 developmental stage: 1
 f0 treatment: 1
 ezh2 mutation: 1
 ezh2 mut: 1
 eyfp: 1
 eye orientation: 1
 extreme: 1
 extrdat: 1
 extrathyroidal.extension..where: 1
 extraprostatic extension: 1
 extraction time: 1
 extraction protocol: 1
 extraction procedure: 1
 extraction order: 1
 extracellular matrix ecm condition: 1
 extra_cold_ischemic_time_min: 1
 externalsampleID: 1
 external rna control: 1
 external magnesium concentration: 1
 external id: 1
 external calcium concentration: 1
 extent of resection: 1
 extent: 1
 expt9_cy5: 1
 expt9_cy3: 1
 expt8_cy5: 1
 expt8_cy3: 1
 expt7_cy5: 1
 expt7_cy3: 1
 expt day actual: 1
 expt day: 1
 expt date: 1
 expt: 1
 expression status: 1
 expression plasmid: 1
 expression level: 1
 expressed genes: 1
 exposured to: 1
 exposure type: 1
 exposure treatments: 1
 exposure to wnv: 1
 exposure to nickel: 1
 exposure to chernobyl radiation: 1
 exposure protocol duration: 1
 exposure paradigm: 1
 exposure level: 1
 exposure length hours: 1
 exposure item: 1
 exposure hours: 1
 exposure dose: 1
 exposure day: 1
 exposure date: 1
 exposure condition: 1
 exposure chemical: 1
 exposed to sustained hypoxia: 1
 exposed to surface water from: 1
 exposed to intermittent hypoxia: 1
 exposed to emb ppb: 1
 explant: 1
 experimentation site: 1
 experimental_group: 1
 experimental station: 1
 experimental setup: 1
 experimental set: 1
 experimental run: 1
 experimental repetition for same subject: 1
 experimental model: 1
 experimental factor: 1
 experimental day: 1
 experimental cells: 1
 experimental block: 1
 experimental batches: 1
 experiment_type: 1
 experiment_sample_name: 1
 experiment series: 1
 experiment number: 1
 experiment group: 1
 experiment 4: 1
 experiment 3: 1
 experiment 2: 1
 experiment 1: 1
 expected date of calving: 1
 expected approximate fatty acids (c12-c20) titer (mg/l culture): 1
 expansion media: 1
 expansion days: 1
 exp.type: 1
 exp: 1
 exosome purification: 1
 exosome added: 1
 exome capture: 1
 exogenous manipulation: 1
 exogenous htert: 1
 exogenous dna: 1
 exhaled bromoform: 1
 exercised leg: 1
 exercise type: 1
 exercise test: 1
 exercise ststus: 1
 exercise status: 1
 exercise stage: 1
 exercise protocol: 1
 exepriment_id: 1
 excluded from analyses based on qc: 1
 exclude for prognosis analysis due to incomplete resection or adjuvant therapy: 1
 excision year: 1
 excision location: 1
 excised band size: 1
 exacerbation visit subgroup  based on k-means clustering: 1
 ex vivo t production ng/ml/12h: 1
 ex vivo e2 production ng/ml/12h: 1
 ewsfli1/empty_vector: 1
 ews-fli1 expression: 1
 evolved strain: 1
 evolution time years: 1
 evolution step: 1
 event_metastasis: 1
 event_death: 1
 event-free interval (months): 1
 event time (years): 1
 event of distant metastasis: 1
 event of death: 1
 event (1: 1
 euthanasia day post treatment: 1
 euploid or aneuploid: 1
 eular response criteria, assessed at week 16 after treatment (no response = 0, moderate response = 1, good response = 2).: 1
 eular response: 1
 etv6-runx1: 1
 ets-1 expression status (western blot): 1
 etiology of liver cirrhosis  1=viral, 2=non-viral: 1
 etiology of infertility: 1
 ethnicty: 1
 ethnic origin: 1
 ethnic background: 1
 ethnic: 1
 ethinicity: 1
 ethicity: 1
 ethanol treatment: 1
 ethanol concentration: 1
 etbr concentration: 1
 estrous cycle: 1
 estrogenreceptorstatus: 1
 estrogen/progesterone receptor status: 1
 estrogen-receptor status: 1
 estrogen-receptor: 1
 estrogen response: 1
 estrogen receptor status by immunohistochemistry: 1
 estrogen receptor (er) status: 1
 estimated fragment size: 1
 estimated days after hiv infection: 1
 estimated age: 1
 established.from.pre.treatment..i....post.treatment..p..or.metastatic..m.: 1
 established cells: 1
 esr1bimod: 1
 esr1 status: 1
 esr1 module tertile: 1
 esr: 1
 escherichia coli o157: 1
 esc line: 1
 es state: 1
 es cell line type: 1
 es cell clone: 1
 erythrocytes x10^12/l: 1
 erlotinib resistance: 1
 erhswk4: 1
 erhswk16: 1
 erhswk0: 1
 erg_insetion: 1
 erg expression: 1
 ercc_spike_in: 1
 ercc_mapping_ratio: 1
 ercc_dilution: 1
 ercc5 10^-5 dilution of ercc in ul: 1
 erbb2p ihc status: 1
 erbb2bimod: 1
 erbb2.tab ihc status: 1
 erbb2.ht ihc status: 1
 erbb2 status by ihc: 1
 erbb2 status (fish): 1
 erbb2 status: 1
 erbb2 positive ihc: 1
 erbb2 module tertile: 1
 erbb2 ihc status: 1
 erbb2: 1
 er2 status: 1
 er/pr/her2: 1
 er/pr status: 1
 er.status: 1
 er.ih: 1
 er-subclass: 1
 er-ihc: 1
 er status by ihc: 1
 er status (1=positive, o=negative): 1
 er pgr: 1
 er ihc status: 1
 er class: 1
 er by gene: 1
 er allred score: 1
 er (%) by ihc: 1
 er   1= positive, 0=nagative: 1
 equivalent who simplified trachoma score: 1
 equivalent who simplified trachoma grade: 1
 equivalent strain name: 1
 equisetum arvense sample: 1
 epstein barr virus infection: 1
 epitope tag: 1
 epitope: 1
 epistaxis grade: 1
 epilepsy status: 1
 epilepsy model: 1
 epigenetic modification: 1
 epididymal region: 1
 epidermal growth factor receptor amplification status: 1
 epc genotype: 1
 ep4 agonist ae1-329 treatment: 1
 eosinophils x10^9/l: 1
 eosinophil blood count mm3: 1
 eosinophil: 1
 eos 10e9/l: 1
 eortc classification: 1
 eortc: 1
 enzyme_treatment: 1
 enzyme expressed: 1
 enzymatic digestion: 1
 environmental sample: 1
 environmental historydisease: 1
 environmental history - reproduction: 1
 environmental history - colony: 1
 environment type: 1
 envelop: 1
 enrichment treatment: 1
 enrichment method: 1
 engraftment kinetics: 1
 energy substrate: 1
 endpointcode: 1
 endothelial cell status: 1
 endosymbiont: 1
 endonuclease for library preparation: 1
 endometriosis/no endometriosis: 1
 endometriosis severity: 1
 endometrioma severity stage: 1
 endometrial cycle phase: 1
 endocrine therapy: 1
 endocrine agent: 1
 ending left ventricular weight mg: 1
 enddiastolicdiameter: 1
 end hr bpm: 1
 end hr (bpm): 1
 emt status: 1
 employed library preparation method: 1
 empe: 1
 embryos pooled: 1
 embryos collected at time after ivf: 1
 embryonic zone: 1
 embryonic stages: 1
 embryoid body size: 1
 embryoid body: 1
 embryoid: 1
 embryo type: 1
 embryo stage for culture prep: 1
 embryo region: 1
 embryo quality score (iets codes): 1
 embryo quality: 1
 embryo name: 1
 embryo id: 1
 embryo genotype: 1
 embryo genotyp/variatione: 1
 embryo fraction: 1
 embryo classification: 1
 embryo characteristic: 1
 emb sensitivity: 1
 elston: 1
 elongationtime: 1
 elicitors: 1
 eletroporated with: 1
 electroporated with: 1
 electroporated construct: 1
 electron transport chain phenotype: 1
 electroacupuncture: 1
 electrical stimulation es: 1
 elastic module: 1
 ejectionfraction %: 1
 ejection fraction: 1
 ejaculate volume: 1
 ehec strain: 1
 egg-producing or eggless: 1
 egg quality: 1
 egfrviii statue: 1
 egfr.ihc: 1
 egfr ihc status: 1
 egfr ihc: 1
 egfp fluorescence: 1
 egf: 1
 efficiency: 1
 effect on susceptibility to develop ms: 1
 edss ms csf: 1
 edss after 5 years: 1
 edss after 2 years: 1
 edmonson: 1
 edd: 1
 ectopic expression: 1
 ecs: 1
 ecotype/subspecies: 1
 ecotype/genotype background: 1
 ecotype of pollen: 1
 ecotye: 1
 ecog ps: 1
 ecm: 1
 ebv strain: 1
 ebv status of the cell line: 1
 ebv latency: 1
 ebna3c epresssion: 1
 eba severity score: 1
 eb formation method: 1
 eau-inducing antigen: 1
 eastern cooperative oncology group performance status: 1
 early senescence: 1
 e2f3 module tertile: 1
 e2a-pbx1: 1
 e2_orion: 1
 e.rfs: 1
 e.os: 1
 e. coli subset: 1
 e. coli inoculation site: 1
 e. coli food source: 1
 e-cadherin expression: 1
 dyt1 mutation status: 1
 dystonia: 1
 dysplasia: 1
 dyslipidemia: 1
 dxdate: 1
 dutch eating behaviour questionarre deqb: 1
 duration of sel-1 rnai feeding: 1
 duration of fluid flow: 1
 duration of disease (month): 1
 duration of disease: 1
 duration mins: 1
 duration from ms diagnosis to therapy initiation in months: 1
 duration from ms diagnosis to therapy initiation (in months): 1
 duration (mins): 1
 duplicate: 1
 duplex: 1
 dup(9)(pter-p13:: 1
 dukes' stage: 1
 dukes: 1
 dtc positiveihc: 1
 dss_time disease specific survival time, months: 1
 dss_event disease specific survival: 1
 dss event defined as death from breast cancer: 1
 dsrna treatment knockdown: 1
 dsrna: 1
 dsn time: 1
 dsm-iv: 1
 dsd010: 1
 dryness group: 1
 drug-response: 1
 drug treatment  linezolid/vancomycin/no: 1
 drug therapy: 1
 drug status: 1
 drug response status: 1
 drug resistant status: 1
 drug resistance status: 1
 drug regimen: 1
 drug concentration: 1
 drug administration: 1
 drought-responsive phenotype: 1
 drought susceptibility: 1
 drought stage: 1
 drivergene: 1
 driver 2: 1
 driver 1: 1
 drinking water: 1
 drfs even time years: 1
 drfs 1 event 0 censored: 1
 drfs: 1
 drb exposure time: 1
 dpa: 1
 doxycycline-induced protein expression: 1
 doxycycline status: 1
 doxycycline concentration: 1
 doxorubicin auc: 1
 dox_induced: 1
 dox treated: 1
 dox concentration: 1
 dox addition: 1
 dox: 1
 downst: 1
 downs: 1
 doubling time days: 1
 doublet?: 1
 dosing schedule: 1
 dosing duration: 1
 dose volume: 1
 dose rate: 1
 dose ppb: 1
 dose or concentration: 1
 dose general application (mm): 1
 dose flutamide: 1
 dose cohort: 1
 dose cognate kavynfatc peptide um: 1
 dose 2: 1
 dose 1: 1
 dose (um): 1
 dose (ug): 1
 dosage_time_resp: 1
 dosage unit: 1
 dosage frequency: 1
 dosR Condition: 1
 dormancy: 1
 donor/status: 1
 donor/recipient strain: 1
 donor#: 1
 donor type: 1
 donor strain and cells: 1
 donor phenotype: 1
 donor mouse genotype: 1
 donor index: 1
 donor identifier: 1
 donor gender: 1
 donor disease state: 1
 donor developmental stage: 1
 donor cell line: 1
 donor bmi: 1
 donor age years: 1
 donor age (years): 1
 donor #: 1
 don concentration: 1
 domoic acid: 1
 dominant p53 mutation: 1
 domain: 1
 dog1 expression level: 1
 dog id: 1
 dog: 1
 dod: 1
 dob: 1
 dnmt3b-knockin: 1
 dnebna1: 1
 dnase treatment: 1
 dna type: 1
 dna subtype: 1
 dna status: 1
 dna methylation subgroup: 1
 dna fragmentation method: 1
 dna fragmentation: 1
 dna fraction: 1
 dna core: 1
 dmsp availability: 1
 dmfs time: 1
 dmfs event defined as distant metastasis or death from breast cancer: 1
 dm: 1
 dlg5 133a: 1
 dlda30 prediction: 1
 dld30: 1
 dlbcl subtype: 1
 dlbcl molecular subtype: 1
 dkfz_patient_comments: 1
 division pattern: 1
 divided in vitro: 1
 distwalked: 1
 distant relapse (1=dr, 0 censored): 1
 distant mets: 1
 distant metastasis-free years: 1
 distant metastasis (m): 1
 distant metastasis (according to tnm classification 2002): 1
 distant metastases: 1
 distance from the tumor center: 1
 dissolved organic carbon (mg/l): 1
 dissociation protocol and sequencing platform: 1
 diseaste state: 1
 diseases: 1
 diseaselocation: 1
 diseased: 1
 disease_staging: 1
 disease/genotype: 1
 disease-free survival time: 1
 disease-free interval months: 1
 disease-free: 1
 disease, age, sex, smoking status: 1
 disease status of patient source: 1
 disease status of blood donor: 1
 disease state time: 1
 disease state phenotype: 1
 disease state of patient: 1
 disease state host: 1
 disease state final pathology: 1
 disease state condition: 1
 disease relapse event: 1
 disease progression event: 1
 disease progression (binary): 1
 disease outcome: 1
 disease free survival month: 1
 disease free survival (months): 1
 disease free survival: 1
 disease free interval days: 1
 disease free interval (months): 1
 disease extension: 1
 disease duration yrs ms csf: 1
 disease duration yrs: 1
 disease duration: 1
 disease development: 1
 disease class: 1
 disease activity score das-28crp: 1
 disease : 1
 diseae state: 1
 discription: 1
 discodermolide resistance status: 1
 disaese activity bvas 2003 persistent/worse: 1
 directional rnaseq: 1
 directional reads: 1
 directional: 1
 direct_lung: 1
 direct rna sequence from: 1
 dinitrobenzene dosage: 1
 dimension: 1
 dilution rate: 1
 digestive enzyme: 1
 diffusing capacity of the lung for carbon monoxide dlco percent predicted: 1
 differention day: 1
 differentiation treatment: 1
 differentiation timepoint: 1
 differentiation time-point: 1
 differentiation time days: 1
 differentiation specificity: 1
 differentiation of escc: 1
 differentiation medium: 1
 differentiation conditions: 1
 differentiation age: 1
 differentiated with: 1
 differentiated days: 1
 differentiated: 1
 differentian stage: 1
 differential potential: 1
 differential expression tool: 1
 differentation grade: 1
 dietary supplement: 1
 dietary response group: 1
 dietary oil: 1
 dietary fat type: 1
 dietary fat sources: 1
 dietary fat source: 1
 dietary calcium: 1
 diet of father: 1
 diet length: 1
 diet intervention started: 1
 diet fed: 1
 diet enriched in: 1
 diet condition: 1
 diet availability: 1
 diease: 1
 dicer status: 1
 dibutyl phthalate dose level: 1
 dibenza,hanthracene ng/m3: 1
 diazepam: 1
 diapause state: 1
 diagnostic test result: 1
 diagnostic group: 1
 diagnosisyr: 1
 diagnosis total: 1
 diagnosis splen flex: 1
 diagnosis rectum: 1
 diagnosis recto sigmoid: 1
 diagnosis note: 1
 diagnosis ibdu, uc, nomoa: 1
 diagnosis hep flex: 1
 diagnosis good,bad: 1
 diagnonsis: 1
 diag_tumour_size: 1
 diag.yr: 1
 diabetic nephropathy susceptability: 1
 diabetic: 1
 diabetes duration years: 1
 dgrp line number: 1
 dgf status: 1
 dfs_time disease free survival time, months: 1
 dfs_event disease free survival: 1
 dfs/follow-up: 1
 dfs-month: 1
 dfs-event: 1
 dfs time (months): 1
 dfs time: 1
 dfs status 1 = recurred: 1
 dfs months: 1
 dfs evt: 1
 dfs event defined as any type of recurrence or death from breast cancer: 1
 dfs - disease-free survival days: 1
 dexamethasone treatment: 1
 dexamethasone: 1
 devolopmetal stage: 1
 device: 1
 develpmetal stage: 1
 developmental zone: 1
 developmental timing: 1
 developmental time hours: 1
 developmental status: 1
 developmental stagedays past sown: 1
 developmental stageage: 1
 developmental stage/condition/extract protocol: 1
 developmental stage/age: 1
 developmental stage of fungus: 1
 developmental stage nf: 1
 developmental stage days post anthesis; dpa: 1
 developmental stage boyes et al plant cell 2001: 1
 developmental stage at isolation: 1
 developmental stage at harvest: 1
 developmental stage (of tissue collection): 1
 developmental stage (culture time): 1
 developmental stage (coombe): 1
 developmental phase: 1
 developmental lineage: 1
 developmental hours post fertilization: 1
 developmental: 1
 developmenta stage: 1
 development time: 1
 development state: 1
 development stages: 1
 development stage/age: 1
 development satge: 1
 development point: 1
 development period of grov: 1
 development of seminiferous tubles: 1
 development hour: 1
 development age: 1
 developed_breast_cancer: 1
 developed metastases: 1
 developed at: 1
 develop. stage: 1
 develolpmental stage: 1
 dev. stage boyes et al. plant cell 2001: 1
 dev. stage (boyes et al. plant cell 2001): 1
 dev. stage: 1
 detected molecule: 1
 details: 1
 detail: 1
 design: 1
 desiccation: 1
 description operation: 1
 derived cell typed: 1
 derived cell type: 1
 derivative of wild-type strain COH1 harboring mtaR: 1
 derivative of wild-type strain COH1 harboring ciaR: 1
 derivative: 1
 der(15)t(15;9)(qter-p1?1:: 1
 depth (m): 1
 depressive features: 1
 depot: 1
 depletion/expression: 1
 depletion status: 1
 density gradient region: 1
 dengue serotype: 1
 dendritic cell subset: 1
 dendritic cell lineages: 1
 dendritic cell: 1
 demographic origin center: 1
 delta leptin: 1
 delta lar: 1
 delta ctm insr-gapd: 1
 delta adipo: 1
 delivery location: 1
 deleted gene: 1
 del8p: 1
 del6q: 1
 del1p: 1
 del16q: 1
 del14q: 1
 del13q: 1
 del11q status: 1
 del11q and/or atmmut: 1
 dek status: 1
 dehydated for: 1
 degreedays: 1
 degree of inflammation/fibrosis: 1
 degree: 1
 deep ulcer: 1
 decitabine: 1
 decidualization: 1
 decay stage: 1
 decay delay: 1
 debris: 1
 deathmonths: 1
 death_time (yrs): 1
 death_event_1death_0censor: 1
 death_event: 1
 death_dd_after_diagnosis: 1
 death.cause: 1
 death from disease: 1
 death from cancer (1=yes, 0=no): 1
 death day: 1
 death 1=dead,0=alive: 1
 death 0=no, 1=yes: 1
 death (1=yes, 0=no): 1
 dead or alive at last followup: 1
 dead 1=yes: 1
 dead: 1
 de-identified research code: 1
 de novo/sec: 1
 ddc treatment: 1
 dd: 1
 dcis cell line: 1
 dc gene: 1
 dbp mmhg: 1
 days_running: 1
 days treatment: 1
 days since surgery: 1
 days since quiet visit: 1
 days pt: 1
 days post-transplantation: 1
 days post-transfection at time of harvest: 1
 days post-stz injection: 1
 days post-stimulus: 1
 days post-lif: 1
 days post-lcmv infection: 1
 days post-fertilization: 1
 days post-exposure: 1
 days post-anthesis fiber: 1
 days post treatment: 1
 days post inoculation dpi: 1
 days post injury: 1
 days post injection: 1
 days post fertlization: 1
 days post coitum: 1
 days off dox: 1
 days of transduction: 1
 days of symptoms: 1
 days of suspension culture: 1
 days of regression: 1
 days of life: 1
 days of incubation: 1
 days of in vitro culture div: 1
 days of expansion: 1
 days of estrus: 1
 days of culture: 1
 days of conventionalized: 1
 days of contact: 1
 days lvad: 1
 days from visit to sample collection: 1
 days from lh peak: 1
 days from last symptom: 1
 days differentiation: 1
 days differentiated: 1
 days degrees: 1
 days cultured after cd71+ isolation at day 6: 1
 days between sample collection: 1
 days between diagnosis and blood collection: 1
 days before relapse/censor: 1
 days before death/censor: 1
 days at 29 c: 1
 days after tumor injection: 1
 days after transduction: 1
 days after sowing: 1
 days after pollination: 1
 days after planting: 1
 days after passage: 1
 days after lof: 1
 days after inoculation: 1
 days after injection: 1
 days after infection: 1
 days after induction of differentiation: 1
 days after induction: 1
 days after germination: 1
 days after flowering: 1
 days after flower opening daf: 1
 days after emergence: 1
 days after dsrna bathing: 1
 days after dicer deletion: 1
 days after antigen challenge: 1
 days after activation: 1
 daypostinoculation: 1
 day-post-infection: 1
 day since admission: 1
 day sample was taken in protocol: 1
 day sample was collected: 1
 day relative to weaning: 1
 day post-weaning: 1
 day post-infection: 1
 day post mortem: 1
 day post infection of extraction: 1
 day post induction: 1
 day of tissue dissection: 1
 day of the oestrous cycle: 1
 day of shock after onset of fever: 1
 day of menstrual cycle: 1
 day of infusion of plasma after onset of fever: 1
 day of infection: 1
 day of gestation: 1
 day of dox treatment: 1
 day of culture: 1
 day of co-culture: 1
 day of blood sampling after onset of fever: 1
 day of birth: 1
 day light regime: 1
 day in vitro div: 1
 day in vitro: 1
 day collected post-infection: 1
 day collected: 1
 day after pollination: 1
 day after lcmvarm infection: 1
 day after infection: 1
 day 46: 1
 day 19: 1
 dategroup of array: 1
 datedx: 1
 date sampled: 1
 date sacrificed: 1
 date planted: 1
 date of transplantation: 1
 date of surgery: 1
 date of scan: 1
 date of sample preparation and hybridisation: 1
 date of sacrifice: 1
 date of relapse: 1
 date of randomisation month/date/year: 1
 date of quality check: 1
 date of microarray experiment: 1
 date of melanoma diagnosis: 1
 date of inoculation: 1
 date of experiment: 1
 date of diagnosis: 1
 date of death or date patient last known to be alive month/date/year: 1
 date of death: 1
 date of cultivation: 1
 date of crna synthesis: 1
 date of collection: 1
 date of blood test dmy: 1
 date of biopsy ii: 1
 date of biopsy i: 1
 date of array: 1
 date of analysis: 1
 date of   recurrence: 1
 date injected: 1
 date culled: 1
 date at surgery: 1
 date at last contact: 1
 date at distant metastasis: 1
 dataset group: 1
 data subset: 1
 data source: 1
 data processing alignment algorithm: 1
 data analysis protocol: 1
 data analysis algorithm: 1
 data: 1
 das28 week 14: 1
 das28 week 0: 1
 daptomycin treated: 1
 damid tagged factor: 1
 dam-fusion: 1
 dam genotype: 1
 dam fusion: 1
 dac treatment: 1
 daa: 1
 d5_pucai: 1
 d3_pucai: 1
 d'amico risk classification: 1
 cytokine withdrawl: 1
 cytokine stimulation: 1
 cytokine activation: 1
 cytogenetic risk group: 1
 cytogenetic group: 1
 cytogenetic background: 1
 cytogenetic aml subgroup: 1
 cystectomy: 1
 cypermethrin concentaion ppb: 1
 cyfluthrin concentration: 1
 cyclophosphamide dosage: 1
 cyclophosphamide auc: 1
 cyclophosphamide: 1
 cycloheximide: 1
 cyclin d1 expression level: 1
 cycles of chemotherapy treatment: 1
 cycle speed: 1
 cycle phase/ gestational age: 1
 cy5: 1
 cy3 pmt: 1
 cy3: 1
 cxr findings: 1
 cxcr5 expression: 1
 cxcr4 mutation: 1
 cxcl12: 1
 cv: 1
 cutured with: 1
 cuspidity: 1
 cuso4 treated: 1
 currentwgt: 1
 current status: 1
 current smoking: 1
 current smoker: 1
 current medications: 1
 current medication: 1
 curd-forming capacity: 1
 curated-cell-type: 1
 cumulative embryo score: 1
 cummulative precipitation at sampling: 1
 culure intensity: 1
 culturing medium: 1
 culturing conditions: 1
 cultured under: 1
 cultured on: 1
 cultured for: 1
 cultured cells: 1
 culture_type: 1
 culture/growth condition: 1
 culture with: 1
 culture variation: 1
 culture time (after dissociation): 1
 culture suplemmentation: 1
 culture substrate: 1
 culture strain: 1
 culture protocols: 1
 culture plate: 1
 culture phase: 1
 culture period: 1
 culture methodology: 1
 culture media 6-day culture period supplemented with: 1
 culture location: 1
 culture environement: 1
 culture doubling time: 1
 culture dish as biological replicates: 1
 culture density/stage: 1
 culture days: 1
 culture day: 1
 culture date: 1
 culture collection: 1
 culture batch: 1
 culture age (days): 1
 cultivator: 1
 cultivation; growth phase: 1
 cultivation time minutes: 1
 cultivation protocol: 1
 cultivation period: 1
 cultivated time: 1
 cultivated temperature: 1
 cultivated on: 1
 cultivated in: 1
 cultivar/line: 1
 cultivar/genotype: 1
 cultivar type: 1
 cucumber line: 1
 ctn: 1
 ctid sample id: 1
 ctc's group: 1
 cstage: 1
 csp: 1
 csa adhesion: 1
 cryotolerance: 1
 cryopreservation: 1
 crt: 1
 crs type: 1
 crp mg/dl: 1
 crowth condition: 1
 crosslinking device: 1
 crossbreed: 1
 crossbred pigs: 1
 cross type: 1
 crna plate: 1
 critical illness myopathy: 1
 crispr guide sequence: 1
 creatnine: 1
 creatinine mg/dl: 1
 cre transgene: 1
 cpr: 1
 cpp conditioning drug and dose: 1
 cpc: 1
 cp: 1
 cowpea line: 1
 cow id: 1
 cow: 1
 cousin 2: 1
 cousin 1: 1
 country/location: 1
 country of origin: 1
 country: 1
 cotinine ng/g placenta: 1
 cosmid: 1
 cosmic id: 1
 corticosteroids: 1
 corresponding bl sample: 1
 correlation: 1
 corrected gestational age weeks+days: 1
 corrected gestational age at sample weeks+days: 1
 coriell sample: 1
 coriell id: 1
 coriell cell line: 1
 coriell catalog #: 1
 core.BL: 1
 core: 1
 cord blood or blood donor: 1
 coral colony: 1
 copy number 16p11.2: 1
 copper level: 1
 copper concentration (mm): 1
 control well: 1
 control volunteer/patient number: 1
 control source: 1
 control or radiosensitive: 1
 control littermates for Ts65Dn mice (B6EiC3Sn-T(1716)65Dn) Age: postnatal day 2 (P2) Tissue: 1
 control cells: 1
 control antibody: 1
 contralateral or ipsilateral: 1
 continuous light time: 1
 contemporary group: 1
 containing plasmid: 1
 construct stably transfected into cell line: 1
 construct expression status: 1
 construct expression: 1
 constriction time: 1
 constitutive signaling pathway: 1
 consortium lung phenotype surrogate variable: 1
 consortium lung phenotype: 1
 conjugation time: 1
 congenital condition: 1
 congenital abnormality : 1
 congenic strain: 1
 conditioning: 1
 conditional expression of snai1: 1
 condition_sample_id: 1
 condition/treatment: 1
 condition/tp dx: 1
 condition/stress: 1
 condition of culture: 1
 condition id: 1
 condition group: 1
 condition description: 1
 conclusions ig/tcr: 1
 concetration: 1
 concentration treatment micro-array analysis (mm): 1
 concentration of chemical: 1
 concentration ng/ul: 1
 concentration ng: 1
 concentration compound: 1
 con rats dyad group: 1
 compound treated: 1
 compound name: 1
 compound dose: 1
 compound concentration: 1
 compound and dose: 1
 compound 2: 1
 compound 1: 1
 composite score: 1
 components of growth medium: 1
 components: 1
 complex type: 1
 completed years of ifn-beta therapy: 1
 completed months of ga therapy: 1
 complete genotype: 1
 complementation: 1
 competitive status: 1
 comparison to normal cells: 1
 comorb: 1
 commercial vendor: 1
 commercial provider: 1
 commercial feed type: 1
 comments: 1
 comment bioanalyzer: 1
 comet.score: 1
 comet: 1
 combat group: 1
 colony/larval stage: 1
 colony transformation line: 1
 colony rearing location: 1
 colony and cellular morphology: 1
 colonoscopy result: 1
 colonization: 1
 colonised bacteria: 1
 colonic location: 1
 colonic histological injury score his: 1
 colon weight (mg): 1
 colon ratio (mg/mm): 1
 colon location: 1
 colon length (mm): 1
 colloquialtimeofday: 1
 collection_day_post_tx: 1
 collection year: 1
 collection time post-treatment: 1
 collection time post-ir: 1
 collection time after 3at treatment: 1
 collection parameters: 1
 collection of blood samples: 1
 collection location: 1
 collection dates: 1
 collected on: 1
 collected from cell line: 1
 collected date: 1
 collected: 1
 colitis: 1
 coitus: 1
 cohoused with: 1
 codon: 1
 code samplebrainpatholms: 1
 cod pr receptor: 1
 cod her2 receptor: 1
 cod er receptor: 1
 cocultured with: 1
 cochlear region: 1
 coatcolor: 1
 coal-burning: 1
 co2 produced before cell collection g/l: 1
 co2 level or day of experiment: 1
 co2 gas input: 1
 co2 condition: 1
 co2 concentration uatm: 1
 co-twin: 1
 co-ip: 1
 co-electroporated construct: 1
 co-cultured on: 1
 co-cultured medium: 1
 co-culture length: 1
 co-culture cell line: 1
 co-cultivated with: 1
 cn stage: 1
 cml phase: 1
 cluster.id: 1
 cluster id: 1
 cluster assignment: 1
 clr4:: 1
 clr3:: 1
 cloning: 1
 cloneid: 1
 clone frequency: 1
 clonal state: 1
 clonal line: 1
 clonal individual: 1
 clonal genotype: 1
 clonal complex: 1
 cln170: 1
 cln160: 1
 cln150: 1
 cln140: 1
 cln130: 1
 cln120: 1
 cln110: 1
 cln100: 1
 cln090: 1
 cln080: 1
 cln070: 1
 cln030: 1
 clipping sequence: 1
 clip variant: 1
 clip beads: 1
 clint_stage: 1
 clinical_treatment_adjuvant_rt: 1
 clinical_treatment_adjuvant_chemo: 1
 clinical_history: 1
 clinical treatment outcome: 1
 clinical status post 1st line chemotherapy cr - complete response; pr - partial response; sd - stable disease; p - progression: 1
 clinical status at last follow-up awd - alive with disease; dod - dead from disease; ned - no evidence of disease: 1
 clinical state: 1
 clinical specimen: 1
 clinical risk score: 1
 clinical response factor: 1
 clinical response 6 months after chemoradiotherapy treatment: 1
 clinical response 2: 1
 clinical response 1: 1
 clinical presentation: 1
 clinical nodal status: 1
 clinical manifestation: 1
 clinical isolate: 1
 clinical intervention day: 1
 clinical information : 1
 clinical form: 1
 clinical features: 1
 clinical diagnosis specimen: 1
 clinical diagnosis patient: 1
 clinical diagnosis: 1
 clinical description: 1
 clinical dementia rating: 1
 clinical comments: 1
 clinical ajcc stage: 1
 clinical Information: 1
 clinic_pheno: 1
 clinial history: 1
 clincial information - overall survival: 1
 clincial information - event free survival: 1
 clincial information - disease outcome: 1
 clincial information - age at diagnosis: 1
 clincial information - MYCN: 1
 clincial information - LOH1p: 1
 clincal outcome: 1
 clin resp: 1
 clin prog: 1
 climate: 1
 classspd10: 1
 classification set: 1
 class_lt_nlt: 1
 class_blu: 1
 class label: 1
 class gene: 1
 clarck level: 1
 clam condition: 1
 cl: 1
 cka staining: 1
 ck5 14: 1
 ck19.ihc: 1
 ck.5.6.ihc: 1
 cit-induced switch: 1
 cit classification: 1
 cisplatin phenotype: 1
 circulating tumor cells: 1
 circadianphase: 1
 circadian timepoint: 1
 circadian time ct: 1
 circadian period: 1
 cin and tumour stage: 1
 cimp.status: 1
 cimp status: 1
 cig/dag: 1
 cic.gene.mutation: 1
 ciat code: 1
 chx: 1
 chrysene ng/m3: 1
 chronicity: 1
 chronic phase: 1
 chromosome stability: 1
 chromosome instability cin phenotype: 1
 chromosome instability: 1
 chromosome composition: 1
 chromosome 5q status: 1
 chromosome 22 monosomy: 1
 chromosomal_translocation: 1
 chromosomal variation: 1
 chromosomal status: 1
 chromogranin staining: 1
 chromatin preparation method: 1
 chromatin feature: 1
 chromatin condensation stage: 1
 chr18qloh: 1
 chp2:: 1
 choline treatment: 1
 choline intake for 12 weeks: 1
 choline intake: 1
 chlorophyll a content (ug/l): 1
 chloride treatment: 1
 chlamydia pneumoniae: 1
 chirp probes: 1
 chipversion: 1
 chips transplanted into: 1
 chipid: 1
 chip_lot_ab: 1
 chip_id: 1
 chip_barcode: 1
 chip/dip antibody vendor: 1
 chip/dip antibody lot#: 1
 chip/dip antibody catalog#: 1
 chip-seq antibody cat. #: 1
 chip-seq antibody cat #: 1
 chip-antibody vendor: 1
 chip-antibody cat. #: 1
 chip-antibodies: 1
 chip'ped factor: 1
 chip vendor/catalog/lot: 1
 chip vendor/catalog#: 1
 chip vendor/catalog: 1
 chip target: 1
 chip seq antibody: 1
 chip sample: 1
 chip processing date: 1
 chip position: 1
 chip or ip antibody: 1
 chip method: 1
 chip characteristics: 1
 chip antibodyies: 1
 chip antibody reference: 1
 chip antibody ref/lot info: 1
 chip antibody manufacturers: 1
 chip antibody lot numbers: 1
 chip antibody lot number: 1
 chip antibody lot #'2: 1
 chip antibody lot: 1
 chip antibody epitope/name: 1
 chip antibody details vendor/catalog #: 1
 chip antibody catalog #'s: 1
 chip antibody catalog: 1
 chip antibody cat. number: 1
 chip antibody batch #: 1
 chip antibody 2 manufacturer: 1
 chip antibody 1 manufacturer: 1
 chip antibodies: 1
 chip ab: 1
 chinese pediatric all subtype: 1
 chimpanzee identifier: 1
 chimp: 1
 chimera type: 1
 chimera genotype: 1
 child: 1
 chiip antibody manufacturer: 1
 chicken line: 1
 chemtype: 1
 chemotherapy sensitivity: 1
 chemotherapeutic response: 1
 chemostat run: 1
 chemosensitivity prediction: 1
 chemoradiation therapy response: 1
 chemoradiation therapy: 1
 chemo-resistance lc50 type: 1
 chemo-resistance cell type: 1
 chemo before tp: 1
 chemo agent: 1
 chemical treatment of isolated rna: 1
 chemical concentration measured: 1
 chemical compound: 1
 chd status: 1
 characteristics: s_found_by_screening_0no_1yes: 1
 channel type: 1
 change: 1
 chamber treatment: 1
 chamber id: 1
 challenge virus: 1
 ch1: 1
 cgsr id: 1
 cgrp status of cell: 1
 cftr genotype: 1
 cetuximab sensitivity: 1
 cervical dilation: 1
 ceph id: 1
 censoring (days): 1
 censored): 1
 censored: 1
 cellular type: 1
 cellular subset: 1
 cellular state: 1
 cellular fraction: 1
 cellular differentiation: 1
 cellular compartment: 1
 cellular basis of adc: 1
 celluar rna type: 1
 cells type: 1
 cells purified from: 1
 cells origin: 1
 cells in well: 1
 cells derived from: 1
 cells cultured in vitro with: 1
 cells collected at: 1
 cells analyzed: 1
 celll type: 1
 cell-stage: 1
 cell-line name: 1
 cell-culture-batch: 1
 cell wall synthesis: 1
 cell type total rna source: 1
 cell type subpopulation: 1
 cell type source: 1
 cell type sorted: 1
 cell type separated by facs: 1
 cell type marker: 1
 cell type enrichment: 1
 cell type effector precursor: 1
 cell type analyzed: 1
 cell type (transplanted into recipient): 1
 cell type (sorted): 1
 cell type (purified cell subset): 1
 cell typ: 1
 cell transfection: 1
 cell synchronization: 1
 cell surface antigens: 1
 cell subtypes: 1
 cell subtype/phenotype: 1
 cell sub-population: 1
 cell sub-popuation: 1
 cell structure: 1
 cell stimulation: 1
 cell sorting time: 1
 cell sorting date: 1
 cell sorted: 1
 cell restimulation: 1
 cell references: 1
 cell purity: 1
 cell purification antibody vendor: 1
 cell purification antibody catalog number: 1
 cell populations: 1
 cell pluripotency: 1
 cell picking temperature: 1
 cell picking session: 1
 cell phase: 1
 cell passages: 1
 cell passage number: 1
 cell part: 1
 cell of origin classifiction defined by ihc: 1
 cell name: 1
 cell motility and invasiveness: 1
 cell modifications: 1
 cell model: 1
 cell migration: 1
 cell location: 1
 cell linr: 1
 cell line/tissue source: 1
 cell line/subline: 1
 cell line/clone id: 1
 cell line/cell type: 1
 cell line vendor: 1
 cell line tissue source: 1
 cell line test: 1
 cell line stably expressing: 1
 cell line stably expresses: 1
 cell line specificity: 1
 cell line resistance: 1
 cell line population: 1
 cell line phenotype: 1
 cell line p. promelas: 1
 cell line manufacturer: 1
 cell line lot #: 1
 cell line lineage: 1
 cell line founder animal: 1
 cell line ebv-status: 1
 cell line derived from gem model of prostate cancer: 1
 cell line derived: 1
 cell line derivation: 1
 cell line code: 1
 cell line clone: 1
 cell line cat. #: 1
 cell line (sorted): 1
 cell line (coriell id): 1
 cell label: 1
 cell l ine: 1
 cell info: 1
 cell identity: 1
 cell growth temperature: 1
 cell growth conditions: 1
 cell genotype/variation: 1
 cell genotype: 1
 cell division cohort: 1
 cell derivative: 1
 cell derivation: 1
 cell density, in klett units (1 ku ~10^7 cells/ml): 1
 cell cyle: 1
 cell cycle timepoint: 1
 cell cycle status: 1
 cell cycle arrest: 1
 cell cultures: 1
 cell culture treatment: 1
 cell culture passage: 1
 cell culture medium: 1
 cell culture id: 1
 cell culture confluency: 1
 cell culture conditions: 1
 cell culture bank: 1
 cell culture age: 1
 cell condition: 1
 cell concentration: 1
 cell composition: 1
 cell collection time: 1
 cell collection details: 1
 cell classification: 1
 cell batch: 1
 cell barcode: 1
 cell apical polarity: 1
 cell antibody: 1
 cell amount: 1
 cell activation: 1
 cell Line: 1
 cell ;ome: 1
 cell (plasmid): 1
 cel line: 1
 cel file path: 1
 cebpa/eyfp induction: 1
 cebpa mutation status: 1
 cebpa double mutations: 1
 ceap grade: 1
 cea: 1
 cdna yield (ng): 1
 cdna quality: 1
 cdna input: 1
 cdna clones: 1
 cdna batch: 1
 cdna amplification kit: 1
 cdna: 1
 cdkn2a: 1
 cdk2 shrna expression: 1
 cdk activity: 1
 cdh1 genotype: 1
 cdeis: 1
 cdc20 allele: 1
 cd98 fraction: 1
 cd8+ t cell type: 1
 cd8+ t cell subsets: 1
 cd8 t cell genotype: 1
 cd8 t cell effector type: 1
 cd68 expression: 1
 cd66 expression: 1
 cd49f: 1
 cd45ro expression: 1
 cd45: 1
 cd44v8-10 expression: 1
 cd44 transfected: 1
 cd4/cd8: 1
 cd4+/cd8+: 1
 cd4+ t cell count, cells/ul: 1
 cd4+ t cell count measurement: 1
 cd4 t cell line: 1
 cd4 t cell clone: 1
 cd4 status: 1
 cd4 single positive (sp) thymocyte subset: 1
 cd4 response to antigens: 1
 cd4 expression: 1
 cd39 status: 1
 cd39 expression: 1
 cd38 status: 1
 cd34 status: 1
 cd27: 1
 cd25 expression: 1
 cd24-cd44+: 1
 cd24 expression: 1
 cd24: 1
 cd20: 1
 cd163 expression: 1
 cd146 and pdgfrb expression: 1
 cd14: 1
 cd133 status: 1
 cd133 expression: 1
 cd133: 1
 cd13: 1
 cd117 staining: 1
 cd10: 1
 cd status: 1
 ccl4 administration: 1
 cbh2_copies: 1
 cb: 1
 cause_of_death: 1
 cause unknown: 1
 cattle sampling time relative to infection: 1
 catfish type: 1
 catelog number: 1
 category of comparison: 1
 category 0 = normal, 1 = hpv without progression, 2 = hpv with progression: 1
 category: 1
 categ: 1
 catalogue#: 1
 catalog/lot#: 1
 cat. #: 1
 castration surgery: 1
 castration status: 1
 castrated: 1
 castrate/intact: 1
 casp3 module tertile: 1
 casenote review date: 1
 caseid: 1
 case/control: 1
 case or control: 1
 case control 0- case, 1 - control: 1
 case (gc is for germinal center; ngc is for none germinal center): 1
 cas number: 1
 carrying the auxotrophic markers: 1
 carries_brca_mutation: 1
 carrier species: 1
 carrier solution: 1
 carrier: 1
 carnegie stage: 1
 cardiovascular disease state: 1
 cardioglycoside treatment: 1
 cardiacoutput: 1
 cardiacindex: 1
 carcinosarcoma status: 1
 carcinoma subtype: 1
 carcinoid type: 1
 carcinoid syndrome: 1
 carcinogen: 1
 carcass weight: 1
 carbonate conc.: 1
 carbon_source: 1
 carbon source substrate: 1
 carbon dioxide produced before cell collection g/l: 1
 car transduction status: 1
 capture site: 1
 capsule phenotype: 1
 capsular.effraction.lnm: 1
 capillary density: 1
 cancer_yes_no: 1
 cancer_type: 1
 cancer_stage: 1
 cancer_nuclear_grade: 1
 cancer_hpe: 1
 cancer.percent: 1
 cancer treatment: 1
 cancer stem cells property: 1
 cancer stem cell population: 1
 cancer or normal: 1
 cancer nuclear grade: 1
 cancer history: 1
 cancer histopathological examination (hpe): 1
 cancer cells isolated from: 1
 cancer cell type: 1
 cancer: 1
 camptothecin exposure time: 1
 calprotectin: 1
 callus: 1
 calf number: 1
 calculated viral set point: 1
 calcineurin gene cnb1 deleted: 1
 cagp risk group: 1
 cagp expression group: 1
 cage mate identifier: 1
 cag repeat size: 1
 cag length: 1
 caecal colonization level: 1
 caeca colonization logcfu/g: 1
 cadi score: 1
 cadaver donor id: 1
 cad disease status: 1
 cachexia status: 1
 ca19-9: 1
 ca04 or pbs treatment: 1
 ca-125 coefficient: 1
 ca: 1
 c_source_conc.: 1
 c5: 1
 c4: 1
 c3: 1
 c1 chip id: 1
 c-peptide ng/ml: 1
 c-myc depletion: 1
 c-kit: 1
 bw body weight: 1
 bw: 1
 burn injury: 1
 bun: 1
 bulk population: 1
 bubr1 allele: 1
 btic culture: 1
 btic: 1
 bsm040: 1
 bsm030: 1
 bsm020: 1
 bru labeling time: 1
 bronchopulmonary dysplasia (bpd) group: 1
 brix level: 1
 breslow depth: 1
 breeed: 1
 breed/lactation stage: 1
 breed type: 1
 breed swine: 1
 breed name: 1
 breast_cancer_family_history: 1
 breast_cancer_cell_line: 1
 breast cancer recurrence: 1
 breast cancer patient: 1
 breast cancer cell line: 1
 breast cancer: 1
 brca2 mutation status: 1
 brca2 mutation: 1
 brca1/2 mutation: 1
 brca1 promoter methylation: 1
 brca1 mutation status: 1
 brca1 methylation status: 1
 brca status: 1
 brca genotype: 1
 brassica napus strain: 1
 braing: 1
 brain status: 1
 brain ph at time of freezing: 1
 brain hemisphere: 1
 brain code: 1
 brain bank source: 1
 brain: 1
 braf.gene.mutation.status: 1
 braf v600e mutation: 1
 braf t1799a mutation: 1
 braf status: 1
 braf signaling status: 1
 braf mutational status: 1
 braf mutation status: 1
 braf mutation: 1
 braf genotype: 1
 bracken fern (orogastrically or h2o): 1
 braak neurofibrillary tangle score: 1
 bpa exposed: 1
 boyes leaf development stage (boyes et al. plant cell 2001): 1
 box: 1
 bovine id: 1
 bortezomib treatment: 1
 bone metastatic potential: 1
 bone marrow status: 1
 bone marrow myeloblast(%): 1
 bone marrow fraction: 1
 bodyweight g: 1
 body size category: 1
 body site: 1
 body position: 1
 body mass kg: 1
 body mass index kg/m2: 1
 body mass index (kg/m2): 1
 body mass index (bmi): 1
 body location: 1
 body fluid: 1
 body fat percentage fm: 1
 body fat percentage: 1
 body fat % before intervention: 1
 bmwid: 1
 bmt type: 1
 bmp4 treatment: 1
 bmp4 treated: 1
 bmnpv resistance status: 1
 bmnpv infection status: 1
 bmn.grade: 1
 bmi1 status: 1
 bmi status: 1
 bmi before pregnancy: 1
 bmi (kg/m2): 1
 bmi (body mass index, kg/m2): 1
 bmd: 1
 bm_blast_(%): 1
 bm sample date: 1
 bm basement membrane thickening: 1
 bloodculture result: 1
 blood type: 1
 blood sampling: 1
 blood processed by: 1
 blood obtained: 1
 blood group: 1
 blood glucose mg/dl: 1
 blood fed: 1
 blood ethanol: 1
 blood eosinophil percentage: 1
 blood draw timepoint: 1
 blood draw: 1
 blood donor: 1
 blocking: 1
 blni allele length: 1
 blm mutation: 1
 bleeding sympotoms: 1
 blaxter clade: 1
 blasts: 1
 blastocyst score: 1
 blast_count: 1
 blast staging method: 1
 blast count, % of sample, -1=unavailable : 1
 blast cell percentage: 1
 bkg_id: 1
 bisulfite treatment of rna: 1
 birthweight g: 1
 births: 1
 birthing outcome sptl 1, pprom 2, term 3: 1
 birthday: 1
 birthdate: 1
 birthcountry: 1
 birth weight of offspringkg: 1
 birth weight category: 1
 birth weight (grams): 1
 birth weight: 1
 birth outcome sptb 1, term 0: 1
 birth: 1
 bird number: 1
 bipsy site: 1
 biovar: 1
 biotic plant treatment: 1
 biosource 4 growth condition: 1
 biosource 3 growth condition: 1
 biosource 2 growth condition: 1
 biosource 1 growth condition: 1
 biosource: 1
 biosample confirmed sub-diagnosis: 1
 biosample confirmed diagnosis: 1
 biopsyid: 1
 biopsy_gleason_grade: 1
 biopsy type (1: 1
 biopsy timepoint: 1
 biopsy taken from: 1
 biopsy site (grouped): 9: 1
 biopsy site (grouped): 7: 1
 biopsy site (grouped): 6: 1
 biopsy site (grouped): 5: 1
 biopsy site (grouped): 4: 1
 biopsy site (grouped): 3: 1
 biopsy leg: 1
 biopsy day: 1
 biopsied leg: 1
 bioploc: 1
 biomaterial source: 1
 biomaterial collected by: 1
 biomat-id: 1
 biomass: 1
 biological.replicate: 1
 biological replicate within time point for given experiment: 1
 biological replica #: 1
 biological repetition: 1
 biological material provider: 1
 biolgical replicate: 1
 biol. replicate #: 1
 biofluid: 1
 biocide sensitivity: 1
 biobank: 1
 bioanalyzer rna integrity number: 1
 bioSource type: 1
 bio source type: 1
 bio rep: 1
 binding/selection: 1
 binding site: 1
 binding protein vendor: 1
 binding protein: 1
 bin: 1
 bifidum strain: 1
 bicarbonate: 1
 bi: 1
 betac module tertile: 1
 beta-catenin staining: 1
 beta-catenin sequence result: 1
 best response if different: 1
 best response: 1
 berry total soluble solids: 1
 berlin_ards: 1
 benzokfluoranthene ng/m3: 1
 benzog,h,iperylene ng/m3: 1
 benzobfluoranthene ng/m3: 1
 benzoapyrene ng/m3: 1
 benzaanthracene ng/m3: 1
 bending time: 1
 behavioral phenotype: 1
 behavioral phase: 1
 behavioral group: 1
 behavioral caste: 1
 behavior - group: 1
 behavior - caste: 1
 bears the isp+ prion: 1
 bears sfp1: 1
 beads vendor: 1
 bead volume: 1
 bd patient: 1
 bcr_free_time: 1
 bcr-abl1: 1
 bcor mutation: 1
 bclc_staging: 1
 bcl6.expr.: 1
 bcl2.expr.: 1
 bcl2: 1
 bcb staininig: 1
 bc tumor stage: 1
 bc accession ids: 1
 batches: 1
 batch_2: 1
 batch/replicate: 1
 batch/lot#: 1
 batch.date: 1
 batch of transduced liver cells: 1
 batch fermentations with: 1
 batch barcode: 1
 bat type: 1
 basophils x10^9/l: 1
 basophil: 1
 baso 10e9/l: 1
 basetms: 1
 baseline severity  nih guideline: 1
 basecalling: 1
 base deficit: 1
 base calling software version: 1
 basal_brca1-like_pred: 1
 basal media: 1
 bart mirna expression: 1
 barrett's esophagus: 1
 bariatric surgery: 1
 barcodes: 1
 barcoded replicate: 1
 barcoded adapters: 1
 barcode2: 1
 barcode1: 1
 barcode srna cloning: 1
 barcode position: 1
 barcode label: 1
 barcode info: 1
 barcode 5': 1
 bap1 status: 1
 banking date: 1
 banff classification: 1
 bamboo sample: 1
 bait dsb: 1
 bait: 1
 bacterial strain used: 1
 bacterial stage: 1
 bacterial production (mg c/l*h): 1
 bacterial inoculation: 1
 bacterial genotype: 1
 bacterial culture conditions, steady-state cell doubling time, limited nutrient, excess nutrient: 1
 bacterial colonisation: 1
 bacteria strain: 1
 bacteria harvested from: 1
 background variety: 1
 background strains: 1
 background stain: 1
 background mutation: 1
 background ecotype: 1
 background cultivar: 1
 background cell type: 1
 background average: 1
 backgroud strain: 1
 backgroud genotype: 1
 backgrond: 1
 backbone: 1
 b240 or saline treatment: 1
 b12 treatment: 1
 b.breve strain: 1
 b. henselae infection: 1
 b-cimp phenotype: 1
 b cells mrna mass ng: 1
 b cell subset type: 1
 aza treated: 1
 aza tolerant: 1
 aza at present: 1
 axix i comorbidity: 1
 axenic or non-axenic: 1
 avidity: 1
 avg body weight: 1
 average_insert_length: 1
 average weight: 1
 average temperature (c): 1
 average side effect score: 1
 average shoot height: 1
 average neuritic plaque density: 1
 average insert size fragment length: 1
 average hw/bw: 1
 average fitness: 1
 average fish body weight: 1
 average blood sugar: 1
 average age days after birth: 1
 autosome: 1
 australian epidemic strain-1 code: 1
 aurka module tertile: 1
 auditory: 1
 attachment status: 1
 ats_packyears: 1
 atrx.protein_expression: 1
 atrophic model: 1
 atrium: 1
 atopy: 1
 atmospheric condition: 1
 athlete identifier: 1
 atcc#: 1
 atcc cell line: 1
 atcc catalog#: 1
 atcc accn: 1
 at least one mutation: 1
 at 14: 1
 asxl1 mut: 1
 astrocyte species: 1
 association: 1
 associated primary tumor no: 1
 associated diseses: 1
 assigned unique patient id: 1
 assigned group: 1
 assigned cell type: 1
 assayed at: 1
 assay type: 1
 assay physiological state: 1
 aspiration site: 1
 asct: 1
 asbestos-fiber count: 1
 asa: 1
 as arteiosclerosis: 1
 aru value: 1
 artificial ai2 added: 1
 article code: 1
 arthritis index: 1
 artery: 1
 arteries: 1
 arterial density: 1
 art treatment: 1
 arrayslide: 1
 arrayid: 1
 arraycd: 1
 array_lot: 1
 array.plate: 1
 array scan date: 1
 array qc: 1
 array processed by: 1
 array platform_id: 1
 array plate number: 1
 array number: 1
 array hybridisation batch number: 1
 array date: 1
 array chip #: 1
 array block id: 1
 array 4-plex id: 1
 arna: 1
 arn_quality: 1
 armcd: 1
 arid4b level: 1
 arid4b densitometry: 1
 arginine: 1
 area/tissue: 1
 area of lung near ipf: 1
 are surgical margins involved: 1
 arabidopsis thaliana columbia  mutant col-0 -  dev.stage boyes et al. plant cell 2001: 1
 arabidopsis thaliana columbia  - age: 1
 arabidopsis thaliana col-0  mutant at5g46800 = bou a bout de souffle  - dev.stage boyes et al. plant cell 2001: 1
 arabidopsis thaliana col-0  - dev.stage boyes et al. plant cell 2001: 1
 arabidopsis thaliana (wassilewskija)  - harvest date: 1
 ara-c sensitivity: 1
 ara-c ic50: 1
 ar-v7 status: 1
 application route: 1
 apple variety: 1
 appearance: 1
 apparatus: 1
 apoptosis: 1
 apoe status: 1
 apoe genotype: 1
 aphid line: 1
 apheresis: 1
 apc status: 1
 apc: 1
 aorta status: 1
 aorta dilation: 1
 antimony tolerance: 1
 antigen specificity: 1
 antigen: 1
 antibodystimulation: 1
 antibody/details: 1
 antibody/capture: 1
 antibody vendor; catalog#; lot#: 1
 antibody vendor/provider: 1
 antibody vendor/catalog number: 1
 antibody vendor, catalog#: 1
 antibody vendor and catalog number: 1
 antibody used for sorting: 1
 antibody transfer to embryo: 1
 antibody ref.: 1
 antibody ref: 1
 antibody quantity: 1
 antibody positivity: 1
 antibody number 2 fraction: 1
 antibody number 1 fraction: 1
 antibody manufacturer 2: 1
 antibody manufacturer 1: 1
 antibody manu.: 1
 antibody lot numbers: 1
 antibody lot number 2: 1
 antibody lot number 1: 1
 antibody included in the instillate: 1
 antibody for run-on transcript enrichment: 1
 antibody for pull-down: 1
 antibody for ip: 1
 antibody for clip: 1
 antibody dilution: 1
 antibody details: 1
 antibody company: 1
 antibody clone number: 1
 antibody clone: 1
 antibody catalogue number: 1
 antibody catalog number 2: 1
 antibody catalog number 1: 1
 antibody batch/lot#: 1
 antibody 2 manufactuer: 1
 antibody 1 manufactuer: 1
 antibodies/ip methods: 1
 antibiotics response: 1
 antibiotic resistance: 1
 anti-tpo: 1
 anti-tg: 1
 anther stage: 1
 anther length (mm): 1
 anther length: 1
 anther development stage: 1
 annual period: 1
 anntotation: 1
 annotation: 1
 animals per sample: 1
 animals: 1
 animalnumber: 1
 animal#: 1
 animal weight g: 1
 animal weight at start: 1
 animal source: 1
 animal replicate number: 1
 animal replicate: 1
 animal pair: 1
 animal no: 1
 animal name: 1
 animal model: 1
 animal ids: 1
 animal identifiers within pooled samples: 1
 animal id number: 1
 animal handling: 1
 animal condition: 1
 animal age at tissue harvest: 1
 animal age at initiation of experiment: 1
 angiography: 1
 angio lymphatic invasion: 1
 ang ii treatment 10-7m: 1
 ang ii receptors antagonists 10-5m: 1
 anet-seq antibody: 1
 androstenone related blup from individuals: 1
 androstenone related blup: 1
 androgen receptor expression: 1
 androgen receptor (ar) status: 1
 androgen indepedency: 1
 androgen deprivation therapy adt: 1
 androgen deprivation: 1
 anchor: 1
 ancestor strain: 1
 anc_(x103/ul): 1
 anc (x10^3/mcl): 1
 anatomy: 1
 anatomic_location: 1
 anatomic site of infection: 1
 anatomic site: 1
 anaplasi grade: 1
 anamorph: 1
 analysis type: 1
 analysis group: 1
 analysis batch: 1
 anagen stage: 1
 anaesthesia method: 1
 ana: 1
 amykor treatment: 1
 amrz functional status: 1
 amputated: 1
 amplified cdna/ not amplified cdna: 1
 amplification type: 1
 amplification strategy: 1
 amplification set : 1
 amplification batch: 1
 amplification and labeling kit: 1
 amp: 1
 amount of dna template: 1
 amount of dietary fat corn oil w/w: 1
 amount in microg: 1
 amount in g: 1
 amount administered: 1
 amount (ng): 1
 ammonium concentration: 1
 ammonium chloride addition: 1
 ammonium (um): 1
 ammonia exposure: 1
 aml fab classification: 1
 amino acid: 1
 alzheimer's disease stage: 1
 aluminum sensitivity: 1
 altitude: 1
 alt: 1
 also known as: 1
 als mutation: 1
 alpha-fetoprotein (afp): 1
 alp concentration: 1
 alopecia.score.post.impovement: 1
 alopecia.improvement.pct: 1
 allograft: 1
 allogeneic state: 1
 allocated treatment: 1
 allen science vignette cell id: 1
 alldeath: 1
 alignment tool: 1
 alignment program: 1
 alias: 1
 alexa 647 dye: 1
 alexa 555 dye: 1
 aldh+: 1
 aldh status: 1
 aldefluor level: 1
 aldefluor assay: 1
 alcohol habits: 1
 albumin level: 1
 albumin: 1
 alalive: 1
 akt/mtor module tertile: 1
 ajcc_stage: 1
 ajcc4: 1
 ajcc2: 1
 ajcc uicc stage: 1
 ajcc: 1
 airn length: 1
 aire locus: 1
 aim2 expression: 1
 ai: 1
 agre id: 1
 agre blood id: 1
 agouti a allele: 1
 agonist/conditions: 1
 agitation speed: 1
 aggressiveness of disease: 1
 aggressive  feather pecking: 1
 aggregation status: 1
 ageyrs: 1
 ageyears/gender: 1
 ageweeks: 1
 agent/stress: 1
 agent/dose: 1
 agent treatment: 1
 agent time: 1
 agent reprogramming factor: 1
 agent post-transduction: 1
 agent during exposure phase: 1
 agent dose during exposure phase: 1
 agent dose (mg/l): 1
 agent compound: 1
 agent (carbon source): 1
 agen: 1
 agegroup: 1
 agedays: 1
 aged week number of individuals: 1
 aged: 1
 agebin: 1
 ageatsampling: 1
 ageatdiagnosis: 1
 ageapprox: 1
 age_tx: 1
 age_enroll: 1
 age_days: 1
 age_at_diagnosis: 1
 age: 17 weeks; mouse ID: 1
 age/size: 1
 age/gender: 1
 age/developmental stage: 1
 age.year: 1
 age.at.operation: 1
 age, yrs: 1
 age x-ray exposure: 1
 age wks: 1
 age wk: 1
 age when treatment starts: 1
 age weight: 1
 age standard deviation: 1
 age stadard error of the mean: 1
 age sacrificed: 1
 age rapamycin exposure: 1
 age post-hatch: 1
 age on study: 1
 age of tissue donor: 1
 age of the mice: 1
 age of the clone: 1
 age of psoriasis onset: 1
 age of plant: 1
 age of patient at diagnosis years: 1
 age of onset of persistent ps aer or censored age: 1
 age of mice wk: 1
 age of mice: 1
 age of ipi yr/mo: 1
 age of ffpe block (years): 1
 age of epilepsy onset yr: 1
 age of epilepsy duration yr: 1
 age of enrollment: 1
 age of embryo: 1
 age of diagnosis (year): 1
 age ms csf: 1
 age mother: 1
 age menopause: 1
 age menarche: 1
 age instar: 1
 age in vitro: 1
 age in months: 1
 age in month: 1
 age in days at diagnosis : 1
 age impairment: 1
 age hours after egg laying: 1
 age days post conception: 1
 age day: 1
 age continuous: 1
 age class at diagnosis infant < 4 yrs: 1
 age class: 1
 age at vaccination: 1
 age at treatment: 1
 age at tissue collection (days): 1
 age at tissue collection: 1
 age at the timeof infection: 1
 age at the end of treatment: 1
 age at surgeryyrs: 1
 age at stroke surgery: 1
 age at start therapy: 1
 age at start of treatment: 1
 age at start of experiment: 1
 age at sacrifice days: 1
 age at sacrafice: 1
 age at rna isolation: 1
 age at rna harvest: 1
 age at rc: 1
 age at ptc operation: 1
 age at operation: 1
 age at infection yrs: 1
 age at ifn-beta therapy onset (baseline blood sampling): 1
 age at ga therapy onset baseline blood sampling: 1
 age at excision years: 1
 age at examination: 1
 age at dx years: 1
 age at diagonosis (years): 1
 age at diagnosisyrs: 1
 age at diagnosis y: 1
 age at diagnosis (y): 1
 age at diagnosis (months): 1
 age at diag: 1
 age at death y: 1
 age at collection: 1
 age at blood withdrawal: 1
 age 1 b: 1
 age (years at surgery): 1
 age (in years): 1
 age (days old): 1
 age (bin): 1
 age (after birth): 1
 ag specificity: 1
 after administration: 1
 after 30 months of treatment): 1
 afpng/ml: 1
 afp_at_baseline ng/ml <400=1, >400=2: 1
 affymetrix id: 1
 affy_batch: 1
 affy chip: 1
 affx-gapdhmur 3'/5': 1
 affx-b-actinmur 3'/5': 1
 affinity selection: 1
 affinity purification using: 1
 affinity purification reagent: 1
 affinity purification: 1
 affinity: 1
 affection: 1
 affected site: 1
 affected gene: 1
 af or sr: 1
 af duration: 1
 aerosol: 1
 aerobic fitness: 1
 aeration condition: 1
 aecc_ali: 1
 adventitious roots length: 1
 advanced disease stage: 1
 adult age: 1
 administration route: 1
 administration method: 1
 administrated reagent: 1
 adjuwant chemotherapy: 1
 adjuvant patient treatment: 1
 adjuvant chemotherapy: 1
 adjuvant: 1
 adj neoadj chemotherapy received: 1
 adipose type: 1
 adipose depot: 1
 adiponectin: 1
 adhesion to plastic: 1
 adenovirus overexpression construct: 1
 adenovirus: 1
 adenoviral vector: 1
 adenoma type: 1
 adenoma: 1
 adenocarcinoma type: 1
 adenocarcinoma permissiveness: 1
 additional processing: 1
 additional information about cells: 1
 addition of methylated compounds: 1
 added gene repressing substance: 1
 adar2 status: 1
 adaptor sequence: 1
 adaptor: 1
 adapted for: 1
 acute/cultured: 1
 acute or recovery: 1
 acute leukemia: 1
 activity state: 1
 activity level: 1
 active state: 1
 active smoking: 1
 active compound: 1
 activator: 1
 activation stimuli: 1
 activation protocol: 1
 activation duration: 1
 activating stimulus: 1
 activated by pha: 1
 acidification treatment: 1
 acetylation level: 1
 acenaphthylene ng/m3: 1
 ace: 1
 accrued radiation dose: 1
 acclimation temperature (celsius): 1
 accessions: 1
 accession/ecotype: 1
 accession number: 1
 accession name: 1
 accession for complete og1rf genome: 1
 ac response: 1
 ac: 1
 abx treatment: 1
 absent: 1
 ability to carry out pigr-mediated endogenous transport of active siga: 1
 abdominalfatg: 1
 abbreviation: 1
 a3243g level of heteroplasmy: 1
 a20 status: 1
 a/t array: 1
 a mutations: 1
 a: 1
 Zeitgeber Time: 1
 Years of Followup after RRP: 1
 XTC.UC1 cells: 1
 Wilkerson_subtype_predicted: 1
 White Blood Cell Count at Diagnosis: 1
 Weiss grade: 1
 Weight range: 1
 Weight of mouse: 1
 Weigh: 1
 Water: 1
 Wash: 1
 WNT (1=WT; 2=Mutation) mutation status: 1
 WHO_status: 1
 WHO: 1
 WBC, 1000/microliter : 1
 Volume: 1
 Viability: 1
 Vehicle: 1
 VHL: 1
 VAP day: 1
 Universal Mouse Reference RNA, cat. No.: 1
 Units of Duration: 1
 Units of Age: 1
 Unit: 1
 UICC: 1
 Twin Pair ID: 1
 TumourSurfaceUlceration: 1
 TumourLocalisation: 1
 TumorStaging: 1
 TumorLocalization: 1
 TumorGrade12: 1
 TumorFreeSurvival_months: 1
 Tumor::Size from surgery: 1
 Tumor stage: 1
 Tumor size: 1
 Tumor site: 1
 Tumor Prop: 1
 Tumor Liver from Patient 3 of Acevedo et al., 2008 (PMID: 1
 Tumor Liver from Patient 1 of Acevedo et al., 2008 (PMID: 1
 True_Label; 0 = good; 1 = poor: 1
 TreatmentTime: 1
 Treatment: Corn Oil vehicleFeed: 1
 Transplants: 1
 Transplant: 1
 Transgene: 1
 Transfection: 1
 Transcriptome Cluster: 1
 TranscriptionallyActiveHumanPapillomavirusInTumor: 1
 TransEpithelialElectricalResistance: 1
 Training.Test: 1
 Training or Validation: 1
 Trained or Immobilized: 1
 Total_Flesh_Lipid: 1
 TotalNodes: 1
 TotalExposureTime: 1
 Total body Z-score: 1
 Total body (g/cm2): 1
 Total Hip Z-score: 1
 Total Hip T-score: 1
 Total Hip (g/cm2): 1
 Total Body Surface Are Burned: 1
 Tobacco Use: 1
 Tobacco Smoking: 1
 Tissure: 1
 Tissue estradiol conc.: 1
 Tissue Harvest Methods: 1
 Tissue & Age: 1
 Tissue : 1
 TimeToMetastasis: 1
 TimeToMetastas: 1
 TimeOfSurvival: 1
 Time since Metastasis: 1
 Time since Diagnosis: 1
 Time (yrs) from RRP to second rising PSA: 1
 Time (yrs) from RRP to first rising PSA: 1
 Time (yrs) from PSA recurrence to systemic disease: 1
 Thermocycle: 1
 TestSubstance2: 1
 TestSubstance1: 1
 TestResult_TripleNegative: 1
 TestResult_PR: 1
 TestResult_Her2: 1
 TestResult_ER: 1
 TestResult_ACR: 1
 TestResult6: 1
 TestResult5: 1
 TestResult4: 1
 TestResult3: 1
 TestResult2: 1
 Test:cell viability LDH absorbance: 1
 Test:cell viability GUAVA via count: 1
 TemperatureUnit: 1
 Temperature (C): 1
 Technical replication #: 1
 Technical repl: 1
 TargetedType: 1
 TREATMENT LINE: 1
 TREATMENT LENGTH: 1
 TP53mut: 1
 TP53 Gene mutation Status: 1
 TP53 Gene mutation Protein: 1
 TP53 Gene mutation Functional consequence: 1
 TP53 Gene mutation Exon number: 1
 TP53 Gene mutation DNA: 1
 TP53 DELETION: 1
 TNM::N: 1
 TNM status: 1
 TN status: 1
 TISSUE: 1
 TEL-AML,t(12;21) : 1
 T: 1
 SurvivalProbability: 1
 SurvivalAfterTwoYears: 1
 Survival.Status: 1
 Survival (days): 1
 Survival: 1
 Surv: 1
 Surgery Type: 1
 Surgery Performed: 1
 Surgery Date: 1
 SupernatantTotalExposureDuration: 1
 SupernatantTestSubstanceConcentration: 1
 SupernatantExposureType: 1
 SupernatantExposureFrequency: 1
 SupernatantExposureDuration: 1
 SupernatantCellTreatmentSubstance: 1
 SupernatantCellLine: 1
 Supercontrol: 1
 Subtype: 1
 Subspecies: 1
 Subsite: 1
 Subject_ID: 1
 Subject ID: 1
 Subject: 1
 Subiste: 1
 StrainorLine: 1
 StrainOrline: 1
 Strain: Han/WistarAge: 1
 Strain or Line: 1
 Strain info: 1
 Strain background: 1
 Strain TW14: 1
 Strain Name : common reference: 1
 Strain H37dosR mutant Condition: 1
 Strain H37Rv Condition: 1
 Strain BY4741-ume6: 1
 Strain BY4741-rpd3: 1
 Strain BY4741-rco1: 1
 Strain BY4741-pho23: 1
 Strain BY4741-msn2: 1
 Strain BY4741 ptc1: 1
 Storage: 1
 Stimulus: 1
 Status at follow up: 1
 Status after 3 years: 1
 StainOrLine: 1
 Stage : 1
 Stable tetracycline-inducible HEK293 cell Lines that express amino-terminal V5-tagged wild-type (amino acids 2-431) or mutant (amino acids 2-334, lacking the forkhead domain) FOXP3 in response to tetracycline as previously described in J Immunol 177: 1
 SputumWeight: 1
 SpinalCordInjury: 1
 Specimen ID: 1
 Species: 1
 SourceOfVesicles: 1
 Sorting: 1
 Soil type: 1
 Soil mix: 1
 SmokingRegimenPhase2: 1
 SmokingRegimenPhase1: 1
 SmokingRegimen2: 1
 SmokingRegimen1: 1
 Smoking (BI): 1
 SmokeType: 1
 Site of relapse: 1
 SiliqueAge: 1
 Signature Score: 1
 Sigma Aldrich: 1
 Shigella flexneri 2a str. 2457T: 1
 Shear exposure: 1
 Sexed: 1
 Sex of recipient mice: 1
 Sex of donor mice: 1
 Set: 1
 Serotype: 1
 Series Sort Key: 1
 SeqTechnique: 1
 SeedStockID: 1
 See: 1
 SecondTreatmentExposureType: 1
 SecondDose: 1
 SecondCompound: 1
 Second site: 1
 SamplingTimeAfterLesion: 1
 SamplingSi: 1
 SamplingMethod: 1
 SamplingAfterExposure: 1
 Sampling: 1
 Sample_Block: 1
 SampleTimePoint: 1
 SampleSource: 1
 Sample time: 1
 Sample stage: 1
 Sample size: 1
 Sample origin: 1
 Sample name: 1
 Sample Preservation: 1
 Sall4: 1
 Sacrifice Method: 1
 ST52 (H37Rv ideR: 1
 ST22 (H37Rv ideR: 1
 SPECIES: 1
 SOURCE POP: 1
 SMA_Positive_CAF: 1
 SL2 Cell line, for more detail see Rehwinkel et al. (2005) RNA, PMID: 1
 SK-Mel-103 treated with 1ug/ml of polyinosine-polycytidylic acid with polyethyleneimine Age: 1
 SK-Mel-103 treated with 1ug/ml of polyinosine-polycytidylic acid Age: 1
 SK-Mel-103 Time: 1
 SIV status: 1
 SISP test: 1
 SCC Histology: 1
 SAMPLE_ONTOLOGY_URI: 1
 S. tuberosum Cultivar: 1
 S: 1
 RiskStatus: 1
 Rezidiv: 1
 Revised Gleason Score: 1
 Retinas from CD1 mice were electroporated at P0 with pSynapsin: 1
 Retinas from CD1 mice were electroporated at P0 with pNdrg4: 1
 Retinas from CD1 mice were electroporated at E16 with pSynapsin: 1
 ResponseToDrugTreatment: 1
 ResponseTo5-FU/irinotecanTreatment: 1
 Response.to.treatment: 1
 Rep: 1
 Relaspe-Free Survival In Month: 1
 Relaspe-Free Survival Event: 1
 Relapse::Metastatic Serous membrane delay months: 1
 Relapse: Metastatic delay: 1
 Relapse: Metastatic Skin delay months: 1
 Relapse: Metastatic Skin: 1
 Relapse: Metastatic Serous membrane: 1
 Relapse: Metastatic Lymph nodes Distant delay months: 1
 Relapse: Metastatic Lymph node Distant: 1
 Relapse: Metastatic Lung delay months: 1
 Relapse: Metastatic Lung: 1
 Relapse: Metastatic Liver delay months: 1
 Relapse: Metastatic Liver: 1
 Relapse: Metastatic Central Nervous System delay months: 1
 Relapse: Metastatic Bone delay(month): 1
 Relapse: Metastasis Date: 1
 Relapse: Metastasis Central Nervous System: 1
 Relapse: Metastasis Bone: 1
 Relapse: Metastasis: 1
 Relapse-Free Survival Status: 1
 Relapse-Free Survival: 1
 Relapse: 1
 Redo: 1
 RectumOrColon: 1
 Recipients: 1
 RecidiveFreeSurvival: 1
 Reb1: 1
 Rattus_norvegicus: 1
 Ratio: 1
 Radiotherapy_Performed: 1
 Radiotherapy Neoadjuvant Performed: 1
 Radiotherapy Adjuvant Performed: 1
 Radiotherapy Adjuvant Date Start: 1
 Radiotherapy: 1
 Radiation: 1
 RSV mono infection: 1
 RNAi name: 1
 RNAi mutant: 1
 RNAi knockdown of Upf2, extracted at day 8 after a re-knockdown at day 4, as described in Rehwinkel et al. (2005) RNA, PMID: 1
 RNAi knockdown of Upf1, extracted at day 8 after a re-knockdown at day 4, as described in Rehwinkel et al. (2005) RNA, PMID: 1
 RNA_source_key: 1
 RNA_quality: 1
 RNAIntegrityNumber: 1
 RNA source: 1
 RNA pool; female, age: 1
 RNA intereference: 1
 RNA from unaffected colon biopsies. Patients clinical characteristics: 1
 RNA from unaffected colon biopsies. Patients clinical characterisitics: 1
 RNA from unaffected colon biopsies. Patients characteristics: 1
 RNA from unaffected colon biopsies.  Patients clinical characteristics: 1
 RNA concentration: 1
 RITUXIMAB: 1
 RIP antibody: 1
 RCC cell line type: 1
 RB1 DELETION: 1
 RAF (1=WT; 2=Mutation) mutation status: 1
 Quality__Scaling_Factor_Dev.: 1
 Quality__Scaling_Factor: 1
 Quality__Outlier_Area_(%): 1
 Quality__Gradient_Severity: 1
 Quality__Distortion_Severity: 1
 Quality__Defective_Area_(%): 1
 Quality__Classification: 1
 Quality__Background_Mean_Dev.: 1
 Quality__Absent_(%)_Dev.: 1
 Quality__Absent_(%): 1
 Quality__3'/5'_Mean: 1
 Quality metric=28S to 18: 1
 Provider_contact_mid_initials: 1
 Prostate cancer specific death: 1
 Progress: 1
 PrognosticSubgroup: 1
 Prognosis on survival data: 1
 Prognosis on neuroradiological data: 1
 ProgesteroneReceptorStatus: 1
 Progesterone Receptor status: 1
 Progesterone Receptor : 1
 Procedure: 1
 Proc Natl Acad Sci U S A 97: 1
 PrimaryTumorStaging: 1
 Primary Sjogren's syndrome diagnosis: 1
 Preservation: 1
 Presenting symptoms: 1
 Posttraumatic course: 1
 PostExposureDuration: 1
 Post-culture sort: 1
 Post Surgical Treatment: 1
 Post Mortem Interval: 1
 Post Burn Day: 1
 Position in Figure 2 (L to R): 1
 Position in Figure 1 (L to R): 1
 Pooled sample: 1
 Pooled from Multiple Samples: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 4d from replicate beaker C. Age: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 4d from replicate beaker B. Age: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 4d from replicate beaker A. Age: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 2d from replicate beaker C. Age: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 2d from replicate beaker B. Age: 1
 Pool of 6 whole body fish exposed to lead (Pb) for 2d from replicate beaker A. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 30d from replicate beaker C. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 30d from replicate beaker B. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 30d from replicate beaker A. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 10d from replicate beaker C. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 10d from replicate beaker B. Age: 1
 Pool of 4 whole body fish exposed to lead (Pb) for 10d from replicate beaker A. Age: 1
 Polyploid level: 1
 Polyp type: 1
 Plate: 1
 Planting location: 1
 Plant protection: 1
 Pig tissue: 1
 Pig age: 1
 PhysicalCharacteristics: 1
 PhysicalCharacteristi: 1
 Physical Capacity standard deviation: 1
 Physical Capacity group: 1
 Physcial Capacity continuous: 1
 Phenotype - TP53: Gene mutation: Status: 1
 Phenotype - PTEN::Gene mutation::Status: 1
 Phenotype - PTEN::Gene mutation::Protein: 1
 Phenotype - PTEN::Gene mutation::Functionnal consequence: 1
 Phenotype - PTEN::Gene mutation::DNA: 1
 Phenotype - PTEN::Gene mutation::Chromosome: 1
 Phase: 1
 PersonalHistory: 1
 PeriodicOrder: 1
 PeriodTillDevelopmentOfDistantMetastases(years): 1
 PerineuralSpreading: 1
 PerineuralSpread: 1
 Perineural Invasion: 1
 Periendoalveolar: 1
 PatientID: 1
 Patient.id: 1
 Patient pair: 1
 Patient identifyier: 1
 Patient code: 1
 Patient age at diagnosis: 1
 Pathological State: 1
 Part of Organism: 1
 Parity status: 1
 Parity: 1
 Papillomas: 1
 Palpable: 1
 PRAME: 1
 PR status: 1
 POOL_ID: 1
 PO: 1
 PMID: 1
 PMI: 1
 PMD 7: 1
 PMD 28: 1
 PMD 20: 1
 PMD 2: 1
 PMD 15: 1
 PMD 0: 1
 PLOIDY STATUS: 1
 PLASMA CELL INFILTRATION: 1
 PI fluorescence: 1
 PHENOTYPE: 1
 PGR: Protein expression: 1
 PAT cells culture time: 1
 P53 (1=WT; 2=Mutation) mutation status: 1
 P46: 1
 OverallSurvival_months: 1
 Overall survival (years): 1
 Overall Survival Event: 1
 Overall Survival (months): 1
 Overall Survival: 1
 Other_TEP: 1
 Other_T: 1
 Original_GeneChip_Type: 1
 Organism_part: 1
 OrganismPartDatabase: 1
 OrganismPart : 1
 Optical Density (OD600) at Harvest: 1
 OperatorVariation: 1
 OVERALL SURVIVAL FROM DIAGNOSIS: 1
 OS_delay: 1
 OS event: 1
 OS delay: 1
 ORGANISM_PART: 1
 OD600: 1
 OD: 1
 NumberOfIndividuals: 1
 Number of plants harvested: 1
 Normal Liver from Patient 3 of Acevedo et al., 2008 (PMID: 1
 Normal Liver from Patient 1 of Acevedo et al., 2008 (PMID: 1
 Normal Liver (not cancer-related) from Patient 4 of Acevedo et al., 2008 (PMID: 1
 NodesPositive: 1
 Node: 1
 Night duration: 1
 Neoadjuvant radiation: 1
 Necrosis: 1
 NasalScrapesWeight: 1
 NPI: 1
 NF2 mutation: 1
 NED_or_failed: 1
 NCBI Taxonomy ID: 1
 NB_th44: 1
 NB_th26: 1
 NB_th24: 1
 NB_th22: 1
 NB_th10: 1
 NB2004 risk group: 1
 N stage: 1
 N Stage: 1
 N: 1
 Myo-inositol treatment: 1
 Mutation: 1
 Mutant: 1
 Muscle type: 1
 Mus musculus strain type: 1
 Multiple sample ID: 1
 Mouse type: 1
 Mouse strain: 1
 Mouse model: 1
 Mouse ID: 1
 Mortality of group at the end of experiment: 1
 Mortality of group at day 2: 1
 Mortality of group at day 1: 1
 Morphology: 1
 Morphologic.diagnosis: 1
 Molecular.Diagnosis: 1
 Mix: 1
 Metastatic stage: 1
 MetastasisFreeSurvivalEvent: 1
 MetastasisFreeSurvivalDelay: 1
 MetastasisDuringFollowUpPeriod: 1
 Metastasis: 1
 MenopausalStatus: 1
 Medication at interview duration: 1
 Medication at blood sampling: 1
 Medication: 1
 Mecp2 genotype: 1
 Mean weight: 1
 Mean neck Z-score: 1
 Mean neck (g/cm2): 1
 Maturation: 1
 Mating type: 1
 Maternal diet group: 1
 Material was derived from inflorescences of synchronized 35S: 1
 Material Type: 1
 Marterial : 1
 Marterial: 1
 Makino, A., Mae, T., and Ohira, K. (1983). Photosynthesis and Ribulose 1,5-Bisphosphate Carboxylase in Rice Leaves: 1
 Maize line: 1
 MYC.Partner: 1
 MOLECULE: 1
 MMR (1=WT; 2=Mutation) mutation status: 1
 MLL : 1
 MARKERS: 1
 M: 1
 LymphNodesRemoved: 1
 LymphNodesInvaded: 1
 LymphNodeStaging: 1
 LymphNode: 1
 Lymph node involvement: 1
 Lung: 1
 Location: 1
 Localized prostate tumor, Gleason sum: 1
 Localization: 1
 Local recurrence: 1
 Litter: 1
 Light sources: 1
 Lesions: 1
 LabelingCondition: 1
 LabeledExtractedMaterial: 1
 Label; 0 = good; 1 = poor: 1
 Label : 1
 LOKALISATION: 1
 LNA number: 1
 LIBRARY_STRAND: 1
 L2-L4 Z-score: 1
 L2-L4 (g/cm2): 1
 L1 Z-score: 1
 L1 (g/cm2): 1
 Kidney isolated from wild type and Lmx1b conventional knock-out newborn mice (Rohr et al. 2002. J Clin Invest 109: 1
 Ki67 data: 1
 Ki.67.score: 1
 KRAS status: 1
 KPS: 1
 K-ras Status: 1
 Irradiation: 1
 Irradiate: 1
 Invasion: 1
 Intervention: 1
 Internal identifier number: 1
 Input regime: 1
 InnocuationSite: 1
 Injection: 1
 InitialTreatmentTime: 1
 InitialTreatmentExposureType: 1
 InitialTimePopint: 1
 InitialTime Point: 1
 InitialDose: 1
 InitialCompond: 1
 Infiltration: 1
 Infection_control time: 1
 Infection time: 1
 IndividualGeneticCharacteristi: 1
 IncubationTime: 1
 Incubate: 1
 Immunopreciate: 1
 Immunocytochemistry: 1
 Image File: 1
 IgVH: 1
 IVP/SCNT#: 1
 ISS STAGE: 1
 IRS_TNM_Stage: 1
 IGVH status: 1
 IGH.BCL2.Fusion: 1
 Humidity: 1
 Human peripheral blood mononuclear cells (PBMC) were enriched on the 12 october 2007 (donor: 1
 Human pancreatic carcinoma, epithelial-like cell line, Gender: 1
 Huh7 cell line: 1
 Hsd: 1
 HoursAfterOviposition: 1
 HoursAfterEggLaying: 1
 HostColony: 1
 HospitalAdmission: 1
 Hormone: 1
 Hormo: 1
 Histology_: 1
 Histology::Type: 1
 Histology::Subtype: 1
 Histology2: 1
 Histology type: 1
 Histological type: 1
 Histological subtype: 1
 Histologic grade: 1
 Histlogical Type: 1
 Her2 status: 1
 Height: 1
 Hdh genotype: 1
 Harvested tissue type: 1
 Harvest time(hours after daybreak): 1
 Haplotype: 1
 Hal genotype: 1
 HaCaT Cell line, Gender: male, Tissue: 1
 HYB DATE: 1
 HPV: 1
 HNF1-alpha status: 1
 HIV infection: 1
 HISTOLOGY: 1
 HIF: 1
 HBS-Ag: 1
 GrowthPhase: 1
 Growth temperature: 1
 Growth phase: 1
 Growth medium: 1
 Growth conditions: 1
 Growth Temperature: 1
 Growth Rate: 1
 Growth Medium: 1
 Growth Condition: 1
 Growth: 1
 Grading: 1
 Grade::Scarff Bloom Richardson: 1
 Grade: Scarff Bloom Richardson: 1
 Gingival tissue phenotype: 1
 Gestational Age: 1
 GeographicParameter: 1
 Genotype : 1
 Genome: 1
 GeneticModifications: 1
 Genetic.Group: 1
 Genetic Modifications: 1
 Genetic: 1
 Generalization 6 on reduced data: 1
 GeneMutated: 1
 GeneChip_Assay_Site: 1
 Gefitinib treatment: 1
 Galectin_3_abundance_in_CAF: 1
 Galectin_1_abundance_in_CAF: 1
 GR inducible system using transgenic Arabidopsis carrying pGL3: 1
 GR inducible system using transgenic Arabidopsis carrying pGL1: 1
 GFP fluorescence: 1
 GCB.ABC.signature: 1
 Freeze_Media: 1
 FollowupTime..months.: 1
 Follow Up: 1
 Follicle Size: 1
 Fish strain: 1
 Fish Mass: 1
 FinalOrder: 1
 Final disposition: 1
 Fertilizer: 1
 FertilityStatus: 1
 Feeding condition: 1
 Feeder cells: 1
 Feed: 1
 FastingPlasmaGlucoseLevel: 1
 Family::Second-degree::Cancer: 1
 Family::Other cancer::Number: 1
 Family::First-degree::Cancer: 1
 Family::Breast cancer::Number: 1
 Family::Breast cancer::Age: 1
 Family History status: 1
 FUSION: 1
 FISHer grade: 1
 FISH-all: 1
 FISH wet weight g: 1
 FISH identifier: 1
 FISH group: 1
 FISH (trisomy 12): 1
 FISH (no del 13q14, no del 11q22-23, no del 17p13, no trisomy 12): 1
 FISH (del 17p13): 1
 FISH (del 13q14): 1
 FISH (del 13q14 single): 1
 FISH (del 11q22-23): 1
 FHC gene expression: 1
 FEV1 % predicted: 1
 FEV1 % baseline: 1
 FALIndex: 1
 FAB grading: 1
 Extraction_concentration: 1
 ExtracapsularSpreading: 1
 ExtracapsularSpread: 1
 Expt id of fish pooled: 1
 Expression profile-based classification: 1
 Experimental treatment: 1
 Experimental conditions: 1
 Experimental condition: 1
 Evidence of relapse: 1
 EventDistantMetastases: 1
 EventDeath: 1
 Ethnic background: 1
 Ethnic Origin: 1
 Estrogen Receptor : 1
 ErbB2 positive (IHC): 1
 EnvironmentalHistory | Time of day at Sacrifice (AM or PM): 1
 EnvironmentalHistory | Time between Dosing and Sacrifice | Unit:hrs: 1
 EnvironmentalHistory | Sacrifice Method: 1
 EnvironmentalHistory | Fasting before Sacrifice: 1
 EnvironmentalHistory | Elapsed Time between Blood Collection and Sacrifice | Unit:weeks: 1
 EnvironmentalHistory | Dose Volume | Unit:ml/kg: 1
 EnvironmentalHistory | Dose Administration Frequency | Unit:Count: 1
 EnvironmentalHistory | Dose Administration Duration | Unit:days: 1
 EnvironmentalHistory | Diet Availability: 1
 EnvironmentalHistory | Blood Collection before Sacrifice: 1
 EnvironmentalHistory | Acclimatization: 1
 Enterohaemorrhagic E. coli O157: 1
 Endoalveolar Tumor: 1
 EmbryonicTemperature: 1
 Embryo stage: 1
 EctopicGeneExpression: 1
 EVI1 overexpression: 1
 ESR1: Protein expression: 1
 ERBB2: Protein expression: 1
 ER status: 1
 ER (H score) system: 1
 EGFR status: 1
 E2A-PBX, t(1;19) : 1
 Dx: 1
 Dukes stage: 1
 Drug: 1
 Dosage: 1
 Do: 1
 DistantMetastasis-Free Survival: 1
 Distant metastasis: 1
 Disorder: 1
 Disease_status: 1
 Disease_factor: 1
 DiseaseStateDatabase: 1
 DiseaseSta: 1
 DiseaseRecurrence: 1
 DiseaseFreeInterval: 1
 DiseaseFreeAfterTwoYears: 1
 DiseaseFactor: 1
 Disease-Free Survival Status: 1
 Disease Subtype: 1
 DifferentiationState: 1
 DifferentiationGrade: 1
 Died: 1
 Diagnosis made by: 1
 Diagnosis Date: 1
 DevlopmentalStage: 1
 DevelpomentalStage: 1
 Developmental stage at harvest: 1
 Developmental State: 1
 DevelopmentStage: 1
 Development temperature: 1
 Derived from Actinosynnema pretiosum (ATCC: 1
 Dependency::Same Family: 1
 DeliveryMethod: 1
 Delay:Overall_Survival months: 1
 Delay:Metastasis_Free_Survival months: 1
 Degree of differentiation: 1
 Death status: 1
 Death: 1
 Dead: 1
 Days from patient diagnosis to excison: 1
 Days: 1
 Day sampled: 1
 Day light regime: 1
 Day 7 Minimal Residual Disease: 1
 Day 28 Minimal Residual Disease: 1
 Day 14 Minimal Residual Disease: 1
 DateFoundDead: 1
 Date planted: 1
 DataSource: 1
 DailyExposureTime: 1
 DSS status: 1
 DOSE2: 1
 DOSE1: 1
 DONOR_SEX: 1
 DONOR_AGE: 1
 DNA CHIP2 ID: 1
 DISEASE_ONTOLOGY_URI: 1
 DISEASE STATE: 1
 DELETION: 1
 DEATH RELATED TO DISEASE: 1
 Cytogenetics_lesions: 1
 Cycle: 1
 CultureTime: 1
 CultureTemperature: 1
 Culture medium: 1
 Cultivation: 1
 Country of origin: 1
 Country: 1
 ConcentrationUnitOther: 1
 ConcentrationEntity: 1
 Concentration of injection: 1
 Component: 1
 ComplexActi: 1
 Common name: 1
 Colony: 1
 ColonoscopyTimePoint: 1
 Collection Day: 1
 Code+F1: 1
 Clone: 1
 Clinicalinformation: 1
 ClinicalTreatment7: 1
 ClinicalTreatment-Third recurrence treatment: 1
 ClinicalTreatment-Second recurrence treatment: 1
 ClinicalTreatment-Initial treatment: 1
 ClinicalTreatment-First recurrence treatment: 1
 ClinicalStage: 1
 ClinicalInformation_: 1
 ClinicalInformation:survival time: 1
 ClinicalInformation:latest news date: 1
 ClinicalInformation:lastest news status: 1
 ClinicalInformation:White Blood Cell Count at Diagnosis: 1
 ClinicalInformation:Specimen Type: 1
 ClinicalInformation:ResistantResponsivePercentageNecrosis: 1
 ClinicalInformation:Relapse-Free Survival: 1
 ClinicalInformation:Relapse Status: 1
 ClinicalInformation:Paired Specimen: 1
 ClinicalInformation:Metastasis: 1
 ClinicalInformation:KRAS_Exon_3_CDS_Mutation: 1
 ClinicalInformation:KRAS_Exon_3_AA_Mutation: 1
 ClinicalInformation:KRAS_Exon_2_CDS_Mutation: 1
 ClinicalInformation:KRAS_Exon_2_AA_Mutation: 1
 ClinicalInformation:HistologyNumlot: 1
 ClinicalInformation:Event: 1
 ClinicalInformation:End of Induction MRD: 1
 ClinicalInformation:EGFR_Exon_21_CDS_Mutation: 1
 ClinicalInformation:EGFR_Exon_21_AA_Mutation: 1
 ClinicalInformation:EGFR_Exon_20_CDS_Mutation: 1
 ClinicalInformation:EGFR_Exon_20_AA_Mutation: 1
 ClinicalInformation:EGFR_Exon_19_CDS_Mutation: 1
 ClinicalInformation:EGFR_Exon_19_AA_Mutation: 1
 ClinicalInformation:EGFR_Exon_18_CDS_Mutation: 1
 ClinicalInformation:EGFR_Exon_18_AA_Mutation: 1
 ClinicalInformation:Disease subtype: 1
 ClinicalInformation:Diagnosis: 1
 ClinicalInformation:Day 7 MRD: 1
 ClinicalInformation:Day 14 MRD: 1
 ClinicalInformation:Chemoresistant: 1
 ClinicalInformation:Age at Diagnosis: 1
 ClinicalInformation:Adjuvant_Chemotherapy: 1
 ClinicalInformation: date of surgery: 1
 ClinicalInformation: TNM staging: 1
 ClinicalInformation: Premortem non-fasting glycemia: 1
 ClinicalInformation: Premortem diagnosis of diabetes: 1
 ClinicalInformation-TZDTreatment: 1
 ClinicalInformation-TCellReceptorType: 1
 ClinicalInformation-ResponseToTZDTreatment: 1
 ClinicalInformation-Responder: 1
 ClinicalInformation-Progression: 1
 ClinicalInformation-PercentTumoralTCells: 1
 ClinicalInformation-MaterialType: 1
 ClinicalInformation-InsulinResistance: 1
 ClinicalInformation-ClampStatus: 1
 ClinicalInformation-Best response: 1
 ClinicalHistory9: 1
 ClinicalHistory8: 1
 ClinicalHistory10: 1
 ClinicalHistory-biopsytime: 1
 ClinicalGroup: 1
 Clinical information: 1
 Clinical Status: 1
 ClarkStage: 1
 ChromosomalAbnormality: 1
 ChromosomalAberrationClassificati: 1
 Chromosomal.Complexity.Score: 1
 Chemotherapy_Performed: 1
 Chemotherapy Neoadjuvant Type: 1
 Chemotherapy Neoadjuvant Performed: 1
 Chemotherapy Adjuvant Type: 1
 Chemotherapy Adjuvant Performed: 1
 Chemotherapy: 1
 Chemo: 1
 Characteristics: 1
 ChanceMortalityIn_10_years: 1
 ChanceAliveIn_10_years: 1
 ChIPAntibody: 1
 ChIP-seq antibody: 1
 Celltype: 1
 Cells were cultured in media (HT29: 1
 Cells used: 1
 Cell_type: 1
 CellTypet: 1
 CellType <3>: 1
 CellType <2>: 1
 CellType <1>: 1
 CellSubType: 1
 CellProperty: 1
 CellMassMorphology: 1
 CellLineage: 1
 CellLineDatabase: 1
 CellLine <6>: 1
 CellLine <5>: 1
 CellLine <4>: 1
 CellLine <3>: 1
 CellLine <2>: 1
 CellLine <1>: 1
 Cell-type: 1
 Cell strain: 1
 Cell 117: 1
 Cell: 1
 Cat Nr: 1
 Caste: 1
 Case-Control Group: 1
 Cardiac weight index: 1
 Carbon source: 1
 CancerSiteCoarse: 1
 CancerDiseaseState: 1
 Cancer: 1
 COPD: 1
 COMPOUND2: 1
 COMPOUND1: 1
 COMPOUND: 1
 COGClassifier: 1
 CNS status : 1
 CLUSTER SUBGROUP: 1
 CIT_subtype_predicted: 1
 CIT_molecular_cluster: 1
 CIT classification: 1
 CHROMOSOMAL ABBERATION 2: 1
 CHROMOSOMAL ABBERATION 1: 1
 CHIP #: 1
 CELL_TYPE: 1
 CDKN2B mutation: 1
 CDKN2A mutation: 1
 CD5.expr.: 1
 CD20.expr.: 1
 CD10.expr.: 1
 CADi: 1
 C57BL6/NCr: 1
 C3H.pde6b-, male, heart, RNA pool including Mouse ID: 1
 C3H.pde6b-, male, eye, RNA pool including Mouse ID: 1
 C3H.pde6b-, male, brain, RNA pool including Mouse ID: 1
 C3 (C3H/HeJ) mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 C-source: 1
 Breslow thickness: 1
 Breast biopsy diagnosis: 1
 Brain_Region: 1
 Bos taurus, beef cattle, female, age 4-7 years: 1
 Bone marrow cells from CX3CR1+/gfp C57BL/6 mice were sorted as follows: 1
 BodyWeightStart(g): 1
 BodyWeightEnd(g): 1
 Body weight: 1
 Blood/NonBlood meta-groups: 1
 Blood: 1
 Biosource type: 1
 Biosource Provider: 1
 BiopsySite: 1
 BiopsySi: 1
 Biopsy Technique: 1
 Biopsy: 1
 Biomaterial: 1
 BiologicalRepeat: 1
 Biological replication #: 1
 Biological replicate: 1
 Biological Replicate: 1
 Biological Repl: 1
 Bioanalyzer Results: 1
 BioSour: 1
 BioMaterialType: 1
 BioMaterialTy: 1
 BioMaterialPurity: 1
 Behavi: 1
 Baermann_time&temp: 1
 BaermannTemperature: 1
 Bacteria: 1
 Background: 1
 BXHF1 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH9 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH8 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH7 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH6 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH4 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH2 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH19 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH14 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BXH10 mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 BT474 human breast cancer cells (Organ: 1
 BMI standard error of the mean: 1
 BMI standard deviation: 1
 BMI group: 1
 BMI continuous: 1
 BL.probability: 1
 BIOMATERIAL_TYPE: 1
 BIOMATERIAL_PROVIDER: 1
 BER (1=WT; 2=Mutation) mutation status: 1
 BEADCHIP POSITION: 1
 BEADCHIP BARCODE: 1
 BCR-ABL, t(9;22) : 1
 BCLC_staging: 1
 BCL6.Break: 1
 BAP1 mutation: 1
 BAC features: 1
 B6 (C57BL/6J) mouse strain (Jackson Lab)  gender- male, age- 8 weeks, n = 1, # of tissue = 1 tissue: 1
 B.Symptoms: 1
 Average temperature (C): 1
 Average spine T-score: 1
 Average neck T-score: 1
 Atmosphere: 1
 ArrayBatch: 1
 Array Type: 1
 Array: 1
 Arabidopsis thaliana landsberg erecta yes - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana landsberg erecta  - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant mpk4 - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant mkk6 - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant mekk1 - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant Vip1D - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant Vip1 - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana columbia  mutant NII: 1
 Arabidopsis thaliana columbia  mutant 14-5sep - harvest date: 1
 Arabidopsis thaliana col-0  mutant bos1 - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana col-0  mutant AT5G46800 = BOU A BOUT DE SOUFFLE  - dev.stage Boyes et al. Plant Cell 2001: 1
 Arabidopsis thaliana (wassilewskija)  mutant (TTT632.7) - harvest date: 1
 Arabidopsis thaliana (landsberg erecta)  mutant (spl1-1) - harvest date: 1
 Arabidopsis thaliana (landsberg erecta)  mutant (ga1-3) - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana (landsberg erecta)  mutant (ga1-3 gai-t6 rga-t2rgl1-1 rgl2-1) - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana (landsberg erecta)  mutant (crc1) - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana (landsberg erecta)  - harvest date: 1
 Arabidopsis thaliana (columbia)  mutant (overexpression_of_MYB77_fragment) - harvest date: 1
 Arabidopsis thaliana (columbia)  mutant (Met2_16A1) - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana (columbia)  mutant (KO_MYB77_gene) - harvest date: 1
 Arabidopsis thaliana (columbia)  mutant (DRN) - age: 1
 Arabidopsis thaliana (columbia)  mutant (Col0: 1
 Arabidopsis thaliana (col-0)  mutant (pER8: 1
 Arabidopsis thaliana (col-0)  mutant (gdh1-2-3-) - age: 1
 Arabidopsis thaliana (col-0)  mutant (at5g58954-) - harvest date: 1
 Arabidopsis thaliana (col-0)  mutant (at5g58951-) - harvest date: 1
 Arabidopsis thaliana (col-0)  mutant (Atlpp2.2 -/-) - age: 1
 Arabidopsis thaliana (col-0)  mutant (517104.9) - harvest date: 1
 Arabidopsis thaliana (cape verde islands)  - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana ( bologna-1 )  - dev.stage (Boyes et al. Plant Cell 2001): 1
 Arabidopsis thaliana  c24   mutant fry2-1 - harvest date: 1
 Arabidopsis thaliana  c24   mutant RD29A: 1
 Anti-CD8 Treatment: 1
 Annotation: 1
 AnnArbor.Stage: 1
 Animals express a dkf-2: 1
 Animal model: 1
 Angioinvasion: 1
 AngioInvasion: 1
 Anesthesia: 1
 Ancestry: 1
 Allele: 1
 Agent: 1
 AgeStatus: 1
 AgeAtDiagnosis: 1
 Age(h): 1
 Age(days): 1
 Age in 1986: 1
 Age at harvest: 1
 Age at first birth: 1
 Age at diagnosis: 1
 Age at Diagnosis: 1
 Age At Diagnosis: 1
 Age (yrs) at RRP: 1
 AgaroseMigrationTtime: 1
 AgaroseMigrationTemperature: 1
 AdultAcclimationTemperature: 1
 Acute trained: 1
 Acronym: 1
 ATCC number: 1
 ATCC: 1
 ASXL1: 1
 ASO sequence: 1
 ARN_quality: 1
 APC (1=WT; 2=Mutation; NA=Not available) mutation status: 1
 AML status: 1
 AML class: 1
 AFP: 1
 ADMINISTRATION: 1
 ACR score at 14 weeks after first infliximab injection: 1
 99(3): 1
 9 bp spacer and 10 bp barcode: 1
 8_week_disease control_1yes_0no: 1
 6xhis immunoprecipitation: 1
 67(1): 1
 6 whole body control fish from each of 3 replicate beakers (A, B, & C).  Age: 1
 6 month weight change: 1
 5q loh: 1
 50hpf: 1
 5-azacytidine status: 1
 5-Bisphosphate Carboxylase in Rice Leaves: 1
 5' end dependence: 1
 5' adaptor: 1
 4t1 tumor bearing: 1
 4su labeling time: 1
 4f: 1
 4c protocol: 1
 4-thiouracil labeling time: 1
 4-thiouracil addition?: 1
 4-thiouracil addition: 1
 4-thio utp labeling: 1
 4-stage iv): 1
 4 whole body control fish from each of 3 replicate beakers (A, B, & C).  Age: 1
 4 meta-groups: 1
 3prime adaptor: 1
 3g of seed presented 8 hours after lights on in a 14:10 light: 1
 3KO: 1
 3: G3): 1
 369 groups: 1
 30 d growth after expansion: 1
 3): 1
 3'-adaptor: 1
 3' linker: 1
 3' barcode nebnext primers: 1
 3' adapter: 1
 2nd troponin: 1
 2: core needle): 1
 2: >1cm): 1
 28s/18s: 1
 28 days outcome: 1
 260/280: 1
 260/230: 1
 24h stimulation: 1
 21usensor: 1
 2-female): 1
 2): 1
 2 hour glucose (ogtt): 1
 1q21 gain: 1
 1p/19q co-deletion: 1
 1oph: 1
 1: positive): 1
 167(2): 1
 15-day-old wild type or loo1 seedlings with roots removed. Channel 2 characteristics for each hybridization: 1
 15-day-old wild type or loo1 seedlings with roots removed. Channel 1 characteristics for each hybridization: 1
 15 meta-groups: 1
 14): 1
 133 status: 1
 120min glucose: 1
 10bp barcode: 1
 104(12): 1
 10112:2064 PMID: 1
 1000 bases): 1
 1000 Genomes dataset: 1
 10): 1
 10 sum total kcal: 1
 10 sum carbohydrate/protein kcal: 1
 1 year) patients: 1
 1 year weight loss %: 1
 1 leu2: 1
 0no: 1
 0: no/censored): 1
 02 exposure: 1
 0-no): 1
 0-female): 1
 0 total subchromosomal and chromosomal lesions: 1
 0 - less than 50y): 1
 0 - less than 10mm): 1
 -barcode: 1
 - chlorambucil: 1
 +der(7)t(7;7)(qter-p15:: 1
 ): 1
 (2004) Cell 117(1): 1
 (2004): 1
 (1997) Mol Cell Biol 17: 1
 'Tissue: 1
 'Genotype: 1
 'Factor: 1
 'Age: 1
 %predicted fvc pre-bd: 1
 %predicted fvc post-bd: 1
 %predicted fev1 pre-bd: 1
 %predicted fev1 post-bd: 1
 %predicted dlco: 1
 %nkts: 1
 %emphysema f-950: 1
 %cd8cd62l- cd45+: 1
 %cd8cd62l- cd45 -: 1
 %cd8cd62l+ cd45+: 1
 %cd8ccr7-cd45+: 1
 %cd8ccr7-cd45 -: 1
 %cd8ccr7+ cd45-: 1
 %cd8ccr7+ cd45+: 1
 %cd8+cd28-: 1
 %cd8+cd28+: 1
 %cd8 cd62l+ cd45-: 1
 %cd4foxp3+: 1
 %cd4cd8-ab+(dn): 1
 %cd4cd62l+cd45-: 1
 %cd4cd25cd62l: 1
 %cd4 cd62l-cd45+: 1
 %cd4 cd62l+cd45+: 1
 %cd4 cd62l - cd45-: 1
 %cd4 ccr7+ cd45+: 1
 %cd4 ccr7+ cd45 -: 1
 %cd4 ccr7 - cd45+: 1
 %cd3gammadelta: 1
 %cd3delta2: 1
 %cd3delta1: 1
 %cd3cd8: 1
 %cd3cd4: 1
 %cd3alphabeta: 1
 %cd3-cd56+cd16+: 1
 %cd19: 1
 %bw: 1
 %Foxp3+ after restaining: 1
 % mapped: 1
 % fall in fev1 late: 1
 % fall in fev1 early: 1
 % blasts pb/r: 1
 % blasts pb/dg: 1
 % blasts: 1
 #pulses: 1
 #pooled microdissections: 1
 # samples pooled: 1
 # plants/sample: 1
 # months follow-up: 1
 # months between diagnosis and bm development: 1
 # cells: 1
 organism part: 1
 19812: 1
 3612: 1
 2002: 1
 1358: 1
 400: 1
 171: 1
 65: 1
 41: 1
 18: 1
 7: 1
 2: 1
 1: 1
 0: 1